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A generalist starts by knowing a little about 
a lot. With the course of time he comes to know 
less and less about more and more until he 
finally knows nothing about everything.
A specialist initially knows quite a lot about 
quite a little. Gradually he comes to know 
more and more about less and less until he 
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SUMMARY
In the Introduction the importance of N-dealkylation in pharm­
aceutical studies is summarised and the scope and potential advan­
tages of microbial transformations in effecting N-dealkylation 
are examined. Possible applications of chromatographic and 
spectroscopic techniques to the study of microbial transformations 
are discussed.
Chapter 2 describes the development of quantitative HPLC 
techniques for the determination of a model substrate codeine, 
and its N-demethylated transformation product, norcodeine, from 
microbial transformation mixtures. Extraction procedures 
applicable to 7 litre fermenter cultures are also investigated.
The effect of carbon source and substrate concentration 
on the growth and N-demethylation of codeine, by Cunninghamella 
sp. are investigated in Chapter 3.
Chapter 4 describes the development of procedures for the 
preparation of a cell-free extract from Cunninghamella sp. with 
optimal N-demethylase activity. Reaction conditions for N- 
demethylation of codeine by cell-free extracts of C. bainieri 
are optimised in terms of substrate concentration and co-factor 
requirements.
Kinetic data for the N-demethylation of codeine and codeine
VI
N-oxide by C. bainieri are presented in Chapter 5. The effect 
of selected inducers and specific enzyme inhibitors is also 
examined. A reaction mechanism for the N-demethylation of codeine 
by cell-free extracts of C. bainieri is proposed.
Chapter 6 describes the development and application of a 
^^C NMR spectroscopic technique to detect the possible intermediates 
in the N-demethylation of codeine by cell-free extracts of C. 
bainieri, and provides further evidence in support of the proposed 
reaction mechanism.
In Chapter 7 a HPLC technique is employed to estimate the 
lipid solubility of a selected series of 1,4-benzodiazepines 
from retention data. The dependence on substrate lipophilicity, 
of N-dealkylation of these compounds by C. bainieri, is examined.
The data are considered with reference to current microbial 
transformation literature. The proposed mechanism of microbial 
N-demethylation is compared to mammalian transformations of 
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ORIGIN AND SCOPE
This project arose out of difficulties experienced by medi­
cinal chemists in effecting N-dealkylation reactions by direct 
chemical means.to prepare useful drug intermediates. Previous 
workers at Bath envisaged that microbial N-dealkylation procedures 
may provide a safer and more efficient alternative to chemical . 
methods. Subsequently, they developed a microbial transformation 
system in which several species of the fungus Cunninghamella 
demonstrated the ability to N-demethylate codeine and a wide 
variety of drug molecules.
The studies reported in this thesis are concerned with 
further developments in this field of research. It was hoped 
that analytical techniques would be developed to enable a more 
detailed examination of the transformation processes involved.
At -the same time, it would be necessary to prepare from the micro­
organisms cell-free extracts which maintain high N-dealkylation 
activity. This would enable the N-dealkylase enzyme(s) to be 
characterised. Of particular interest would be the elucidation 
of the mechanism of microbial N-dealkylation of the model substrate, 
codeine, since this would facilitate optimisation of the reaction.
It was also intended to extend these studies to investigate 




1.1 The pharmaceutical importance of N-dealkylation of drug molecules
N-alkyl functions are present in a wide variety of drug molecules, 
usually in saturated cyclic structures or alkylamine chains. In the 
design of a new drug it is often required to remove the N-alkyl 
function from the parent drug to form the nor-intermedia te, and 
replace it with different N-substituents. This can be done to 
establish relationships between the chemical structures of a series 
of drugs and pharmacological activity. With this acquired knowledge 
it is possible to predict and design more selective products.
This is demonstrated by the classification of the 1,4-benzod-
1 2iazepine group of anxiolytics where studies by Sternbach et al. '
demonstrated that these compounds were biologically active, provided
that they possessed the 1,4-benzodiazepine ring system with
both 7-chloro and 5-phenyl groups. The data in Table 1.1
illustrates how the modified N-substituent significantly affects
the plasma half-life of the drug, and its presumed duration of 
3action .
1.2 Chemical methods of N-dealkylation
The N-dealkylation of tertiary amines has traditionally been
4effected by the Von Braun reaction employing cyanogen bromide. 
This reagent is extremely toxic, and by this procedure low or 
variable yields of the N-dealkylated product are often obtained^.
Table 1.1. Effect of N-substituent variation on the classification 
of benzodiazepines according to duration of action.
H-Ç-R
Cl
Drug ^3 ^2 Half-life*(hours)
Class of 
drug
Oxazepam OH H -H 5-15 Short acting
Diazepam H H -CH3 26-53 Moderate
long-acting
Prazepam H H 30-100 Long acting
Flurazepam H F -CH CH N
^ E t
40-200 Very long 
acting
* Plasma half-life in normal humans.
4
especially when complex alkaloidal molecules such as codeine are 
N-demethylated by this technique^.
Subsequently, the Von Braun procedure has been superseded
by alternative methods of N-dealkylation, in particular, those
utilising chloroformate esters. These often improve selectivity
7and produce cleaner reaction products . Chloroformâtes react
with tertiary amines to give carbamates, and these are hydro-
5lysed to give the corresponding secondary amine .
CICO R Hydrolysis
R1R2N-CH3 -------- -— ^  R^RgNCOgR ----------- >  R^RgNH
However, studies by Gadamer and Knoch on the effect of ethyl 
chloroformate on a variety of cyclic tertiary amines found that
the N-methyl function of alkaloids such as morphine and tropine
8 5 9were not cleaved . Phenylchloroformate and vinylchloroformate
have been found superior to ethyl chloroformate in the cleavage
of tertiary amines. More recently 2,2,2-trichloroethylchloro-
formate^^ and its derivatives have found wide application as
protective groups to give carbamate intermediates. These are easily
hydrolysed by treatment with zinc and acetic acid. Although N-
demethylation with chloroformâtes may give satisfactory yields in
many cases^'^'^^ they are all potent 1achrymators and potentially
hazardous reagents. Other chemical methods of N-dealkylation
have been tried with limited success. For example, diethylazo- 
12carboxylate , and a photochemical procedure in the presence 
of oxygen^^. Clearly there is a requirement for an alternative
N-dealkylation technique to improve product yields,and to eliminate 
the hazardous and toxic reagents used in existing chemical methods.
1.3 The scope and potential advantages of microbial transformations
A microbial transformation can be described as a simple, 
specific chemical modification of a substrate, effected by microbial 
enzymes, to produce a closely related product. In the case of 
N-dealkylation, the N-alkyl group is cleaved from the parent 
structure to leave an N-H bond.
'^N-CH^R ------- >  ^NH + RCHO (R = hydrogen or
alkyl)
Since the earliest microbial transformation reported by 
14Pasteur in 1864, the production of vinegar from ethanol, 
microbial transformation studies have progressed considerably.
A wide range of substrates have been transformed, and a variety 
of reaction types have been effected by microorganisms^^.
These include oxidation, reduction, hydrolysis, dehydration, 
condensation and isomérisation reactions, and also the formation 
of new carbon-carbon or hetero-atom b o n d s I t  has been 
estimated that there is probably an enzyme catalysed equivalent 
for every type of chemical catalysed reaction^^. Furthermore, 
microbial transformations offer a potential alternative to existing 
chemical methods of N-dealkylation.
There are a number of potential benefits of using microbial
methods to synthesise drugs, as opposed to chemical methods.
Primarily, microbial transformations may give rise to increased
and more consistent yields. They are usually specific with
respect to a particular substrate or a reaction type^^, and
some reactions that are not chemically possible may be mediated
by microorganisms^^. It may even be possible to achieve several
15coupled reactions in one transformation step . In addition, 
microbial transformations are normally conducted under mild 
conditions, in aqueous media, with cheap raw materials as growthf'
media, so they are generally economical. Especially as the un­
reacted starting material may be recovered and recycled^^.
The mild conditions may also ensure that complex medicinal
compounds are not decomposed in the transformation mixture,
17especially if the compound is acid, base or heat labile
However, some disadvantages that may be incurred with micro­
bial transformations should also be considered. These include 
the necessity to operate under sterile conditions, the high 
energy consumed in sterilising procedures, and the expense of 
recovering and purifying the transformation product^^.
1.4 Studies on the microbial N-dealkylation of drug molecules
Previous workers at Bath envisaged that a microbial trans­
formation system, capable of effecting the N-dealkylation of 
drug molecules, could be developed to overcome the difficulties 
experienced by medicinal chemists in preparing useful drug inter­
mediates. The system may also be of value in drug metabolism studies,
18The initial studies carried out by Sewell were concerned with 
the development of a microbial process with the capacity to 
N-dealkylate a variety of pharmaceutically important compounds.
He selected a series of 'model' compounds for the initial screening 
experiments with me thy lotrophi c Pseudomonads. This enabled the 
N-alkyl function to be presented in several of the different 
chemical environments typically encountered in pharmaceuticals.'
The structures of the 'model' test substrates are shown in Figure
1.1. Trimethylamine (1) represented the simplest tertiary aliphatic 
amine. N-methylpiperidine (2) is a simple tertiary amine in a 
saturated cyclic structure. Codeine (3) is a naturally occurring 
alkaloid based on a phenanthrene ring structure which is common 
to the family of morphine-like analgesics. In addition to the 
N-methyl functions, it also possesses a phenolic methyl ether, 
thus offering sites for both O- and/or N-demethylation.
Tropinone (4) represented the molecular nucleus typically found 
in the naturally occurring tropane family of alkaloids. Penta­
zocine (5) is a typical example of a 6,7-benzomorphan analgesic, 
and was included in the screening programme to determine the 
ability of the test microorganisms to cleave a bulky nitrogen 
substituent.
Screening experiments with me thylotrophic Pseudomonads sugg­
ested that the N-dealkylating capability of these microorganisms 
was limited to simple aliphatic amines, such as trimethylamine, 
and the screening programme was extended to include strains of 
Streptomyces and fungi, mainly species of Cunninghamella,
Figure 1.1. Test substrates selected for screening experiments



















In these studies, he again selected 'model* compounds to be 
representative of the main classes of nitrogenous drug molecules 
of pharmaceutical interest (Figure 1.2).
Amitriptyline (6) a tricyclic antidepressant drug, with 
its dime thy lamino group part of a propylid&ne side chain,may 
be N-demethylated to produce nortriptyline, and again to produce 
desmethylnortryptyline. Chlorpromazine (7), a central nervous 
system depressant, may be N-demethylated at the dimethyl- 
aminopropyl side chain to give the secondary amine (8) des- 
methylchlorpromazine, and again to produce the desdimethyl- 
derivative. In addition, the entire dimethylaminopropyl group 
may be cleaved from the phenothiazine nitrogen *tom. Desmethyl- 
chlorpromazine (8) was screened separately as it presented a 
secondary amine system for transformation. Diazepam (9) is a 
member of the benzodiazepine gro\ç> of minor tranquilizers, and 
was included because it is a cyclic amide, and not an amine. 
Metazocine (10) is a synthetic analgesic representative of 
the 6,7-benzomorphans. Codeine (3) was also screened to test the 
selectivity of microorganisms for O and/or N-demethylation. These 
microbial transformation experiments were conducted in submerged 
liquid culture, and demonstrated the ability of several of 
these microorganisms to N-demethylate the drug molecules.
A few of the Streptomyces species were able to transform 
one or two of the test compounds. S, lincolnensls N-demethylated 
codeine, metazocine, and amitriptyline to nortriptyline and also
10
Figure 1.2. Chemical structures of model substrate compounds



















to desmethylnortriptyliner S. rimosus N-demethylated diazepam
and amitriptyline, and S. paucisporogenes N-demethylated codeine
only. However, the most promising microorganisms screened were
the Cunninghamella since all test substrates, with the exception
of pentazocine, were N-dealkylated by several species of this 
18genus
18Continuing these studies, Sewell developed defined and 
semi-defined growth media to facilitate the quantitative investi­
gation of various growth medium parameters on N-demethylation.
C. echinulata IMI 199844, was selected as the test organism 
since the strain had demonstrated the N-demethylation of a 
wide range of compounds with product yields estimated to be 
superior to those achieved by other active organisms. Codeine 
was selected as the substrate for these studies, and in order to 
quantify the transformation results, norcodeine, the trans­
formation product, was estimated by GC assay, and the microbial
growth by determination of dry cell weight. On the basis of
18both microbial growth and codeine transformation, Sewell was 
able to ascertain the most suitable growth medium for futther 
transformations. Transformation experiments conducted in culture 
media containing carbon sources which supported a rapid microbial 
growth rate , e.g. maltose, gave low conversions to norcodeine, 
whereas cultures containing a less utilised carbon source such 
as succinate produced higher transformation yields of norcodeine. 
A carbon source regulatory mechanism was suspected.
Casein hydrolysate, an organic nitrogen source, added to
12
the culture media, improved microbial growth and codeine trans­
formation. Further investigations with the 13 individual amino- 
acids found in casein hydrolysate, omitting each one in turn 
from the culture media, showed that only the absence of leucine 
resulted in an increase in microbial growth and codeine trans­
formation. This 'modified' amino acid mixture, containing the 
remaining 12 amino acids, was adopted in preference to casein 
hydrolysate, or inorganic nitrogen sources, such as ammonium 
sulphate and sodium nitrate, as it gave the highest yi&ld of 
norcodeine.
The addition of a vitamin supplement to the growth medium
produced no significant effect on transformation, and was
subsequently omitted. However, the substrate concentration,
in the medium was critical and concentrations above 1 mM reduced
the transformation dramatically, probably due to substrate 
18inhibition
Further studies with C. echinulata disclosed that it exhibited 
typical pelleted fungal growth with cube root, rather than expon­
ential kinetics. The growth curve, of dry cell weight against 
incubation time exhibited a short lag period, followed by a slow 
growth phase which continued up until the fourth day of incubation. 
Cell lysis, measured as the leakage of 260 nm absorbing substances 
from the cell, and the extracellular protein concentration, both 
increased until the seventh day of incubation and then levelled 
off. This suggested that codeine transformation was not dependent 
upon cell lysis as a means of enabling contact between the codeine
13
substrate and N-demethylating enzyme system. The extent of 
fungal growth was found to be limited by carbon source exhaustion 
which occurred between the fifth and sixth days of incubation. 
N-demethylation occurred only after the glucose carbon source had 
been depleted, providing further evidence for the presence of 
a carbon source regulatory mechanism. This was attributed to 
catabolic repression rather than catabolic inhibition, supported 
by subsequent experiments with resting cell suspensions. Cells 
harvested from cultures in which carbon source depletion was 
incomplete were unable to effect significant codeine N-demethyl­
ation when resuspended in basal-salts medium, but cells 
harvested from cultures in which glucose was exhausted demon­
strated comparable codeine N-demethylation to that obtained with 
growing submerged cultures. These findings suggested an absence 
of preformed N-demethylase in cells harvested prior to glucose 
depletion in the culture medium.
Since C. echinulata IMI 199844 had demonstrated N-demethyl-
ase activity with a variety of different substrates in the
18screening programme, Sewell , proceeded to attepipt.to characterise 
the enzyme responsible for N-demethylation. To do this it was 
necessary to extract the N-demethylase from the fungal cells in 
order to study the enzyme, independent of enzyme production and 
cell permeability effects.
A cell-free extract was prepared from C. echinulata which 
retained a measurable degree of N-demet&ylase activity. The 
success of various enzyme extraction procedures was measured in
14
terms of the supernatent protein concentration after the removal 
of cell debris, and the determination of the formaldehyde produced 
by codeine N-demethylation with the cell-free extract.
18Sewell found the most effective extraction procedure was
homogenisation, with subsequent treatment of the homogenate with
Triton X100,a nonionic surfactant. The homogenisation process
was observed to disrupt the mycelial pellets, and the Triton
XlOO was thought to solubilize the hydrophobic part of the^
enzyme associated with the cellular membrane fragments. Fungal
monooxygenase enzymes which are frequently implicated in oxidative
transformations have been shown previously to be membrane
19,20
associated systems
The N-demethylase activity of cell-free extracts was in-
2+creased by the addition of Fe to incubation mixtures, but
surprisingly reduced by the addition of NADPH. This was thought
to be due to an inhibitory effect of NADPH, also reported by
21Edelson and McMullen for 0-demethylation of p-nitroanisole by
E. coli, but the reasons for this observation remain uncertain.
The C. echinulata cell-free extract exhibited a broad temperature
o o
optimum of around 30 - 32 C, and a pH optimum of 7.5, for the
N-demethylation of codeine. The active component of the cell- 
free extract behaved as a typical monooxygenase enzyme since 
codeine N-demethylase was inhibited by anoxic conditions, CO 
and SKF 525A. Furthermore, carbon monoxide and SKF 525A
22 23are classicial inhibitors of monoo%ygenases whether of mammalian ' 
or microbial^^'^^ origin, therefore Sewell suggested, although
15
he could not confirm, that the C. echinulata codeine N-demethylase 
maybe a typical cytochrome P-450-linked monooxygenase.
1,5 Processing and isolation of the transformation product
It is usually necessary to scale up a microbial transformation
in order to produce usable quantities of the desired transformation.
product^^. The scale of the fermentation employed will be
dependent on the objectives of the project. Screening studies
are usually conducted in small shake flasks containing 5 - 50 ml
medium, whilst preparative scale studies may be donducted in large
Erlenmeyer flasks ,in multi-litre stirred laboratory fermenters
27or in large industrial fermentation equipment . In addition 
to the biological and engineering problems associated with the 
scale of microbial transformations considerable difficulties may 
arise in the detection and analysis of the transformation product 
in relatively large volumes of medium. Often the substrate 
is expensive,or in short supply, or the transformation 
yield may be unavoidably low. In these cases it may be 
necessary not only to detect and assay the transformation product 
in the presence of the substrate and the growth medium components, 
but also to quantitatively separate the product from the substrate 
to facilitate recycling of the untransformed substrate. Separation 
and purification procedures can be expensive and time consuming 
especially on an industrial scale and the economic viability of 
a microbial transformation process will depend upon the careful 
selection of such procedures,
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The choice of the most rapid and convenient separation
procedure requires careful evaluation of. many factors which include
properties of the transformation product itself.such as its
stability, the scale of the operation, the time required,
operation costs and' material costs. A knowledge of the
conditons under which the end product is stable is essential
when selecting a separation procedure. Details of the effect
of pH, temperature, solvent, and light on the compound are 
29required . Extraction procedures may involve drastic changes in 
pH, temperature or other laboratory stresses which could result 
in decomposition of the transformatcLon product.
At the completion of the transformation the end product is
almost always extra cellulcir and dissolved or suspended in the
28microbial growth/transformation medium. In the case of fungal
fermentation, the cellular material can usually be removed from the
medium by filtration, but recovery of the end product requires
29a stepwise process of separations
The relative affinity of a substance for two phases is the
distribution coefficient, frequently expressed as the ratio of
concentration in the two phases. The ratio of the distribution
coefficients for two substances is the separation factor (a)
for the substances in the system under consideration. If the
separation factor value is very large, it is generally termed
a 'group' separation, and if it is small it is termed a
29'fractionating'separation
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The overall isolation of an end product from a fermentation mixture 
usually requires 'group' separation, followed by a 'fractionating' 
separation. Initially , the group separation results in enrich­
ment of related substances from the mixture, including the end 
product, unconverted starting material and some constituents 
of the nutrient medium. ,This process should be as selective 
as possible to eliminate many unwanted compounds. The appli­
cation of the fractionating process serves to isolate the 
end product in high purity and yield.
Substances encountered in transformation studies can usually
be group separated based on their ionic or polar properties,
28often utilising a solvent extraction technique . However, 
many solutes of biological or pharmaceutical interest are weak 
acids or bases and their extraction from aqueous environments 
such as transformation mixtures has proved difficult by conven­
tional extraction procedures. Other classical group > separation 
techniques such as freeze-drying and steam distillation have 
serious limitations in terms of recovery, capacity and possiüe 
loss of sample during processing, especially for temperature- 
sensitive compounds^^.
More efficient separation procedures have been developed
which involve the adsorption of the product onto a solid surface ;
Recoveries of 90 - 100% from aqueous samples have been reported
for a wide range of organic molecules using a macro-reticular
31XAD-2 resin packed in glass tubes . Other materials -.such as
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XAD-4 resins, spherocarb and HPLC packing materials have also been
32used successfully for sample enrichment from biological media 
The aqueous sample containing the end product is injected onto 
the adsorption surface and «.the species becomes immobilised .until 
the elution strength of the solvent mixture is increased. When 
the sample is eluted it is concentrated, prior to the application 
of the final fractionating step.
A fractionating separation method is required to produce 
a product of high purity and good yield. To achieve this a 
counter-current contact of the two phases is necessary, utilising 
a chromotographic method. Over the years, chromatography., in 
its various forms, has found wide application to the analysis 
of drugs in complex solutions because of its ability to isolate 
the compounds of interest. Gas liquid chromatography (G.L.C.), 
has been pre-eminent in the field, although it has always 
lacked the selectivity enjoyed by liquid chromatography with 
its wide choice of stationary and: mobile phases.
1.6. High-performance Liquid Chromatography ( H P L C . )
1.6.1 Advantages^of HPLC in transformation studies
The . advantages of High Performance Liquid Chromatography 
(H P L C ) , like gas chromatography (G C ) lie in the 
combination of sensitivity, efficiency, reliability and speed 
of analysis of the technique . A major advantage of H P L C .  over
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G.C. is the versatility of the technique. As there are a wide 
range of stationary and mobile phases available, HPLC may often 
achieve separations that are impossible by G.C. In addition, 
many organic compounds are too unstable or insufficiently volatile 
to be handled by G.C. without prior modification or dérivâtisation. 
Although derivatisation is not required for separation in HPLC, 
sensitivity can be dramatically enhanced by the formation of 
strongly U.V. absorbing^^ or fluorescent derivatives^^
(either chemical or physicochemical e.g. ion pairing).
There is a wide choice of detectors available for use .iin
HPLC The most widely used detector is the ultra-violet (U.V.)
29photometer , but others include electrochemical, fluorescence 
and refractive index detectors. Many of these detectors are 
selective so a complète separation need not necessarily be made 
on the column but a detector can be chosen that will monitor 
only the species of interest.
Finally, recovery of the sample in HPIÆ can be achieved 
more easily and quantitatively than in G.C., and this is possible 
on a much larger scale using preparative liquid chromatogr^hy.
The lower temperatures that are used in HPLC complement the 
mild conditions used in microbial transformations when dealing 
with heat labile products. In addition, HPLC columns tend to 
have a long working life without regeneration. These particular 
advantages make HPLC a most suitable fractionating separation 
procedure to use in transformation studies.
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1.6.2 Stationary phases
Liquid chromatography phase systems may be described as 
being either straight (or normal) phase or reversed phase, 
according to the nature of the mobile and stationary phases.
In straight phase systems the stationary phase is more polar 
than the mobile phase, which typically is a mixture of organic 
solvents. In reversed phase, the stationary phase is non-polar 
and the mobile phase is polar, usually aqueous, in combination 
with an organic modifier.
37In HPLC the stationary phase may be a pellicular or porous
solid such as silica^^, alumina^^ or carbon^^, a resin^^
or a liquid physically bound to an inert support. The
development of chemically bonded phases constitute another type,
42and are now the most widely used . The majority of modern bonded 
phases are prepared from silica by reacting the surface silanol 
groups with an organochlorosilane or alkoxysilane to give an 
Si-O-Si-R linkage which is hydrolytically stable. The R group 
is usually a straight chain hydrocarbon of known and uniform 
chain length (e.g. C8 or C18) or a hydrocarbon with a polar 
terminal group (e.g. R-CM, R-NH^) . Thus the bonded phase may 
range from polar to non polar depending on the type of terminal 
group.
Bonded phases may possess cross-linkages between the hydro­
carbon chains, and these are described as being polymeric in 
form. More commonly, the bonded moiety is arranged at right
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angles to the solid surface to achieve a 'brush-type' orientation. 
The Si-O-Si bond is generally stable over a pH range of 2 to 7.5. 
which can limit its usefulness. The polar hydroxyl groups re- 
m aining on the surface of the silica after bonding can be removed 
or 'capped' by reaction with a small chlorosilane such as tri- 
methylchlorosilane. Both capped and uncapped bonded phases are 
available commercially in a range of products.
1.6.3 Retention mechanisms
a) Liquid solid adsorption chromatography :
Polar inorganic materials such as silica or alumina 
are most often used, and the mobile phase is predominantly an 
organic solvent mixture. The surface of silica consists primarily 
of slightly acidic silanol groups which may be associated with 
water molecules via hydrogen bonding. Silica is heated to 
150°C to drive off the associated water and increase the surface 
activity. Retention and selectivity are the result of adsorption 
of the polar or polarizable functional groups of the solute 
molecules directly onto the surface of the packing. The adsorption 
interaction is the displacement of mobile phase molecules from the 
adsorbent surface by the solute in a competitive reaction. In the 
absence of steric effects, solute retention is proportional to 
the relative number and.type of polar functional groups in the 
solute.
This mode of chromatography has an important role in thin 
layer chromatography, preparative scale column chromatography
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and straight phase High Performance Liquid-Solid Chromatography 
(HPLSC) in the separation of moderately polar solutes.
(b) Partition (Liquid-Liquid Chromatography ):
Retention of the solute is due to the partitioning
between the mobile phase, and the organic phase physically coated 
onto the surface of the particle. The stationary phase is usually 
polar, and is immiscible with the mobile phase. These phases are 
rarely used today having been superseded by chemically bonded 
phases.
(c) Bonded phase chromatography:
Bonded phases with non-polar functional groups (C^-C^g) 
are the most widely used materials in HPLC, especially hydrocarbons 
Cg and C^g or octadecylsilane (ODS). These are available as a 
ragge of products that vary in their percentage carbon loading, 
the extent of silanol capping, the surface area, and the particle 
size and shape of silica to which it is bonded. The mobile phase 
is usually aqueous and buffered at a pH that enhances selectivity. 
It may contain an organic modifier,such as methanol or acetonitrile 
to adjust the retention. It has been shown that provided the 
amount of organic modifier is enough to wet the surface of the 
bonded phase, then a monolayer of organic modifier is adsorbed 
at the hydrocarbon surface^^. This layer is not displaced by 
solute and so must take part in the retention mechanism.
However, the retention mechanism is complex and not fully
44understood. It has been proposed that solutes having some
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hydrophobicity are squeezed out of the aqueous mobile phase and 
into the hydrocarbon brush because solute interactions with 
water are weaker than interactions between water molecules. This 
is called the Hydrophobic Effect. Increases in carbon loading 
and chain length enhance the hydrophobic surface area, and hence 
retention. Interactions between polar functional groups on the 
solute and water will reduce retention, and explains why pH 
control is important when dealing with ionizable solutes.
(d) lon-Pair Chromatography
This is a special form of Liquid-Liquid Chromatography 
used for the separation of ionic or ionizable compounds. In 
its most usual form it is used in the reversed phase mode, in 
which the aqueous mobile phase containing organic modifier, 
buffer and pairing ion is passed through a hydrocarbon bonded 
stationary phase. The mechanism of retention is subject to 
debate^^ although two mechanisms have been proposed, the 
partition mode and the ion-exchange mode. In the partition 
mode, the ionizable solute has insufficient lipophilic character 
to be retained, and forms an ion-pair with a suitable counter­
ion (or ion-pair agent) added to the mobile phase. The ion- 
pair has increased lipophilic character and increased affinity 
for the stationary phase. In the ion-exchange mode the polar 
counter-ion is assumed to be absorbed by the hydrocarbon stationary 
phase to create an ion-exchange site onto which the polar sample 
molecule is adsorbed much as in ion-exchange chromatography.
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In ion-pair chromatography the control of pH, the size and 
nature of the counter-ion, and to a lesser extent, the nature of 
the stationary and mobile phases all have an effect on the degree 
of selectivity. In the pH range 2 - 8  strong acids and bases 
are completely ionized, weak acids and bases will be ionized 
depending on the pH chosen. If the equilibrium
non ionic ionic
lies to the left they elute as non-ionic components on a non­
polar stationary phase. If the equilibrium lies to the right they 
can interact with the ion-pair agent as for strong acids or bases.
1.6.4 Definitions
The following expressions have been employed in order to 
assess various chromatographic parameters used in this thesis.
(a) Retention:
The term used to describe solute retention in column 
and gas chromatography is the column capacity ratio, k. The 
retention and therefore the separation of components in a 
mixture will depend on the distribution of each component between 
the two chromatographic phases.
K = ^  D §2. ... 1.1I Cm.Vm Vm
where C and V are the solute concentrations in, and the volumes
















D is the distribution ratio of the solute between the two phases, 
In practice the capacity ratio may be determined from
< = .V
to
where t_ and t are the elution times or chart distances of the 
°retained or unretained peaks respectively (Fig. 1.3).
(b) Band broadening:
As a solute band passes through the column, the width 
of the band increases as the solute is diluted by the mobile 
phase. Band width, W, is commonly expressed in terms of the 
theoretical plate number, N, of the column and is a useful 
measure of column efficiency, i.e. the relative ability of a 
given column to provide narrow bands and improved separations. 
The number of theoretical plates N of a chromatographic systen 
may be defined from a single chromatographic band(Fig. 1.3)
1.3
where t , W , and  ̂are the retention time, width at 0.1 of R 0.1 0.5
the peak height (h^ )̂ and width at half the height (h^ )̂ of
the peak, respectively. The peak width measurement  ̂takes
into account peak tailing at the lower parts of the elution
curves, and gives a more realistic measurement of column
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In comparing column efficiencies a more useful parameter 
is the height equivalent to a theoretical plate (HETP) or plate 
value (H)
H = —  ... 1.4
N
where L is the length of the column and H measures the efficiency 
of the column per unit length.
The reduced plate height, h, is a measure of column packing 
performance taking into account the particle size, dp,
. H _ _h = —  ... 1.5dp
where dp is the diameter of the stationary phase particles.
(c) Velocity:
The flow rate (ml/min) is a measure of the volume flow 
of mobile phase through the column. Linear velocity (u) is a 
measurement of flow rate independent of the cross-sectional 
area of the column
L _ _u = —  ... 1.6
o
and the reduced velocity, v is a term independent of particle 
size and mobile phase characteristics, e.g. viscosity, given 
by
V  = u ^  ... 1.7Dm
where Dm is the diffusion coefficient of the mobile phase.
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Experimental values of reduced plate height h obtained from 
Equation 1.5 plotted against reduced velocity v of mobile phase 
for a given solute and set of conditions, produce a typical 
l^nox curve.This can be used to determine the most efficient 
flo-W rate for a particular sample (Fig. 1.4).
(d) Resolution and Selectivity:
The degree of resolution R^ of two adjacent solute bands 
is defined by the empirical relationship
R = ... 1.8
+ W^)
where t is the elution time or chart distance of solutes A and R
B and W is the width at the base of their peaks (Fig. 1.3).
In theory an R^ value of 1 would give complete separation at 
the baseline, but in practice, because the peaks are Gaussian 
in shape, a R^ value of 1.2 is usually required for a base 
line separation.
47Purnell has shown that for column chromatography the 
resolution (R̂ ) can be related to the average capacity ratio 
(k) , the relative retention (a) and the number of theoretical 
plates (N) by the relationship :
R = i  . /n. •••s 4 a 1+ K
(i) (ii) (iii) 
where the relative retention value a compares the degree of 
retentivity of one peak with another and is given by:
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a = —  for peaks A and B ... 1.10
Each term (i) to (iii) in equation 1.9 can have an independent 
effect on resolution. The column selectivity (term (i)) is varied 
by changing the composition of the mobile and/or stationary 
phases, and to a lesser extent, the temperature. An increase in 
column efficiency N (term Xii))will increase the resolution.
This is achieved by using a longer column, reducing the solvent 
velocity or employing a different column packing material. 
Finally, relative retention (term (iii)) is varied by changing 
the mobile phase composition.
(e) Peak shape:
The symmetry factor at 10% of the peak height (A^^^)
can be described as
2 r
10% r + s 1.11
where r and s are measurements at 10% of the peak height illustrated 
in Fig. 1.3. Ideally a value of A^^^ of 1 is required. The effect 
of sample loading on peak shape and symmetry are reported in 
Section 2 of this thesis.
(f) Functional Group Contribution Value :




T = log a = log —  ^
1
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where k are the capacity ratios of solutes 1 and 2 which differ 
by a functional group. The reference solute 1 is taken as the 
parent compound. Values of x for a series of 1,4-benzodiazepines 
are reported and discussed in Section 7.5.
(g) Porosity:
The total porosity of a column (e) is the sum of the 
interparticle porosity (e^) and the porosity of the individual 
particles where :-
_ volume of spaces between the particles ^
I volume of the column tube
volume of pores _ _ .and e = ■ ■ ̂   _■--------— — :---  ... 1.14p total volume of the particle
so E = ^   1.15
In practice the total porosity (e) can be determined from
F X t . - ̂Vm c o ...1.16e = ---- -z—  = -----------
A  d u 19.625 X L4 c
where F^ is the flow rate in ml/sec, t^ is the elution time of 
an unretained peak (seconds) and L is the column length in metres, 
The total porosity is estimated for all newly packed columns.
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1.7 Nuclear Magnetic Resonance (N.M.R.)
1.7.1 General principles of N.M.R.
The basic principles of Nuclear Magnetic Resonance (NMR)
52 53are reviewed in several spectroscopy reference books ' ,
hence, the following is a brief summary of the necessary concepts.
Many atomic nuclei possess intrinsic angular momentum, 
a property characterized by the spin quantum number (I). For 
such nuclei there.are 2 1 + 1  allowed spin states. Those nuclei 
with I = *2 (̂ H, ^^N, fall into the most common NMR
category where only two states are possible. In the presence of 
an applied magnetic field these spin states correspond to 
different energy levels and it is the transitions between these 
levels that are detected by NMR spectroscopy. In the NMR 
e3q)eriment the net absorption of electromagnetic radiation by 
the nuclear spins is detected as a resonance, frequency between 
the two spin states. The frequencies at which signals are 
observed depend on the energy differences between spin states, 
which in turn are dependent on the magnetogyric ratio (V) of 
the nucleus under observation, the strength of the applied 
field, and the electronic environment of the resonant nucleus.
Excited nuclei return to their ground spin population in 
two ways. By transfer of energy to neighbouring nuclei in 
the molecular framework or lattice (spin-lattice relaxation), 
with an assoc iated time constant (T^), the spin-lattice relaxation
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time. Secondly, by mutual exchange of spins between excited 
nuclei and neighbouring nuclei (spin-spin relaxation) with 
an associated spin-spin relaxation time (Tg), which affects 
the natural line width of an NMR absorption peak.
The field experienced by a particular nucleus in a molecule 
differs from the applied field by a small amount depending on 
the screening (deshielding) effect of surrounding electrons.
The extent of deshielding, the chemical shift, is expressed 
relative to a standard in parts per million (ppm) and is thus 
independent of the applied field. chemical shifts are
normally measured relative to tetramethylsilane (TMS, O ppm) 
and usually fall within the range O - 210 ppm.
NMR spectroscopy is a relatively insensitive spectroscopic
technique compared with other spectroscopic techniques (U.V.,
52I.R.) . This is due to the small energy difference between spin
states resulting in only a slight population imbalance in favour
of the ground state, and because the signal is proportional to
the population difference, a relatively small proportion of
nuclei are accessible to the environment. Furthermore, as excited
-2 8 ■states are relatively long lived (in the order of 10 - 10 sec.
for ^^C), the application of excessive power leads to equalization 
of spin populations (saturation) with no net emission of energy.
There are also significant differences in sensitivity
13existing between nuclei. Hence, a c nucleus gives rise to only
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l/64th of the signal that a proton would yield. In addition, 
isotopes vary in their natural abundance. For example, 
and are present in nature in high isotopic abundance, whilst 
occurs as only 1,1% of total carbon.
1.7.2 Techniques for recording NMR spectra
To overcome the sensitivity problem it is possible to 
record several spectra from a sample and add them together.
The signal-to-noise ratio (S/N) will improve by the square root 
of the number of spectra accumulated. Using digital computers 
to store and add the spectra it is possible to accumulate 
numerous spectra (scans) in this manner. Using a conventional 
continuous wave (C.W.) spectrometer, radiation at a single 
frequency is slowly swept across the magnetic field spectral 
width. The main disadvantage of this technique is the time
taken to record a continuous scan from low field to high field
(100 - 500 seconds). Consequently the time taken to obtain a 
spectrum can be incredibly long,sometimes prohibiting its use.
The advent of routine Fourier Transform spectrometers, 
equipped with a computer, has given a solution to the problem. 
In the pulse technique all the frequencies in a spectrum 
are irradiated simultaneously at constant magnetic field by 
employing a strong radio frequency pulse of 5 - 50 ysec.
duration over a broad band width. When the pulse is switched
off the nuclei undergo relaxation processes and re-emit the
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energies simultaneously in a complex interacting pattern, which 
decays rapidly and is called the free induction decay (F.I.D.).
This output is digitalised in a computer, and each individual 
frequency is filtered out from the complex pattern. Each of 
these frequencies in plotted on a linear frequency scale, which 
corresponds to the conventional nmr spectrum. The FID is a 
time-based process, a measurement of intensity as a function of 
time. Transformation to the frequency domain signal used in C.W. 
measurements can be carried out mathematically by a process 
known as Fourier Transformation (F.T.). This is achieved in modern 
spectrometers by the same computer which is used to accumulate 
and store the data. After excitation by one pulse, the nuclei 
cannot be re-excited until T^ (the spin-lattice relaxation time) 
has elapsed. The time for this is usually short,approximately 
2s. allowing for the pulse itself, acquisition time and pulse 
delay, and many pulses may be made over a relatively short period 
of time to produce a final spectrum with an acceptable signal- 
to-noise ratio..
1.7.3 Proton noise decoupling ( COM)
The low natural abundance of carbon-13 may produce a 
sensitivity prcblem in carbon-13 magnetic resonance spectroscopy, 
but it also has one advantage. It is unlikely that two carbon-13 
nuclei will be in adjacent chemical positions in the same 
molecular structure, so that the possibility of finding two 
coupled carbon-13 nuclei . is negligible. The absence of carbon-
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carbon couplings simplifies the spectra greatly.
However, carbon-proton (^^C-^H) coupling does occur, and 
this can produce extensive multiplets which may overlap in the 
spectra. As a result it may be difficult to assign the peaks 
corresponding to different carbon-13 nuclei. In addition, the 
sensitivity is seriously reduced.
To overcome this problem, a proton noisa-decoupling technique 
is applied to simplify the spectrum. This procedure depends 
upon strongly irradiating all protons in the sample with a second 
intense band of radio frequency, so that their spins are effect­
ively decoupled. The carbon-13 nmr spectra are then observed as 
single sharp lines rather than as complex multiplets. Since 
interaction, with neighbouring nuclei (usually protons) is a major 
pathway for spin-lattice relaxation of nuclei, irradiation 
at proton resonance frequencies will increase the population 
differences between spin states and lead to an enhancement of 
signal strength. This phenomenon is known as the Nuclear 
Overhauser Effect (NOE). The signals of nuclei directly 
bonded to protons give a NOE of approximately 3x, in addition 
to enhancement brought about by collapse of spin multiplets.
1.7.4 Off-resonance decoupling (OFR).
Proton noise decoupling simplifies the nmr spectra, but 
all the coupling information is lost, so that fully decoupled
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spectra may be difficult to assign. One way of overcoming- this
problem is by employing the technique of off-resonance decoupling
(OFR). A partially decoupled spectrum is obtained by setting
the proton decoupling frequency between 1000 - 2000 Hz above
TMS (i.e. 1000 - 2000 Hz outside the proton region) and turning
13 1the noise modulation off. Under these conditions all the C - H 
couplings (H attached directly to carbon) and these one-bond 
couplings will be reduced to about 30 - 50 Hz in magnitude.
Hence, primary carbons will appear as quartets, secondary carbons 
as triplets, tertiary carbons as doublets and quaternary carbons 
as singlets.
1.8 Applications of N.M.R. to biosynthetic and metabolic 
studies
NMR spectroscopy offers several advantages when applied to
biosynthetic problems as it is probably the only technique
which can separately detect the presence of isotopes of all bio-
synthetically useful elements (̂ H, ^H, ^^N, ^^O, etc.)^^.
Like other spectroscopic techniques NMR is non destructive, so
samples can be recovered and utilised for other analytical 
57techniques . Furthermore, it is capable of directly determining 
the locations and concentrations of isotopic labels in a metabolite. 
Spin coupling effects can provide direct evidence for the incor­
poration of intact biogenic units, and for biosynthetic processes 
involving bond formation and cleavage. Such information can only
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be deduced Indirectly by other methods^^. The use of 
spin-lattice relaxation data (T̂ ) can provide a considerable 
aid to the assignment of carbons, for example, in molecules 
containing large numbers of carbon atoms, where serious overlapping
of the multiplet structures limits the use of off-resonance
n * 54decouplings
The availability of materials enriched with istopes, 
in particular, has simplified biosynthetic studies of microbial 
metabolites^^. It is possible to follow the incorporation of 
labelled precursors into molecules by means of and 
NMR, and in many cases, spectral analysis of the labelled product 
permits detection and identification of the incorporation sites, 
without need for chemical degradation^^. Biosynthetic in­
formation can be obtained from the assignment of resonances. 
Selective enrichment may simplify assignments as chemical shifts 
and coupling patterns (e.g. in off-resonance decoupled spectra) 
may be more easily identified following enrichment. Ambiguities 
due to partial overlap can often be resolved. For example,
biosynthetic enrichment has been used to assign resonances in
59the complex spectrum of gramicidin , and chemical introduction 
13of C labels was used to distinguish the resonances of the four 
meso carbons in protoporphyrin IX^^.
1.8.1 Labelling techniques
13Labelling with stable isotopes, for example C employs
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similar procedures to radioisotope labelling.However, it is 
normally necessary to obtain a higher degree of enrichment, 
because measurements are far less sensitive than radioactive 
labelling techniques, and also because enrichments are 
measured against a 1.1% natural abundance background.
The degree of enrichment of into the precursor over the 
natural abundance of 1.1% depends on the amount of ^^C-labelled 
product required for identification. Normally, the level of 
enrichment must be 0.5 - 2% above the natural abundance 
to be detectable. High enrichment levels (e.g. 90% allow
a lower yield of metabolite to be detected. The simplest way 
of incorporating labelled atoms is to employ a precursor 
containing a single specifically enriched carbon atom. For 
example, using enriched acetic acid as the precursor it is 
possible to employ molecules selectively labelled at either the 
1 or 2 position (* denotes the site of enrichment)
*CH^ - COOH CH^ - *COOH
13 132 - C acetic acid 1 - C acetic acid
The creditability of the method can be illustrated by a study
on the biosynthesis of Cytochalasin B, a member of a group of
56compounds displaying cytostatic activity . Radiotracer studies 
14showed that C acetic acid is incorporated into Cytochalasin 
B, but the distribution of label from acetate was only partially
revealed by degradation steps. In contrast, all sites enriched
13 13by 2 - C acetic acid were readily detected by C NMR and
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confirmed the stages of the biosynthetic pathway.
Most applications of NMR have been confined to metabolites 
produced by microorganisms^^, because of good precursor incorpor­
ation and high yield of product, but any system which produces 
a sufficient yield of reasonably enriched material can be used^^.
It is also possible to employ precursors containing two (or
more) enriched positions, such as doubly labelled acetic acid
(*CH2*C00H, 1,2 - acetic acid)^^. If the two enriched
13 13atoms are directly bonded to one another, then C - C
coupling will be observed between the two labelled positions,
and the fate of the enriched substrate can be determined by the
absence or presence of this coi%)ling in the enriched metabolite.
For example, if coupling is preserved in the spectrum of
the labelled product it is good evidence that at least part
of the precursor is incorporated intact. Loss of coupling
accompanied by enrichment is proof of bond scission, and changes
1 3in the type of coupling (e.g. ^ )̂ may indicate a
rearrangement.
Doubly labelled precursors in NMR have been employed in the 
study of rearrangements^^, as an aid in structure elucidation^^, 
and to distinguish biogenic alternatives^^.
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1.8.2 The scope and potential of NMR in metabolic studies
The first applications of NMR to biosynthetic problems^^ 
in the late sixties traced the fate of enriched precursors 
by the increases in intensities in the NMR spectrum.
However this method was seriously limited by the inability to 
provide information for carbons not directly bonded to hydrogen, 
and was soon superseded by continuous wave (CW) NMR spectro-
scopy^^'^^. This permitted every enriched site to be identified 
directly from differences in the intensities of corresponding 
resonances in the NMR spectra of naturally occurring and labelled 
metabolite. A major advance was provided by the increase in sensi­
tivity resulting from the development of pulse Fourier transform 
13(PFT). C NMR. This powerful technique has allowed many new 
areas of biosynthetic and metabolic interest to be explored, such 
as the study of metabolism in living cells, achieved as early 
as 1972^^.
However, the rate of progress of NMR metabolic studies in vivo
has been hindered partly due to problems associated with obtaining
well-resolved NMR spectra in salt solutions and biological
fluids. Differences in magnetic susceptibilities within the
biological sample tend to distort the magnetic field, and result
13
in losses in sensitivity and resolution. Association of C 
nuclei with certain paramagnetic ions can also result in greatly 
broadened signals^^. To produce a well defined NMR spectrum by 
the PFT technique, the pulse-FID collection sequence is generally 
continued until adequate signal-to-noise (S/N) is achieved, but
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a limiting factor for data accumulation is the . relaxation 
rate of the species under examination. A second pulse given 
prior to re-establishment of equilibrium magnetization (T̂ ) will 
result in a reduction of signal intensity (saturation). Hence 
the-.longer the of the nucleus, the longer the time interval 
required between pulses. Since values for all carbon atoms 
of a molecule may be different, in practice a compromise has 
to be made between the pulse interval and the S/N ratio achieved 
in the shortest time.
Finally, in addition to the instrumental problems, there have 
been difficulties associated with peak assignment of an unknown 
and possibly transient ^ecies, that, in the case of a singly 
enriched substrate may give rise to only one resonance whose 
chemical shift does not correspond with the anticipated value.
Despite these problems, NMR studies have been successfully
performed using a variety of living biological systems including
tissues (e.g. mammalian nerves^^, arterial tissues^^), whole
organ.preparations (e.g. perfused mouse liver^^) and whole
55 13organisms (e.g. tobacco budworm ). C NMR techniques have
also been employed as a tool for the study of microbial metabolism
72employing both intact cells in suspension and cell-free
extracts^^'^^.This has been achieved by following the fate of
a particular carbon atom of an enriched substrate molecule and
analysing the time-flux spectra. Apart from precise measurements
13of the rates of metabolic processes, direct examination of C
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distribution in intracellular metabolic products enables the 
degree of randomization as a function of time to be accurately 
assessed.
73In their now classic experiment Shulman et al, followed
the course of 1 - glucose metabolism in packed E. coli
(MKE 600) cells. Under rapid pulsing conditions at high field
(90.5 MHz; 0.3 sec. 60° pulses), they were able to obtain well-
resolved spectra of anaerobic cells with one-minute accumulations.
Signals for the C-3 of lactate and C-2 of succinate were
observed 2 minutes after the addition of labelled glucose, while
that for C-1 of fructose diphosphate (FDP) was observed after 13
minutes. The intensity of the FDP C-1 signal was observed to
decrease concomitantly with the increase of lactate C-3, alanine
C-3, valine C-3, valine C-4, 4', ethanol, and acetate C-2 signals.
Subsequent oxygenation of the cell suspension after all the
glucose had been consumed led to slow consumption of lactate
with accumulation of glutamate labelled in the C-2, 3 and 4 
73positions
The glycolytic process in red blood cells has also been the
74subject of some study. Styles et al, monitored the events
following 1 - ^^C glucose addition to human erythrocytes by
13 31simultaneously acquiring C and P spectra using a specially 
modified probe. Thus the accumulation of 3 - ^^C lactate 
and 3 - ^^C -2,3-diphosphoglycerate (DPG) was observed at 
the same time as the utilization of ATP, ADP, and the production
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of inorganic phosphate.
71 13Recently Cohen et al. demonstrated that C NMR could
be applied to the study of whole organs. They determined the effect
of ethanol on alanine metabolism in perfused mouse liver by
following the fate of enriched carbons from 3 - ^^C alanine
in the presence and absence of unlabelled 2 - ^^C ethanol.
From the spectra accumulated over 30 minutes they demonstrated
that in the presence of ethanol, label from 3 - ^^C alanine
entered the tricarboxylic acid cycle exclusively through pyruvate
carboxylation, and ethanol was the sole precursor of acetyl-CoA.
However, in the absence of ethanol, alanine was observed to flow
through both the tricarboxylic acid cycle and the pentose cycle.
While an immense amount of information has been abstracted 
from time dependent, high resolution spectra of cells and intact 
organs, significant results have also been achieved at lower
55resolution on whole organisms. For example, Scott and Baxter 
performed a time course experiment on a single larva of the 
tobacco budworm, Heliothus virescens (F.), after the admini­
stration of 20 yM . 1 - glucose. Spectra (21.5 MHz)
taken at 0.5, 3 and 12 hours after injection of label clearly 
showed the flux of glucose into a , a'-trehalose, the major 
blood sugar of the insect.
Finally, NMR spectroscopy has been employed to detect 
the presence of transient or unstable intermediates in metabolic
45
73 13studies. Ugurbil et al, . used C-enriched glucose and a 
high-frequency NMR spectrometer to monitor metabolism in 
aerobic and anaerobic E. coli suspensions. The time-course of 
glucose metabolism was followed in well-resolved spectra 
obtained with 1-minute accumulations, enabling the intermediates 
as well as end products to be identified. These NMR experiments 
determined in vivo the extent of labelling among intermediates 
that may have rapid turnover rates, and thus avoided the uncertain­
ties encountered in extracting such metabolites.
CHAPTER TWO
THE DEVELOPMENT AND APPLICATIONS OF
HPLC TO THE STUDY OF MICROBIAL
TRANSFORMATIONS.
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CHAPTER 2. THE DEVELOPMENT AND APPLICATIONS OF HPLC TO THE STUDY 
OF MICROBIAL TRANSFORMATIONS
2.1 Introduction
Drug transformation studies often involve relatively small changes 
in substrate or endproduct concentration, especially in the early 
stages of transformation development. To monitor these changes 
accurate sensitive assay procedures were required, which were 
reproducible, and without interference from any of the test mixture 
components. Furthermore, the analysis time was required to be as 
short as possible.
18
A G.L.C. assay system was employed by Sewell to study the 
N-demethylation of codeine by C. echinulata, and quantitatively 
estimate the norcodeine transformation product. However, there 
were several disadvantages associated with this procedure when 
used to assay drugs in transformation mixtures. It was.necessary 
to extract the codeine and norcodeine from the transformation media, 
and also to derivatise the sample, prior to GLC analysis. This 
extended the analysis time, and the accuracy and reproducibility 
of the technique relied on the complete extraction and derivatisa- 
tion of the sample each time. In addition, the GLC assay was found 
to be unsuitable for the analysis of norcodeine in cell-free 
extract studies. This was due to interference, attributed to 
Triton X-100 and its breakdown products,prohibiting quantitative 
determination of the transformation and also confusing the 
identification of the transformation product
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Clearly, if further progress was to be achieved with these 
studies an alternative quantitative assay procedure was required. 
The potential benefits offered by HPLC, described in Section
1.6.1 of this thesis, could be utilised to overcome many of the 
inherent disadvantages associated with Sewell's GLC procedure.
The transformation of codeine by C. echinulata has been scaled
up from shake flasks to a laboratory fermenter with a 7 litre 
18volume capacity . However, a suitable method had yet to be 
developed to efficiently recover and isolate the transformed drugs 
from the liquor. A further advantage of H P L C is that the 
sample can be recovered more easily than in GLC, and this is 
possible on a much larger scale using preparative H P L C  
This fractionating technique could be utilised for the final 
stages of purification of the transformation product from these 
larger volumes of transformation media.
For purposes of clarity this chapter has been divided into 
two sections. In the first section analytical HPLC methods 
developed for the quantitative determination of norcodeine and 
codeine in transformation media and cell-free extract mixtures 
are described. The second section describes the development of 
two complete systems to recover and isolate codeine and norcodeine 
from 7 litre batches of transformation media,incorporating either 
straight phase or reversed phase preparative HPLC. Various 
column packing materials were also investigated for their ability 
to extract codeine and norcodeine to isolate these drugs prior to 
the application of the final preparative HPLC step.
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Part A. Analytical HPLC Methods
2.2 Materials
2.2.1 Test compounds
Codeine phosphate; Macfarlane Smith Ltd., Edinburgh.
Codeine base; This was prepared from codeine phosphate by 
basifying (5 N NaOH) and extracting into 1,2-dichloroethane.
The organic layer was dried (anhydrous MgSO^) and evaporated to 
yield codeine base.
Norcodeine base ; This was prepared by adapting the method 
75used by Montzka et al. to N-demethylate morphine. A solution 
of 2,2,2-trichloroethylchloroformate (15.0 ml) in dry toluene 
(30 ml) was added dropwise over 2 hours to a mixture of codeine 
base (5.7 g), very dry Na^CO^ (5.0 g) and dry toluene (75 ml) 
contained in a 250 ml. 3-necked flask. The mixture was refluxed 
for 48 hours with vigorous stirring, and then cooled to room 
temperature. Diethyl ether (100 ml) was added, and the whole was 
washed with 2 N HCl (2 x 100 ml) and water (100 ml). The organic 
layer was separated and evaporated to a yellow oil which was 
dissolved in glacial acetic acid (250 ml) and refluxed with 
zinc dust (18.0 g) for 1 hour. The mixture was stirred at room 
temperature for a further 4 hours and was then poured onto ice, 
basified (5 N NaOH), and extracted into 1,2-dichloroethane.
The organic layer was dried (anhydrous MgSO^) and evaporated 
to give an off-white solid (3.8 g). This was dissolved in the 
minimum quantity of hot acetone, filtered and allowed to cool to 
room temperature to yield a crystalline product (2.50 g).
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Analytical: Melting point 184°C (lit^^ 185°C).
NMR. (100 MHz; CDCl^; Norcodeine base); 1.86 (2H, m, 
C^g-H); 2.7 (5H, m. C^^-H, C^Q-H, C^^^); 3.22 (2H, s,
OH, NH, exchanges with DgO); 3.63 (IH, m. C^-H); 3.8
(3H, s , O-^) ; 4.18 (IH, m. C^-H); 4.88 (IH, d, J = 7.0 Hz, 
C^-H); 5.29 (IH, q, C^-H); 5.72 (IH, d, J = 10.5 Hz, Cg-H); 
6.59 (2H, d.d, C^-H, C^-H).
Norcodeine HCl: This was prepared from norcodeine base, by 
precipitating it from a dry solution in 1,2-dichloroethane b y  
the addition of ethereal HCl.
Analytical: m.pt. 308°C (lit^^ 309°C)
2.2.2 Internal standards
Dihydrocodeine: Extracted from DF118 tablets (Duncan 
Flockhart, London). 20 tablets (30 mg) were crushed and dissolved 
in H^O (25 ml). The solution was filtered, basified (2 N NaOH) 
to pH 10.O and extracted into chloroform (4 x 25 ml). The organic 
phase was separated, dried (anhydrous MgSO^) and evaporated 
to dryness to yield the free base (520 mg). Morphine sulphate, 
strychnine, thebaine and,atropine sulphate (Macfarlane Smith 
Ltd., Edinburgh).
Quinine sulphate - B.D.H. Ltd., Poole, Dorset
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2.2.3 Solvents
Acetonitrile, methanol, chloroform, 1,2-dichloroethane, 
tetrahydrofuran, propan-2-ol, of HPLC grade and ethanol,butan-l-ol 
dioxan, toluene, diethylether and acetone of Laboratory Reagent 
grade, were supplied by Fisons Ltd., Loughborough, U.K.
Deuterated chloroform NMR solvent, containing 1% v/v tetra­
methylsilane (TMS) as ihternal standard, was purchased from 
Aldrich Chemical Co., Gillingham, Dorset.
The water used for the preparation of aqueous mobile phases 
was deionised and double distilled from a Fisons 'Fl+streem' 
all glass water still - deioniser.
2.2.4 Chemicals, reagents and stationary phases
2,2,2-trichloroethylchloroformate; Aldrich, Gillingham 
U.K. Sodium carbonate, sodium bicarbonate, zinc dust, magnesium 
sulphate (anhydrous), sodium hydroxide, monopotassium phosphate 
(KHgPO^), disodium phosphate (Na^HP0^.2H^0), ammonium acetate 
(all of Analar grade) and triethylamine and diethylamine 
(Laboratory grade) were obtained from B.D.H. Ltd., Poole, U.K. 
Hydrochloric acid, sulphuric acid, glacial acetic acid, and 
pentane sulphonic acid pairing ion (HPLC grade) were obtained 
from Fisons, Loughborough, U.K.
Silica Gel G.F.^^^ TLC stationary phase, Partisil 5, Partisil 10 ODS-2, 
and ODS-Hypersil. HPLC stationary phases were purchased from 
Jones Chromatography, Glamorgan, U.K.
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2.2.5 Equipment and instrumentation
Melting point apparatus : open ended capillary tube method, 
Gallenkamp, London.
NMR spectrometer; 100 MHz, Jeol JNM PS-100, Jeol, Tokyo.
Analytical balance; Shanton Unimatic, reading to 0.01 mg, Oertling 
Ltd., London.
Rotary Evaporator; Buchi, Fisons Scientific Apparatus 
Ultra-violet/visible spectrophotometer; Perkin Elmer 550-s 
(Perkin Elmer Ltd., Slough,U.K.)
pH Meter; Pye Unicam Ltd. (Model PN 9418), standardised with 
biffer solutions of pH 4.0, 7.0 and 10.0. A constant pressure 
pump (Haskell model 27502, Olin Energy Systems, Sunderland, U.K.) 
was used for column packing.
HPLC instrumentation; The HPLC instrumentation was assembled 
from commercially available components. Mobile phase was pumped 
to the column by means of a constant flow liquid pump (either a 
Constametric III or a Milton Roy Minipump, LDC, Stone, UK) . It 
was necessary to incorporate a pulse dampener when using the 
minipump.
The chromatography columns employed are listed in Table 2.1. Low 
dead volume Swagelok fittings (HETP) were used for the connections 
for the valve and detector.
Temperatures of the mobile phase reservoir, the column and injector 
were controlled by immersion in a heated water bath (Gallenkamp 
type 400-010). The output to the detector was recorded on a 
potentiometric chart recorder (Servogor 220, LDC Ltd.) and was 
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Slough, UK). Samples were introduced onto the column by means of 
a loop valve (Rheodyne 7125, Jones Chromatography).
The ultraviolet detectors were either a Cecil Model 212 variable 
wavelength (Cecil Instruments, Cambridge, UK) or a Pye Unicam 
LC-UV variable wavelength (Pye Unicam Ltd.).
2.3 Methods
2.3.1 Thin layer chromatography (TLC) methods
(a) Preparation of plates : 30 g silica gel was homo­
genised with 60 ml distilled water. The slurry was spread over 
ten 10 X 20 cm glass plates at a thickness of 0.25 mm. Plates 
were air dried eind stored in a desiccator at 20°C. To ensure an 
even solvent front the outer 5 mm of adsorbent was stripped from 
both sides of each plate before use.
- 1.
(b) Sample application: Samples of codeine and norcodeine
base were applied to the plates in solutions of methanol (1 yg ml '") 
delivered from a 5 yl glass capillary applicator. The samples 
were applied in thin bands, 5 mm in length, positioned at 20 mm, 
above the bottom of the plate. Several layers were applied to
each band, and the solvent evaporated from the plate between 
each application to prevent band broadening.
(c) Development: Freshly prepared mobile phase solvent (200 ml)
was poured into a chromatography tank which was sealed. The
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tank was placed in a heated water bath at a temperature of 25°C, 
and allowed to eqiiilibriate for at least 4 hours. TLC plates were 
then lowered into the tank , which was resealed, and the solvent 
front was developed for 10 cm. at this temperature.
(d) Visualisation: Developed plates were initially examined
under 254 nm ultraviolet light so that eluted components were
detected by their fluorescence quenching. The plates were then
sprayed with a 10% sulphuric acid solution and heated in an oven 
oat 120 C for 15 minutes until visualised.
(e) Treatment of TLC results: Data relating to the TLC
migration of sample components are expressed ashRf values:
hRf - Distance travelled by component (mm) x 100  ̂^
Distance travelled by solveht front (mm)
A Both upper and lower limits of each component spot are given.
2.3.2. High Performance Liquid Chromatography (HPLC) Methods
(a) Column packing
The columns used were slurry packed downwards in
29propan-2-ol using the apparatus described by Hamilton and Sewell . 
Packing material (1.4 g per 100 mm x 5 ram i.d. of column) was 
dispersed in about 25 ml of solvent by immersion of the container 
in an ultrasonic bath. The slurry was then poured into the slurry
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reservoir, and attached to the guard column and column (which 
contained propan-2-ol which was displaced as the column was filled). 
The pump was then charged to full pressure (5000 p.s.i.) and 
switched on, to pump the slurry through the column at maximum 
pressure. This was continued until the rate of flow from the column 
was reasonably constant, estimated by collecting the eluent over 
fixed time periods. At this stage the flow was switched off and 
the pressure allowed to fall to zero. After removing the column 
from the packing apparatus, a stainless steel mesh (2 ym) was 
placed on top, followed by a porous PTFE collar and the column 
head.
(b) Column testing
The quality of the column packing was tested according
77to the methods described by Bristow and Knox . For straight
-6phase columns, a test mixture of n i t r o b e n z e n e d O  % v/v) and 
-3benzene (10 % v/v) in hexane was used, and the mobile phase
was 1% v/v acetonitrdle in hexane. For the reversed phase columns, 
the test solution was anisole (0.03% v/v) and phenetole (0.07% 
v/v) in methanol, and the mobile phase was methanol :water (70:30). 
Column efficiency, as described by h, (Eq. 1.5) for the columns A,
B and C (Table 2.1) was found to be 3.6, 5.4 and 6.4 respectively.
(c) Preparation of mobile phases
(a) Non aqueous mobile phases were prepared by pipetting 
the appropriate amounts of each solvent into the reservoir and 
gently mixing them together.
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(b) Aqueous mobile phases were prepared by pipetting the 
appropriate amounts of organic modifier, buffer (and pairing ion) 
solution into grade B volumetric flasks and adjusting to volume 
with double distilled-deionised water. All mobile phase solutions 
were passed through a 0.45 ym lAillipore membrane filter under 
negative pressure and degassed with helium for 5 minutes before use.
2.3.3 Quantitative HPLC procedures
A series of analytical HPLC methods was developed for the 
separation of codeine and norcodeine. The methods involved one or 
other of the two procedures described below:-
(a) Internal standard procedure: To minimize errors due to sample
preparation, apparatus and technique, a known compound of fixed 
concentration (the internal standard) was added to the unknown 
sample to give a separate peak in the chromatogram. The 
standard compound selected must be miscible with the sample, must 
be chemically stable, must not react with the sample components, 
and its retention time should be close to that of the sample 
component(s) of interest.
Calibration curves were obtained by chrcanatographing suitable 
volumes of calibration mixtures containing the compounds of 
interest with a constant concentration of the internal standard. 
Triplicate injections were made at each concentration. Peak 
heights and areas of the compounds of interest were determined, .
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and ratios were obtained from equations 2.2 and 2.3
Peak Height Ratio ^Hex.ght of analyte p e ^  ^---- 2.2
Height of internal standard peak
Peak area Ratio = f  a n a l ^ p e a k    2.3Height of internal standard peak
Peak height and area ratios were plotted against concentration of 
compound, and each plot was subjected to regression analysis to 
determine the slope, intercept and correlation coefficient. The 
amount of compound (codeine or norcodeine) in a sample may be 
determined by division of the peak height/area ratio by the 
respective calibration slope. Between each set of assays, the 
calibration of the detector was checked by injecting a standard 
solution of codeine and norcodeine. If the peak height/area 
ratio deviated from the calibration curve by more than 5% the 
system was recalibrated.
(b) External standard procedure: This was adopted when it was
not possible to 'fit in' a standard without overlapping another 
peak ̂ which may often be the case in the analysis of samples 
from cell-free extract studies. A calibration plot was constructed 
by injecting a fixed volume of standard samples containing known 
weights (concentrations) of the compound(s) of interest. Plots of 
peak height and/or area versus weight (concentration)for each 
compound were obtained, and these checked for linearity by 
subjecting the data to linear regression analysis. The calibration
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factor S (peak size/concentration) is equivalent to the slope, and 
the amount of the dompound X (codeine or norcodeine) in an unknown 
sample was obtained from :-
wt of X  = height or area of x^ 2.4
To allow for possible changes in instrument parameters during 
analysis, the calibration factor (S) was checked at regular intervals 
This was achieved by injecting standards of similar strength to 
the sample before and after each unknown sample.
(c) Precision of the detector response
This was determined for each developed HPLC assay by injecting 
sample solutions containing known concentrations of compound within 
the calibration range ten times. The mean standard deviation and 
coefficient of variation was determined for the responses obtained.
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2.4 Experimental
2.4.1 Determination of the pKa's of codeine and norcodeine
The degree of ionization of a base (BH) can be expressed 
by acidic ionization constants
for ' BH"" B + h'"
ka = i s l i B l  2 5M )
More conveniently the ionization constant is usually expressed as 
the pKa:-
pKa = pH + log (bh "̂) - log ( b ) 2.6
Thus, the proportion of nonionized molecules of a base present 
in aqueous solution at a given pH can be calculated from:-
% non ionised = i + antil^ (pH - pkk) 2.7
pKa values for codeine and norcodeine were determined by
potentiometric titration employing the method of Albert and 
78Serjeant . The temperature dial on the pH apparatus was set 
to the required temperature, and the glass electrode was standardized 
with buffer solutions at pH 4.0, 7.0 and 10.0. A solution of 
the substance was prepared (0.01 M) in double distilled-deionized 
water (50 ml) (codeine base 0.1497 g; norcodeine base 0.1427 g), 
and the solution brought to the required temperature. The pH 
of the solution was recorded initially. Then ten equal portions, 
each a tenth of an equivalent, of titrant (0.1 N HCl, f = 0.9074)
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were added, and the pH recorded as soon as equilibrium was reached 
after each addition. Data from the titrations enabled the pKa's 
for codeine base and norcodeine base to be determined from equation 
2.6. The results obtained were as follows
codeine base; pKa =' 7.84 (±0.02) at 0.01 M and Ï5°C
(using 9 values in the set)
79(literature value pKa 8.21 )
norcodeine base; pKa = 8.79 (±0.02) at 0.01 M and 25°C
(using 9 values in the set)
(no lit. value found)
A prior knowledge of these pKa values was required in order to 
predict suitable conditions for the extraction and chromatographic 
studies described in this section.
2.4.2 U.V. absorption characteristics of codeine and norcodeine 
The following experimental procedure was performed to find 
out if both codeine and norcodeine possess sufficient UV absorption 
characteristics to enable a UV detector to be employed in the 
subsequent HPLC studies.
Solutions of codeine (0.1 mg/ml) and norcodeine (0.05 mg/ml) 
were prepared in acetate (1%), acetic acid buffer at pH 5.5.
The UV absorbance of each solution was recorded from 180 to 
350 nm wavelength, using acetate buffer solution as a blank, 




norcodeine 0.05 mg/ml 












The UV absorbance of codeine and norcodeine 
in acetate buffer against wavlength
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Codeine and norcodeine produced absorption optima at about
1% 1%285 nm wavelength (e, codeine 31.5; e, norcodeine 62,2) ,1cm 1cm
1% 1%and 225 nm (e, codeine 122; e, norcodeine 252.7) , and an 1cm 1cm
absorption minimum in both cases at about 260 nm. The results 
indicate that the U.V. detector could be employed in the HPLC 
analysis of codeine and norcodeine. However, the wavelength 
of choice for an assay will depend on the UV absorption character­
istics of the mobile phase, as well as those of codeine and nor­
codeine.
2.4.3 Straight phase HPLC development 
a) Selection of the mobile phase
The primary step in the development of an HPLC separation 
is selection of the mobile phase. Thin Layer Chromatography (TLC) 
provides a rapid and economical method to achieve this.
A TLC method for the separation of codeine and norcodeine
80has been reported by Mulé , but the Rf values were not in the 
region 15 to 35, necessary for an adequate separation on a silica 
HPLC column. However, this system was used as a basis for the 
development of a suitable TLC system for the separation of codeine 
and norcodeine. The TLC procedure described in Section (2.3.1) 
was employed, and the solvent composition in the mobile phase 
modified to give Rf values between 15 and 35. Details of the 
original TLC system of Mulé and more suitable TLC systems developed 
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Systems 2 and 3 (Table 2.2) gave Rf values in the desired 
region and were considered for further investigation in the straight 
phase HPLC analytical separation of codeine and norcodeine.
(b) Assay conditions
A Partisil 5 ym silica column (Column A, Table 2.1)
was selected for its similar adsorbent characteristics to TLC
silica gel. Some of the characteristics of Partisil 5 are listed
in Table 2.1. The mobile phases developed from TLC in the previous
section were investigated for their suitability in separating
codeine and norcodeine, although the concentration of triethyl-
-5amine was reduced from 1% v/v to 4 x 10 % v/v to minimise
baseline noise.
Samples of codeine and norcodeine base dissolved in mobile 
phase (1 mg/ml) were injected onto the column, and the column 
capacity ratios (k) and resolution (Rs) determined (from 
Equations 1.2 and 1.8 respectively) for each mobile phase.
The results obtained are shown in Table 2.3. System 4 was 
selected for the quantitative determination of codeine and nor­
codeine because the best peak shapes were obtained with adequate 
retention and resolution of the components. A typical chromatogram 
is shown in Figure 2.2.
(c) Selection of internal standard
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Fig. 2.2. Example of straight phase HPLC chromatogram








column; Partisil 5 ym, 150 x 4.6 mm ID
mobile phase; Ethanol (50), 1,2-dichloroethane (45), Acetonitriie 











standards, were dissolved in mobile phase (System 4) to give a 
concentration of 1 mg/ml, and each sample was injected onto the 
Partisil 5 column. From the retention data, the column capacity 
ratios (k) were determined (Equation 2.2) for each alkaloid.
The results obtained are given in Table 2.4.
Table 2.4 . HPLC retention data for codeine, norcodeine and a 
series of alkaloids











The HPLC retention of strychnine (5.3 min) was equidistant
between the retentions of codeine (3.1 min) and norcodeine (8.1 min)
and was therefore selected as internal standard.
(d) Calibration procedure
Stock solutions containing codeine (100 mg) and norcodeine 
(100 mg) in mobile phase (System 4, Table 2.3) (50 ml) and
strychnine, internal standard (75 mg) in mobile phase (25 ml),
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were prepared. Sample volumes of the codeine and norcodeine stock 
solution from 1 ml to 8 ml were pipetted into volumetric flasks. 
Strychnine solution (1 ml) was also pipetted into each flask, 
and mobile phase to give a final volume of 10 ml in each case.
The concentrations of codeine and norcodeine in each sample are 
listed in Table 2.5.
Table 2.5. Preparation of calibration samples for the straight
phaëe assay of codeine and norcodeine










Each sample was assayed in triplicate. Plots of the peak height, and 
peak height ratios of codeine and norcodeine against the concen­
tration of the respective component in the calibration sample 
were constructed (Figure 2.3 and 2.4 respectively) and the results 
subjected to regression analysis . The data obtained are given 
in Table 2.6.
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Table 2.6. Linear regression analysis of data obtained for the 
straight phase HPLC assay of codeine and norcodeine
Peak height Peak height ratio
Codeine Norcodeine Codeine Norcodeine
Slope 63.1 113.5 0.825 2.37
Std. dev. of slope 0.629 1.119 0.00816 0.0252
Intercept 0.971 0.399 0.0138 0.0166
Std. dev. of intercept 0.512 0.766 0.0063 0.0080
Correlation co­
efficient 0.9997 0.9998 0.9998 0.9998
Coefficient of 0.996 0.985 0.989 1.063
variation of slope
The results show that the HPLC system is suitable for the quanti­
tative determination of codeine and norcodeine in the concentration 
range employed. However, the drugs have to be extracted from the 
transformation media prior to analysis, although this may not be 
necessary if a reversed phase system was employed.
2.4.4 Reversed phase HPLC - Partisil 10 ODS-2
(a) Selection of mobile phase
A series of organic modifiers listed in Table 2.7 was 
investigated. Each organic modifier was mixed with various ratios 
of acetate/acetic acid buffer (1%) at the arbitrary pH of 5.0.
A mixture of codeine and norcodeine in mobile phase (1 mg/ml of 
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phase in turn to find a system which separated the two compounds.
The pH of the aqueous buffer, and the mobile phase flow rate, were 
later adjusted to optimise the separation.
The solvent systems which gave the best separation of codeine 
and norcodeine in terms of adequate resolution (Equation 1.8) in 
the least analysis time,and peaks exhibiting good column efficiencies 
(Equation 1.3) with the minimum of peak tailing are shown in Table 
2.8.
Table 2.8. HPLC retention data for codeine and norcodeine on 
Partisil 10 ODS-2 column (B)
System Mobile phase pH of Flow rate Codeine Norcodeine
buffer ml/min tĵ (min) X tĵ (min) X
8 Methanol(30),
Acetate (70) 5.5 1.5 5.6 7.0 3.1 3.4
buffer
9 Acetonitriie(15) ^ 
Acetate buffer 
(85)
1.5 5.5 8.8 3.1 4.5
(b) Assay conditions
System 8 (Table 2.8) was selected for the quantitative 
determination of codeine and norcodeine employing Column B. An 
ultraviolet variable wavelength spectrophotometer was employed for 
detection. To achieve the maximum sensitivity for the detection 
of codeine and norcodeine it was necessary to determine the wave­
length at which these compounds have the highest absorbance, but
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the other components in the mobile phase have the lowest.
An ultraviolet scan of mobile phase was recorded against 
a distilled water blank from 180 to 350 nm. This was superimposed 
over the UV scans of codeine and norcodeine (Figure 2.1) determined 
in Section 2.4.2. The optimum wavelength was taken to be that 
where there is the maximum difference in UV absorbance between 
the compounds and mobile phase. This was observed to be 240 nm.
Morphine was selected as the internal standard. At a mobile 
phase flow rate of 1.5 ml/min the retention times of morphine , 
norcodeine and codeine were 1.6 mins, 3.0 mins and 5.6 mins 
respectively. A typical chromatogram is shown in Figure 2.5. 
with a summary of the operating conditions.
(c) Calibration procedure
Stock solutions containing codeine (100 mg) and nor­
codeine (100 mg) in mobile phase (System 8, 50 ml) , and also 
a solution containing morphine standard (75 mg) in mobile phase 
(25 ml) , were prepared. From these stock solutions a series of 
calibration solutions were prepared as shown in Table 2.5. 
Morphine internal standard was added to each calibration solution 
to a final concentration of 0.3 mg /ml. Each calibration solution 
was assayed in triplicate by the reversed phase HPLC procedure. 
Regression analysis of the peak height/area against concentration 
data gave the results shown in Table 2.9.
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Fig. 2.5. Example of HPLC chromatogram obtained in the assay










Detection; UV 240 nm
Partisil 10 ODS-2, 100 x 4.6 mm ID 
Methanol (30), Acetate buffer (70), pH 5.5
25°C
-11.5 ml min
Injection volume; 100 yl
Table 2.9. Linear regression analysis of data obtained for the 
Partisil 10 ODS-2 assay of codeine and norcodeine
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Peak height ratio Peak area ratio
Codeine Norcodeine Codeine Norcodeine
Slope 0.569 2.380 2.069 2.93
Std.Dev. of slope 0.0103 0.0206 0.0031 0.0228
Intercept 0.0186 0.037 0.0720 -0.051
Std.Dev.of intercept 0.0085 0.0161 0.0344 0.0017
Correlation
coefficient 0.9993 0.9998 0.9995 0.9998
% Coeff. of variation __ _ _ i•oO/ of the slope 0.865 0.149 0.778
These results demonstrated that the HPLC assay was suitable
for the quantitative determination of codeine and norcodeine in
the concentration range likely to be encountered in general trans- 
18formation studies , However, for enzyme kinetic studies lower 
concentrations would be encountered, so it was necessary to 
determine the linear range at the detection limits of the assay.
(d) Linear range and detection limits
The linear range of the detector response was determined 
by chromatographing successive dilutions of the codeine and nor­
codeine stock solution with mobile phase. Morphine internal 
standard was added to each solution and the peak height/area 
responses determined in each case. It was necessary to adjust 
the detector sensitivity between dilutions to obtain a measurable
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response on the chart recorder, but the corrected response to 
internal standard was found to be constant at each sensitivity 
confirming correct dilution procedure.
The detection limit was considered to be the concentration
at which the response was not less than 10% of a full-scale
deflection, at the maximum sensitivity of the UV detector.
-3This was found to be equivalent to 10 mg ml, for both
codeine and norcodeine in mobile phase 8. Regression analysis
carried out on plots of peak height and area ratios of codeine
and norcodeine against their concentration in the samples are
-3 -1given in Table 2.10 and suggest a linear range from 1 x lO mg ml 
— 1to 1 mg ml for each compound.
Table 2.10. Linear regression analysis of data obtained for the 
linear range of the detector response for codeine 
and norcodeine with the Partisil 10 ODS-2 Column
Peak height ratio Peak area ratio
Codeine Norcodeine Codeine Norcodeine
Slope 0.936 1.984 3.444 3.358
Std.dev. of slope 0.0074 0.0058 0.0479 0.0274
Intercept -0.0076 -0.0135 -0.0048 -0.0024
Std.Dev. of intercept 0.0034 -0.0026 0.0021 0.0011
Correlation
coefficient 0.9998 0.9999 0.9996 0.9998
% Coeff. of variation 
of the slope 0.791 0.292 1.391 0.816
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(e) Precision of the detector response
A solution of codeine and norcodeine in mobile phase 8 
was chromatographed ten times using the conditions described in 
Figure 2.5. The concentration of solution selected (0.05 rng ml 
was approximately from the middle of the linear range tested. 
The results obtained are given in Table 2.11.
- 1.
Table 2.11. Precision results for the Partisil 10 ODS-2 HPLC 
assay of codeine and,norcodeine in mobile phase
For 10 injections Peak height ratio Peak area ratio
Codeine Norcodeine Codeine Norcodeine
Mean 0.58 2.35 2.07 2.87
Standard deviation 0.011 0.0458 0.0418 0.0614
% Coefficient of 
variation ± 1.89 1.95 2.02 2.14
% range of error ± 3.02 3.116 3.228 3.419
Hence for assays determined employing duplicate injections 
the % range of error = ± where t is the 't' test value
at 95% confidence and N is the number of replicate injections 
per sample (2).
The HPLC assay was repeated with calibration solutions 
prepared in transformation media to check for any interference 
from components in the transformation mixture. Unfortunately 
the resulting chromatograms revealed a variably large solvent 
front which occluded the standard peak and prevented the peak
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height/area ratios from being determined. The regression
analysis for the peak heights and areas against concentration,
in the absence of internal standard, gave the results shown in 
Table 2.12.
Table 2.12. Linear regression analysis of data obtained for the
Partisil 10 ODS-2 assay of codeine and norcodeine in
transformation media
Peak height Peak area
Codeine Norcodeine Codeine Norcodeine
Slope 1824 3865 80.42 78.44
Std.dev. of slope 6.58 33.08 0.64 0.516
Intercept -0.249 0.215 0.0063 0.068
Std.dev. of inter­
cept 0.089 0.076 0.0031 0.023
Correlation
coefficient 0.9999 0.9998 0.9999 0.9999
% coeff of 
variation of slope 0.36 0.85 0.796 0.658
A sample of codeine and norcodeine in transformation media 
-1(0.05 mg ml ) chromatographed ten times gave the results in 
Table 2.13.
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Table 2.13. Precision results for the Partisil 10 ODS-2 HPLC
assay of codeine and norcodeine in transformation media






Mean 15.6 24.4 4.23 3.87
Standard deviation 0.318 0.548 ' 0.0914 0.086
% Coefficient of 
variation ± 2.04 2.24 2.16 2.22
% range of error ± 3.26 3.58 3.45 3.55
These results indicate that the peak heights and areas could 
be employed in an external standard procedure (Section 2.3.3(b)) 
for the determination of codeine and norcodeine directly from trans­
formation samples. However, it was thought that this assay 
would not be sufficiently sensitive for the determination of these 
drugs at the concentrations encountered in enzyme kinetic 
studies.
2.4.5 Reversed phase HPLC assay - ODS-Hypersil, 5 ym
(a) Assay conditions
A mobile phase was selected for Column C by employing 
the systematic procedure established in the previous section for 
Column B. This consisted of acetonitriie organic modifier 16% v/v 
with phosphate buffer at pH 6.5. Also included was an ion-pairing 
agent, pentane sulphonic acid (5 mM) to enhance the retention
8 0
of codeine and norcodeine. A summary of the operating conditions 
employed and a typical chromatogram of the separation are shown 
in Figure 2.6. For these conditions the retention times of 
norcodeine and codeine were 8.0 and 12.P minutes respectively.
(b) Calibration procedure
The external standard procedure described (Section 
2.3.3(b)) was employed. A calibration plot was constructed 
to check the linearity of the detector response, and the limits 
of detection for codeine and norcodeine, using the procedure 
described previously for the Partisil 10 ODS-2 system, except 
that in this assay no internal standard was included.
-4The detection limit was 1 x 10 mg/ml for both codeine 
and norcodeine, and the linear range of the detector response,
calculated from the peak height and peak area measurements,
-4 -2was 1 X 10 mg/ml to 25 x 10 mg/ml supported by the re­
gression analysis given in Table 2.14 .
(c) Precision of the detector response
Sample solutions containing codeine and norcodeine 
(0.05 mg/ml) in mobile phase and transformation media respectively 
were each injected ten times onto column C. Table 2,15 shows 
the results obtained indicating that the precision of the 
detector response was unaffected by components in the trans­
formation mixture.
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Fig. 2.6. Example of chromatogram obtained with ODS-Hypersil 
HPLC assay for codeine and norcodeine in mobile 













Flow rate; 1.5 ml'min
Detection; UV 240 nm
ODS-Hypersil 5 ym, 150 x 4.6 mm I.D.
Acetonitrile (16), Phosphate buffer (84), pH 6.5 




Table 2.14. Linear regression analysis of data obtained for the 
linear range of the detector response for codeine 
and norcodeine with the OPS Hypersil Column
Peak height Peak area ̂
Codeine Norcodeine Codeine Norcodeine
Slope 9.100 16.5 4192 8037
Std.dev. of slope 0.3605 0.223 95.57 100.46
Intercept -0.15 -0.250 -0.64 -1.35
Std.Dev. of inter­
cept 0.059 0.113 0.028 0.54
Correlation
coefficient 0.9977 0.9997 0.9996 0.9995
% coeff. of 
variation of slope ± 3.96 1.35 2.28 1.25
Table 2.15. Precision results for the ODS-Hypersil HPLC assay of 
codeine and norcodeine in mobile phase (A) and in 
transformation media (B) based on peak height measurements




Mean 41.6 64.2 40.8 63.7
Standard deviation 0.765 1.129 0.799 1.159
% Coeff. of
variation ± 1.84 1.76 1.96 1.82
% range of error ± 2.94 2.81 3.13 2.91
A sample in mobile phase B sample in transformation media
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Part B. Recovery and Purification Methods
2.5 Materials
2.5.1 Column packing materials and HPLC stationary phases
Amberlite XAD-2, XAD-4 and XAD-7 non-ionic resins - BDH Ltd. 
Lichroprep silica, 15 - 25 ym particle size (Merck) and 
Lichroprep RP18 silica, 25 - 40 ym particle size (Merck) were 
purchased from Jones Chromatography, Glamorgan.
2.5.2 Equipment and instrumentation
Phase separating filter paper; Fisons Ltd., U.K. 7 litre
laboratory fermenter, 2000 series, - LH Engineering Co. Ltd.,
Stoke Poges was used to produce 7 litre batches of transformation
material. The design, construction and operation of this
18fermenter were described by Sewell
GLC oven; Perkin Elmer Type Fll (Perkin Elmer Ltd., Slough, UK) 
was employed for the attempted reactivation of preparative 
HPLC columns.
(a) Instrumentation for group extractions with Partisil 10 ODS 
The sample to be extracted was pumped to the column by 
means of a constant pressure liquid pump (2 ml volume Haskell 
type). The column was stainless steel (100 mm x 5 mm i.d.) 
packed with 1.02 g of Partisil 10 ODS-2. It was connected to 
the pump by means of stainless steel tubing and standard 
Swagelok fittings (HETP). A graduated glass vessel and timer
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were used to collect and measure the flow rate of sample through 
the column. Experimental temperatures were maintained by 
immersing the column and sample reservoir in a thermostatically 
heated water bath.
(b) Instrumentation for group extractions with Amberlite
resins
For the preliminary investigations a glass column 
(100 mm X 5 mm i.d.), with tap, was plugged at the tap end, 
with a stainless steel filter (mesh size 5 ym) and glass 
wool, and filled with 1 g of accurately weighed resin material.
For the preparative extraction studies a glass column (500 mm 
X 25 ram i.d.) was plugged in a similar manner, and filled 
with lOO g of the selected resin material. All the resin materials 
were washed thoroughly with methanol (HPLC grade) followed by 
distilled water, before they were poured into the columns as 
a slurry in distilled water. The sample to be extracted was 
pumped from the reservoir to the top of the column by means 
of a peristaltic pump (Loughborough Glass Co. Ltd.). Samples 
were eluted from the column under gravity flow, at a rate 
controlled by the tap at the base of the column, and collected 
in a graduated glass vessel.
(c) Preparative HPI/Z instrumentation
All the preparative HPLC studies were carried out using
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an 830 Preparative High Performance Liquid Chromatograph 
(Dupont, USA). This consisted of the following essential com­
ponents contained in a complete unit:-
(a) A 70 ml stroke capacity constant pressure pump; to pump 
mobile phase from a 2 litre capacity stainless steel 
reservoir to the column;
(b) Loop valve;^Kehodyne 7125, with sample loops of either 
2 ml or 10 ml volume, connected to the injection valve 
via 1/16" O.D. stainless steel tubing;
(c) Detector; Ultraviolet variable wavelength spectrophotometer 
(Du^ofc ,USA) fitted with a short path length preparative 
flow cell;
(d) Fraction collection valve assembly; to direct the flow
of mobile phase from the column either back to the reservoir, 
to drain, or through one of three fraction outlets to a 
collecting vessel.
(e) A thermostatically controlled oven; which housed the prepar­
ative HPLC column, and injection port assembly. The oven, 
with the aid of a mobile phase preheater, connected between 
the pump outlet and injection valve inlet, were used to 
control the operating temperature.
A schematic diagram of how these components were connected 
is illustrated in Figure 2.7. The preparative chromatography 
columns were stainless steel and of dimensions listed in 
Table 2.16.
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2.6.1 Batch extraction procedure with Partisil 10 ODS-2 and
Amberlite resins
A solution of codeine and norcodeine base (10 mg of each) 
in the medium to be extracted (100 ml), was adjusted to pH by 
the dropwise addition of acid (2N HCl) or base (2N NaOH) . The 
sample solution was passed through a 0.45 ym membrane filter 
(Millipore Type HA) to remove particulate matter. The filtrate 
sample was poured into the reservoir, and pumped through the 
column (Partisil 10 ODS-2 or Amberlite resin) at a controlled 
flow rate and temperature. When the reservoir was almost empty, 
distilled water (25 ml) was added and pumped through the 
system to flush remaining sample solution from the pump and 
connections to the column. The column and pump were disconnected 
and acetone (200 ml) passed through the pump to clear it out.
The column and pump were then reconnected, and an eluting solvent 
pumped through the column at a controlled flow rate. The organic 
eluent was collected, dried (anhydrous MgSO^) and filtered, and 
the solvent was then evaporated in a rotary evaporator under 
reduced pressure over a water bath at 50°C. On cooling, the 
residue was dissolved in mobile phase (5 ml), containing 
strychnine internal standard (0.3 mg/ml), and the,amount of 
test compound (codeine, norcodeine) recovered in the organic 
phase,was determined by straight phase HPLC (Section 2.4.3).
The amount of test compound extracted per gram of adsorbent 
material was expressed by:-
Amount recovered in organic phase (mg)  ̂g
Amount of adsorbent material (g)
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and the extraction efficiency was expressed by
Amount recovered in organic phase ^  ̂9
Amount added to medium
At least 10 column volumes of 0.1 N HCl followed by 10 column 
volumes of distilled water were pumped through the column before 
the next sample solution was introduced.
2.6.2 Preparative HPLC methods
(a) Column packing and testing
The columns used were slurry packed downwards using 
the technique described in Section 2.3.2(a). Packing material 
(0.7 g per c.c. internal volume of the column) was dispersed 
in chloroform (4) ; methanol (1) to produce the slurry. At the 
completion of column packing, the excess packing material was 
collected, dried and weighed, and subtracted from the initial 
weight of stationary phase used to determine the weight of 
stationary phase in the.column. These values, and details of 
the preparative columns packed are listed in Table 2.16.
All the columns packed were subjected to the column tests 
described in Section 2.3.2(b) to evaluate the quality of the 
packing.
(b) Injection procedure
The sample to be separated was dissolved in the minimal 
quantity of mobile phase, and filtered through a 0.45 ym Millipore
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(Type HA) membrane filter to remove particular matter. The 
resulting solution was injected into the sample loop, of 2 ml 
or 10 ml capacity, as appropriate. Mobile phase was pump6.dl 
through the column at a predetermined rate, and when a peak was 
detected, the eluate was collected from one of the fraction 
collection outlets. The mobile phase flow rate was determined 
by collecting the column eluate in a graduated vessel over a 
known time interval.
2.7 Experimental
2.7.1 The group extraction of codeine and norcodeine from trans­
formation media employing Partisil 10 ODS-2 HPLC packing 
material
In order to determine the parameters which provide efficient 
and consistent extraction of codeine and norcodeine from trans­
formation mixtures , systematic studies were carried out on trans­
formation media to which codeine and norcodeine were added. The 
effects of various parameters on the capacity of Partisil 10 ODS-2 
reversed phase material to quantitatively extract codeine and 
norcodeine from transformation media were investigated. These 
parameters included; pH of the transformation media, the temp­
erature at which the extraction was achieved, the flow rate of 
transformation media through the column, the polarity of the 
eluting solvent, and the addition of methanol to the transformation 
media before extraction.
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For 1.02 g of Partisil 10 ODS-2 material in the column 
extraction efficiencies were determined (from Equation 2.9) 
for the extraction of codeine and norcodeine (10 mg of each) 
from transformation media for each of the parameters investigated. 
The results are shown in Table 2.17. Acetone was selected as 
the solvent to elute the compounds from the column since it was 
found to be far more effective than 1,2-dichloroethane and 1,2- 
dichloroethane (80), propan-2-ol (20).
The optimum recovery of codeine and norcodeine occurred 
when the pH of the medium was 8.5, the temperature was 4°C, the 
flow rate of medium through the column was 5 ml/min; acetone was 
the eluting solvent and 5% v/v methanol was added to the medium. 
Extraction efficiencies for codeine and norcodeine under these 
conditions were 70% and 68% respectively, or 6.86 and 6.66 mg/g 
of test compound per gram of packing material.
2.7.2 Group extraction of codeine and norcodeine from transformation 
mixtures employing Amberlite resins (1 gram scale)
Amberlite XAD-2, XAD-4 and XAD-7 resins were examined for 
their capacity to quantitatively extract codeine and norcodeine 
from transformation media as a function of pH of the media.
Codeine and norcodeine sample solutions in media, adjusted to 
the selected pH, were passed through the columns containing each 
type of resin material (1.0 g). Acetone was employed to elute the 
drugs from the column in the desorption stage. The flow rate of 
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experimental temperature was maintained at 25°C in each case.
Extraction efficiencies were determined using Equation 2.9 
and the values obtained are listed in Table 2.18. The maximum 
extraction efficiency was achieved with XAD-4 resin, at a pH of
9.5 for the extraction of norcodeine (95%) and at a pH of 8.5 
for the extraction of codeine (78%). Under the same conditions 
values of 12.6 mg/g and 9.9 mg/g were obtained for the amount 
of norcodeine and codeine extracted per gram of resin. This 
was a considerable improvement compared to the Partisil 10 ODS-2 
material. On the basis of these findings the XAD-4 material was 
employed for the preparative scale extraction of codeine and 
norcodeine from transformation media.
2.7.3 Group extraction of codeine and norcodeine - Amberlite XAD-4
resin (100 g)
In the previous section the extraction efficiency of XAD-4 
resin (1.0 g) was determined by spiking transformation media with 
a known quantity of codeine and norcodeine at a fixed concen­
tration. However, in microbial transformation studies, variable 
concentrations of substrate and the transformation products 
are encountered, with the product concentration in the trans­
formation mixture increasing at the expense of the substrate. 
Therefore the recovery of codeine and norcodeine was determined 
over a range of concentrations employing the XAD-4 resin column 
method. A recovery curve was constructed where the amount 
recovered by extraction was plotted on the ordinate against the
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Table 2.18. The effect of pH on the extraction of codeine and
norcodeine from transformation media by XAD-2 , XAD-4
and XAD-7 Amberlite resins
Resin material pH of Extraction efficiency (%)
media codeine norcodeine
8.5 71 ' 74
XAD-2 9.5 69 87
10.5 67 86
8.5 78 79
XAD-4 9.5 76 95
10.5 75 94
8.5 30 24
XAD-7 9.5 30 25
10.5 35 30
Temperature, 25°C 
Flow rate; 1 ml/min 
Eluting solvent; Acetone
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amount added to the growth medium (abscissa) and the slope of 
the plot was determined. Since the theoretical maximum recovery 
would have a slope of unity the % recovery is given by :-
% recovery = slope of recovery plot x 100%
The extraction of codeine and norcodeine was determined 
simultaneously from transformation medium containing glucose 
(1% w/v) and casein hydrolysate (1% w/v). Codeine and nor­
codeine base were added to the above growth medium (250 ml) 
in each of five flasks to give the ratios given in Table 2.19.
Table 2.19. Ratios of codeine to norcodeine in samples of 
transformation medium (250 ml) for their group 
extraction by Amberlite XAD-4 resin (100 g)
Solution Weight of compound added







The contents of each flask were basified to pH 9.5 by the 
dropwise addition of 2N NaOH, and passed through the XAD-4 (100 g)
96
-1resin column at a controlled flow rate of 2 ml min . Acetone
was passed through the column to desorb the drugs, and the
eluate collected, dried (anhydrous MgSO^), filtered (Whatman 
No. 1 filter paper) and evaporated to dryness on a rotary 
evaporator. The residue was reconstituted in mobile phase, and 
the codeine and norcodeine concentration determined by the straight 
phase HPLC procedure (Section 2.4.3). The total amounts of codeine 
and norcodeine recovered from each flask were plotted against 
the respective amounts of codeine and norcodeine added, and then 
subjected to linear regression analysis. The results obtained 
are given in Table 2.20.
Table 2.20. The % recovery of codeine and norcodeine from
transformation media using the XAD-4 resin procedure,









1 84.9 84.9 - -
2 58.51 83.6 28.95 96.5
3 41.25 82.5 47.87 95.75
4 24.93 83.1 68.11 97.3
5 - - 97.7 97.7
CODEINE NORCODEINE
Slope 0.858 0.985
Std. dev. of slope 0.01026 0.0079
Intercept -1.264 -0.916
Std.dev. of intercept 0.674 0.434
Correlation coeff. 0.9999 0.9999
% coeff. of variation of slope ± 1.196 0.802
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The linearity of the recovery plot demonstrated that the 
extraction efficiency is independent of codeine and norcodeine 
concentration over the range examined. Extraction efficiencies 
of 85.8% and 98.5% respectively, indicated the suitability of 
the procedure for the extraction of both compounds from trans­
formation media.
2.7.4 Straight phase preparative HPLC
(a) Selection of chromatographic conditions
A stainless steel column (250 mm x 22 ram internal diameter)
packed with Lichroprep Si60 silica (15 - 25 ym particle size) was
employed for these studies (Column D, Table 2.16). Generally,
the easiest and most economical way to a preparative separation
8Xis a scale-up from the analytical separation . It uses less 
solvent and time than does the direct use of a preparative column. 
Therefore, the mobile phase developed in Section 2.4.3 for the 
analytical separation of codeine and norcodeine on the Partisil 
5 column, consisting of: 95% ethanol (50), 1,2-dichloroethane 
(45), acetonitrile (5) and triethylamine (4 x ID ^% v/v), was 
initially employed. Detection of the compounds was by UV. It 
was necessary to employ the UV detector at a wavelength ex­
hibiting the lowest sensitivity to codeine and norcodeine, so 
that the peak response remciined on the chart recorder. This 
was determined to be 260 nm for codeine and norcodeine from the 
UV scans of the drugs (Figure 2.1).
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. (b) Determination of the optimum flow rate
Codeine and norcodeine base were dissolved in mobile 
phase to produce a solution containing 4 mg/ml of each compound. 
Samples of this solution (2 ml) were injected onto the preparative 
HPLC column at mobile phase flow rates from 15 to 40 ml/min.
From the chromatograms produced at each mobile phase flow rate, 
values were determined for the average plate number (N) , the 
reduced plate height (h) , the linear flow rate (u) and the 
reduced velocity (v) from Equations 1.3, 1.5, 1.6 and 1.7 
respectively. These data were used to construct plots of h 
against v (Figure 2.8(a)) and (v/h) against v, (Figure 2.8(b)) 
for both codeine and norcodeine. The most efficient flow rate 
for the separation of codeine and norcodeine was then determined 
from these plots, for the stated chromatographic conditions.
In the h against v plot the most efficient flow rate was obtained
46 hwhen h was at a minimum , and in the (v/h) against v plot
82when (v/h) was at a maximum , On this basis the optimum flow 
rate for the separation of codeine and norcodeine on the Lichro­
prep Si60 column was found to be 25 ml/min.
(c) Determination of the column loading capacity at the 
optimum flow rate
The loading capacity of the preparative column was 
determined by injecting successively increasing quantities 
of sample until the components of interest remain just suffi­
ciently pure for the purpose of separation. The loading capacity 






















Fig. 2.8. Determination of the most efficient flow
rate for the separation of codeine (Q ) and 
norcodeine ( A  ) on Lichroprep Si 60 column
100
Loading capacity _ weight of sample separated (mg) ^
(mg/g) weight of column materials (g)
Equal quantities of codeine and norcodeine base were dissolved 
in mobile phase to give a range of increasing concentrations from 
2 mg/ml to 100 mg/ml. Each solution was filtered (Millipore 0.45 ym) 
and samples (2 ml) were injected onto the LiChroprep Si-60 column.
As the components eluted from the column, fractions of the 
peaks were collected, and analysed for purity using the Partisil 
5 straight phase HPLC assay (Section 2.4.3). The following parameters 
were determined from the resulting chromatograms for both codeine 
and norcodeine:- the column capacity ratio at the peak front 
(k )̂ and the peak tail (k^), the average plate number measured 
at 10% of the peak height (N^ ^), the resolution (Rs) between 
codeine and norcodeine peaks, and the symmetry factor (A^^^) for 
each peak. These data were used to construct plots of and ,
Rs and A^^^ respectively, against the quantity of codeine 
and norcodeine loaded onto the column. The plots are shown in 
Figures 2.9 to 2.12. The effect of loading on the peak shape 
of the codeine and norcodeine peaks is illustrated in Figure 2.13.
It was concluded from the column loading studies that a 
maximum of lOO mg each of codeine and norcodeine could be separated 
and resolved on the Lichroprep Si-60 column. Analysis of the 
component fractions collected by analytical HPLC established that 
both codeine and norcodeine were of 100% purity at this loading.
The loading capacity for column D, determined from Equation 2.10, 





Figure 2.9. Column capacity ratios (k) for the peak tail 
of codeine on a used o , regenerated à and repacked column a 
and the peak front of norcodeine on a used • , regenerated











Figure 2.10. Resolution (RS) between codeine and nor­
codeine on a used ( •  ), regenerated (A ) and a 







Figure 2.11. Column efficiencies (N) of codeine on a used 
o , regenerated A and repacked a column, and nor­
codeine on a used # , regenerated 4 and repacked m












Figure 2.12. (A^g^) of codeine peaks on a 
and repacked column a , and
____________  Peak symmetry
used o , regenerated A 
norcodeine peaks on a used • , regenerated
repacked column ■ with column loading.
and
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Fig. 2.13. The effect of loading on the peak shape of codeine 
and norcodeine
codeine 1. 4 mg
2. 50 mg 
3.100 mg 
4.150 mg








Column; Lichroprep Si 60, 15-25 ym, 250 mm x 22 mm I.D,
Mobile phase; 95% ethanol (50); 1,2-dichlogoethane (45); acetonitrile 
(5); Triethylamine (4 x 10 % v/v)
Temperature; 25°C
Flow rate; 25 ml/min
Detection; UV 260 nm
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However, it was envisaged that the loading capacity could be 
increased by 'cleaning' the column, and so a column regeneration 
procedure was attempted.
2.7.5 Attempted regeneration of the straight phase column
The following column regeneration procedure was attempted 
with column D (Table 2.16).
The organic solvents, methanol (15 column volumes), acetone
(15 column volumes) and tetrahydrofuran (15 column volumes) , were
pumped through column D in turn. The column was then removed
from the HPLC pump, and attached to a nitrogen cylinder. A
-1slow bleed (5-10 ml min ) of nitrogen gas was passed through 
the column for 4 hours. The column was then placed inside a 
G.C. oven, and attached to the oven by the inlet end, leaving 
the exit end of the column open. A slow bleed of nitrogen gas 
was passed through the column, as the oven temperature was 
raised slowly at a rate of 2°c per hour until a temperature 
of 150°C was reached. The column was baked for 15 hours at 
150°C with the nitrogen gaë still passing through. Then the 
GC oven was turned off and allowed to cool down naturally, 
without opening the oven door. The column was then disconnected 
from the GC oven, and attached to an HPLC pump. Hexane was 
pumped through the column at 2 ml/min for 2 hours. At least 
10 column volumes of tetrahydrofuran, acetone and methanol 
were pumped through the column in turn at 2 ml/min. Finally, the 
desired mobile phase was pumped through, and allowed to equilibrate
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with the column for one hour.
The loading capacity for the reactivated column (D) was
determined at the optimum flow rate (as described in Section
2.7.4(c)) and the values obtained for the parameters k̂ ,
N , Rs and A used to reconstruct the plots of k, and < ,U • X X 6
^ , Rs and A^^^ respectively against column loading of 
codeine and norcodeine, shown in Figures 2.9 to 2.12 by the 
broken line.
These results show a marginal improvement in column per­
formance with regard to the separation of codeine and norcodeine,
-1but the loading capacity of 3.86 mg g was not a significant 
improvement. Subsequently, column D was repacked with the 
same stationary phase, and the column loading studies with codeine 
and norcodeine repeated once more (see Figures 2.9 to 2.12) .
As a consequence, a mixture containing 135 mg of both codeine 
and norcodeine were separated with 100% purity, giving a loading 
capacity of 5.12 mg codeine and norcodeine per gram of 
stationary phase. These results were compared with values ob­
tained for reversed-phase materials in the following section.
2.7.6 Reversed-phase preparative HPLC
(a) Chromatographic conditions
To save analysis time and solvent usage the codeine- 
norcodeine separation was initially achieved on an analytical 
scale employing column E (Table 2.16). The ratio of methanol
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(organic modifier) to acetate (1% w/v), acetic acid buffer 
was varied to obtain a separation, and this was optimised by 
final adjustment to the pH of the buffer. This occurred with 
a mobile phase of methanol (40), acetate (1% w/v), acetic acid 
buffer (60), pH 6.5 and a flow rate of 1 ml/min. So these 
conditions were used in an attempt to separate codeine and 
norcodeine on a preparative HPLC column (500 mm x 22 mm i.d.) 
packed with a similar stationary phase material (column F,
Table 2.16) . It was found that the optimum separation of 
the components on column F was obtained with a mobile phase 
consisting of methanol (40), acetate (1% w/v), acetic acid 
buffer (60), pH 7.0 and a flow rate of 20 ml/min. When the 
acetate buffer was replaced by phosphate buffer at the same 
pH, the resolution between codeine and norcodeine was improved, 
but the peak shapes were not as good. Typical chromatograms 
obtained with these systems are shown in Figure 2.14.
(b) Loading capacity of column F
For these studies a 10 ml sample loop was employed. 
The detector wavelength was adjusted to its lowest sensitivity 
for codeine and norcodeine (260nm) as shown in Figure 2.1. 
Mobile phase B in Figure 2.14 was selected at a flow rate of 
20 ml/min. Equal quantities of codeine and norcodeine salts • 
were dissolved in the minimum of mobile phase, filtered 
(0.45 ym Millipore Type HA), and injected onto column F .
The peak fractions were collected and analysed for purity 
using the Partisil 10 ODS-2 reversed-phase assay (Section 















quantities of test compounds until a separation was no longer 
achieved, and the purity of the eluted compounds was less than 
95%.
It was concluded that a maximum quantity of 1002 mg 
(equivalent to 552 mg codeine base and 450 mg norcodeine base) 
in a 10 ml injection sanple could be separated and resolved 
from column F, with a purity of 98%. This corresponds to a 
loading capacity (from Equation 2.10) of 9.48 mg test compounds 
per gram of stationary phase.
2.7.7 The combined group and fractionating extraction of codeine 
and norcodeine from 7 litre fermenter samples 
6,900 ml of transformation mixture was taken from the 7 
litre fermenter after ten days incubation with Cunninghamella 
bainieri (C43) and basified to pH 9.5 by the dropwise addition 
of 5N NaOH. The fungal cells were filtered (Whatman No. 1 
filter paper) under negative pressure and washed with distilled 
water. An aliquot (1 ml) was taken for HPLC analysis (Partisil 
10 ODS-2 method, section 2.4.4) to determine the initial 
quantity of codeine and norcodeine present in the mixture.
The mixture was then divided into approximately three equal 
portions. Each portion was extracted in turn employing the 
Amberlite XAD-4 resin (100 g) column procedure described in 
Section 2.7.3, and acetone to finally desorb the alkaloids 
from the column. The acetone eluates were combined, dried 
(anhydrous MgSO^), filtered (Whatman No. 1 filter paper)
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and divided into two equal fractions. Each fraction was evaporated 
to dryness on a rotary evaporator to leave two residues. These 
were dissolved in the minimum of the respective mobile phases, 
and the codeine and norcodeine in one of the samples was separated 
by straight phase preparative HPLC (Section 2.7.4), and in the 
other sample, by reversed-phase preparative HPLC. Pure codeine 
and norcodeine were recovered from the straight phase mobile phase 
fractions by evaporating the organic solvent to dryness. Recovery 
from the reversed phase mobile phase was achieved by removing 
the organic component by evaporation (Rotary evaporator), basifying 
to pH 9.5, and re-extracting the drugs using the XAD-4 (lOO g) 
column. A schematic diagram to illustrate the total extraction 
scheme is shown in Figure 2.15. At every stage of the proceedings 
aliquots of sample were taken for analytical HPLC analysis to 
determine the recovery and purity of the drugs. These data are 
shown in Table 2.21 and are discussed on page 126.
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Figure 2.15. The total extraction and isolation of codeine and 
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2.8.1 Analytical HPLC methods
Codeine and norcodeine both contain basic groups which ionise 
in aqueous solution depending on the pH. The pKa values of 7.84 
and 8.79 (± 0.02) were obtained for the potentiometric titration 
of 0.01 M solutions of codeine and norcodeine respectively at 
25°C. These pKa values were required in order to calculate the 
extent of ionization of these compounds in aqueous media (from 
Equation 2.7) at a given pH. This acquired data was employed, 
for example, to predict the optimum pH for the extraction of 
codeine and norcodeine from the media, as generally only uncharged 
species tend to partition into the organic phase. Alternatively, 
the degree of ion pairing in reversed phase HPLC depended on the 
pH of the aqueous mobile phase, so that ion pairing only occurred 
if the solutes were in their charged or ionized state.
In order to study codeine and norcodeine by HPLC a suitable
method for their detection was required. The ultraviolet (UV)
29detector is probably the most widely used of detectors , and 
is employable if the substances of interest absorb radiation 
in the UV region of the spectrum. The UV scans shown in 
Figure 2.1 demonstrated adequate UV adsorptions for both drugs.
The UV detector was therefore employed for all the HPLC studies 
described in this chapter.
The codeine and norcodeine separation was initially achieved 
by T.L.C. This is an acceptable procedure, because the mode of
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separation in both TLC and straight phase HPLC is based on 
liquid-solid adsorption, and there is often a direct correlation 
between the TLC separation, and the separation on a silica 
HPLC column^^. This was found to be true for a series of 
alkaloids investigated as potential internal standards for 
the Partisil 5 HPLC assay (Section 2.4.3(c)). For each of 
the alkaloids investigated the column capacity ratio (k )
84was determined on column A. From published TLC retention data 
on silica gel TLC plates impregnated with a base, and ethanol 
as mobile phase, a series of Rm values was also obtained 
for the alkaloids investigated, where :-
Rm = log ( ^  - 1 ) 2.11
The Rm value is a measure of the TLC retention of the solute.
The graph of log k against Rm (Figure 2.16) was linear suggesting 
that there was a direct correlation between the TLC retention 
of each alkaloid and HPLC retention.
The distance travelled by a compound on a TLC plate will 
depend on the relative affinity of the compound for the stationary 
and mobile phase, and the choice of solvent(s) in the mobile 
phase will determine the retention value. Attempts have been 
made to quantify the strength of solvents by giving them 
numerical values based on their dielectric constants^^, their 
solubility^^ or their polarity^^. Snyder^^ introduced à 
solvent characterization parameter (P*) which distinguishes 
between solvent strength (the ability to dissolve more polar
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Fig. 2.16. Relationship between HPLC retention data and
published TLC retention data for a series of alkaloids.
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molecules preferentially) and solvent selectivity (the ability 
to dissolve one compound selectively as opposed to another where 
the polarities are similar). Solvents were classified into groups 
on the basis that similar classes of solvent will behave 
similarly, and each solvent was quantified to give even greater 
precision in the characterization of solvents used in chromato­
graphy. Solvents were therefore selected from Snyders classi- 
88fication tables to modify the composition of mobile phase and 
give an adequate separation of codeine and norcodeine by TLC 
(Table 2.2).
From the TLC data a series of mobile phases were developed
(Table Z.3) to achieve a separation on the Partisil 5 )jm column
(A). These were essentially of the same composition as the TLC
mobile phases developed previously except for the concentration
of base (triethylamine), which was reduced to minimise baseline
noise. Strychnine was found to be the most suitable internal
standard, of the alkaloids investigated, because its retention
was equidistant between the retentions of codeine and norcodeine.
An HPLC assay was performed to quantitatively determine codeine
and norcodeine in a concentration range likely to be encountered
18in transformation studies , employing strychnine as the 
internal standard. Although this procedure produced excellent 
linear regression results (Table 2.6), it suffered from a dis­
advantage that the drugs have to be extracted from the trans-
18formation media prior to their analysis. Sewell has reported 
a possible extraction procedure employing 1,2-dichloroethane 
at pH 10.5, with extraction efficiencies of 98 and 96%
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for codeine and norcodeine respectively, but this presents an 
extra time consuming step in the analysis. However, it was 
envisaged that this problem may be overcome by employing a 
reversed phase HPLC method, and analysing the samples directly 
from transformation mixtures.
In the initial studies column B (Table 2.1) containing 
Partisil 10 ODS-2 was selected for its high carbon loading of 
15%, which was thought to be an advantage for the increased 
retention of codeine and norcodeine in complex biological 
samples such as transformation media.
In reversed phase chromatography the mobile phase is 
usually a combination of water, and a water miscible organic 
solvent (organic modifier). Solute retention can be modified 
in various ways, for example, by manipulation of the water to 
organic modifier ratio , by changing the pH if the solute is 
ionizable, or by selecting a different organic modifier. Unlike 
the straight phase system, it would have been uneconomical to 
employ TLC to find a suitable mobile phase, because reversed 
phase TLC plates are relatively expensive.
A systemetic procedure was adopted to select the most
suitable mobile phase. First, an organic modifier was sought
which separated the compounds of interest. The separation was
then optimised by adjusting the organic modifier to water ratio
and/or the pH of the mobile phase. The organic modifier was
88selected from Snyder's classification of solvents , where the
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relative ability of each solvent to interact as a proton donor, 
proton acceptor or dipole is measured by Xd, Xe and Xn values 
respectively. Solvents with the same solvent strength P ', but 
different values of Xd, Xe and Xn contributions will show 
selectivity changes,which may lead to a better separation of the 
sample components. The organic modifiers investigated are listed 
in Table 2.7, with their particular solvent strengths and 
selectivity values. As a result of this investigation, the 
mobile phase consisting of methanol (30): acetate buffer (70), 
pH 5.5 was selected for the HPLC assay of codeine and norcodeine
-3employing column B. With this system, detection limits of 1 x 10 
-1mg ml were obtained for both codeine and norcodeine, and the
-3 -1detector response exhibited a linear range from 1 x 10 mg ml 
-1to 1 mg ml , with the precision of response shown in Table 2.11. 
These results demonstrated the suitability of the Partisil 10 
ODS-2 method for the quantitative determination of codeine and 
norcodeine in mobile phase. However, when the assay was repeated 
with samples in transformation media the resulting chromatograms 
revealed a variable large solvent front peak which partially 
and sometimes completely obliterated the morphine standard 
peak. It was not considered feasible to employ a standard that 
eluted after the codeine and norcodeine peaks. This was because 
the transformation levels normally encountered are of the order 
5 to 20% norcodeine, which ensures that the codeine peak will be 
variable and about 5 - 1 0  times greater than the norcodeine 
peaks. As codeine elutes after the norcodeine, it would 
probably obliterate a standard if included. However, regression 
analysis results for peak heights and areas against concentration
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of codeine and norcodeine in transformation media, indicated 
that the assay was unaffected by components in the media. This 
was further ratified by the excellent precision obtained for 
repeated injections of sample in transformation media (Table 
2.13). It was concluded therefore that the Partisil 10 ODS-2 
assay could be employed as an external standard procedure for 
the determination of codeine and norcodeine directly from trans­
formation media.
A more sensitive assay was required for the determination 
of these drugs at the low transformation concentrations that 
may be encountered in enzyme kinetic studies. Column C (Table
2.1) packed with ODS-Hypersil 5 ym was employed in an attempt 
to achieve this, and the systematic procedure established in 
the previous section to select a mobile phase for Column B 
was now repeated for Column C. The more compact nature and 
smaller particle size of ODS-Hypersil, compared with Partisil 
10 ODS-2, created a higher back pressure in the system, which 
restricted the mobile phase flow rate. This was overcome 
by replacing methanol with a less viscous organic modifier, 
acetonitrile, in the mobile phase. Acetate buffer was replaced 
with a phosphate buffer to improve the column efficiency and 
reduce peak tailing, but the most significant modification 
of all, was the addition of an ion-pairing agent to the 
mobile phase. Pentane sulphonic acid was employed, and the pH 
adjusted so that both codeine and norcodeine paired with it, 
enhancing their retentions at the expense of the solvent front 
(Figure 2.6(A)).
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The results of the HPLC assay of codeine and norcodeine, 
using the ODS-Hypersil column, demonstrated a tenfold increase
in sensitivity over the Partisil 10 ODS-2 method with detection
—4 . —4limits of 1 X 10 mg/ml, and a linear range tested of 1 x 10
-2mg/ml to 25 x 10 mg/ml. Furthermore, there was no interference 
from the solvent front, illustrated by a typical chromatogram 
of the codeine-norcodeine separation in transformation media 
(Figure 2.6(B)), and the precision was unaffected when repeated 
in transformation media (Table 2.15). It was concluded that 
the ODS-Hypersil 5 ym HPLC assay was suitable for the direct 
analysis of codeine and norcodeine in transformation media, 
and sensitive^ enough for enzyme kinetic studies.
2.8.2 Isolation and purification methods
Hydrophobic surfaces of non polar Cg or C^g reversed-phase
HPLC materials have been employed previously for the extraction
of a wide range of organic molecules^^. Little and Fallick^^
reported on the use of very large injection volumes of up to
200 ml for relatively non polar compounds applied from an
aqueous solution to a Cg reversed-phase column. Similar
techniques were reported for peptides and alkaloids injected
90 91from aqueous solutions ' . The relatively non polar organic
species are injected from an aqueous solution onto the 
hydrophobic surface, and become immobilised until the elution 
strength of the solvent mixture is increased. This allows the 
compound(s) to concentrate into a very small zone on top of 
the reversed-phase column. The components are eluted with a
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suitable agent usually with little band broadening, and this 
provides a method for the extraction of components from biological 
samples such as transformation mixture*.
The extraction of codeine and norcodeine from transformation 
media by the Partisil 10 ODS-2 reversed-phase material was found 
to depend on the pH of the transformation media, the addition 
of methanol to the transformation media before extraction, tran­
sformation media flow rate through the column, the polarity of 
the eluting solvent and the temperature at which the extraction 
was achieved (Table 2.17). Optimum extraction efficiencies
for codeine and norcodeine of 70% and 68% respectively (and
-16.86 and 6.66 mg g test compound per gram of packing material
respectively). were obtained at a pH of 8.5, with 5% v/v added
methanol, at a flow rate of 5 ml/min, with acetone as the
oeluting solvent and at a temperature of 4 C. However, it was 
considered that the results could be improved if a more suitable 
material was employed.
The extraction of drug molecules from body fluids with
Amberlite resins has been shown to be comparable, if not better
than, conventional liquid/liquid extraction techniques in terms
92-94of time, efficiency and cost . For example, procedures
92for the rapid, efficient and reproducible extraction of morphine ,
93amphetamine and phenobarbitone from urine by XAD-2 resins 
have been described with recoveries of 90 - 100% The resin 
extraction procedure involves single adsorption and desorption 
steps, and the overall resin-extraction efficiency is dependent
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upon several parameters including the pH of the media, flow
rate of media through the column, polarity of the eluting solvent,
93and the flow rate of the eluent
Of the resins examined (Table 2.18) the best recoveries 
of codeine and norcodeine from transformation media were achieved 
with XAD-4 resin. This occurred at a pH of 9.5, flow rates of 
1 ml/min for media and the eluent through the column, and using 
acetone to elute the components from the column. Under these
conditions 95% norcodeine and 76% codeine were extracted from
-1 -1 the media, with'values of 12.6 mg g and 9.9 mg g respectively
for these compounds per gram of XAD-4 resin. This represented
a considerable improvement over the Partisil 10 ODS-2 material.
The parameters which affect the extraction of drugs from
biological fluids by Amberlite resins have been discussed by 
92Miller et al. . It is possible that the same parameters apply
to drug extractions with reversed phase HPLC materials. These
authors found that the extraction of morphine frcxn urine by
XAD-2 resin was significantly influenced by the urine pH.
Adsorption of morphine by the non-ionic resin was thought rto
92occur by Van der Waals forces , hence it was highest at the 
pH where morphine is electrically neutral, and adsorption was 
decreased at pH's where the phenol or amine function of the morphine 
molecule were ionized. The extraction of codeine and norcodeine 
from transformation media, with both Partisil 10 ODS-2 reversed 
phase HPLC material, and the Amberlite resins, increased with 
the pH of the media (Tables 2.17 and 2.18). Incorporating
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the pKa values for codeine and norcodeine (determined in Section
2.4.1) into Equation 2.7 shows that only 0.25% codeine and 1.96%
norcodeine is ionized at pH 10.5. This could explain the
higher extraction efficiencies at alkaline pH's, because the
non-ionized drug will be less soluble in aqueous media, and
more likely to be adsorbed onto the non-ionic resin surface.
With the reversed phase procedure the addition of 5% v/v methanol
to the transformation media was found to improve the extraction
results (Table 2.17). The additional methanol may serve to
increase the reversed phase to water surface area by keeping
the brush surface wetted and open during the adsorption stage
of the extraction procedure. Another parameter influencing the
adsorption of codeine and norcodeine from the transformation
media was the flow rate of media through the column (Table 2.17) .
92Miller et al. , comparing the extraction efficiency of morphine 
from urine when passed through an XAD-2 resin column at gravi­
tational flow rates and at controlled flow rates found that 
increased adsorption efficiency and reproducibility were obtained 
when the flow was controlled, and generally the adsorption
was improved at lower flow rates. A controlled flow rate of 
-11 ml min was subsequently employed for the extraction of 
codeine and norcodeine from transformation media using the 
Amberlite resins.
The desorption of drugs from the resin is a competition
between the resin adsorption forces and the ability of an organic
92solvent to solubilise the drugs adsorbed onto the resin surface 
Thus acetone was found to be more efficient than 1,2-dichloroethane,
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or 1,2-dichloroethane (80); propan-2-ol (20) for the elution 
of codeine and norcodeine. The addition of polar propan-2-ol 
would be expected to be beneficial only if the drugs used were 
significantly polar.
Finally, the experimental temperature at which the extraction 
was conducted influenced the results (Table 2.17). The ex­
traction efficiency was improved at the lower temperature of 
4°C. However, it was not considered practicable or economical 
to use such a temperature on a continuous basis.
As a result of the group extraction experiments, XAD-4 
resin was selected for the extraction of codeine and norcodeine 
from transformation media,and using a lOOg of XAD - 4 resin 
these drugs were simultaneously recovered from media (250 ml). 
with extraction efficiencies of 85.8% and 98.5% respectively.
There are two parameters generally used to describe the
95performance of a preparative HPLC system . These are the 
'loading capacity' defined as the maximum amount of sample that 
can be applied without impairing the separation efficiency, 
and the 'throughput' defined as the amount of pure substance 
that can be separated per unit time. The design and operation 
of a preparative system is usually based on optimising these 
parameters with respect to time, solvent consumption and the 
smallest possible dilution of the sample in the effluent. 
Theoretical and experimental investigations have been carried
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out to find rules for the selection of the optimal working
95conditions in preparative HPLC . They have shown that the 
loading capacity and throughput are determined by a series of 
parameters, of which the most important are column length and 
diameter,linear flow velocity, particle size, sample size and 
concentration, number of theoretical plates required and 
separation efficiency of the column in terms of plate height 
and selectivity^^. It has also been demonstrated^^ that as 
soon as the phase system, column dimensions and particle size 
have been selected the throughput is proportional to (v/h) 
where v is the reduced velocity and h is the reduced plate 
height. This means that one must work under conditons where 
v/h is as high as possible, and h is as low as possible, for 
a particular mobile phase flow rate.
Adopting these principles, the optimum mobile phase flow
rate for the codeine-norcodeine separation on the LiChroprep
Si 60 column (D, Table 2.16,) was determined fron plots of h
against v, and (v/h) against v, (Figures 2.8(a), (b)) to be 
-125 ml min . Column loading studies performed at the optimum 
flow rate revealed a loading capacity for the complete separation 
of equal quantities of codeine and norcodeine on Column D to be 
3.76 mg codeine and norcodeine per gram of LiChroprep Si 60 
silica.
The continuous injection of large amounts of sample and/or 
dirty samples (such as transformation media) can contaminate 
any HPLC column.Strongly adsorbed contaminant may accumulate
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gradually on the packing material. If they are not washed off 
the column, and for example, the eluting power of the solvents 
used remains constant, then the effect can be seen on decreased
kappa (k ) values for the compounds tested and a reduced resolution.
97HPLC columns are expensive . and therefore it is desirable
to salvage existing columns by some method of regeneration
without unpacking and repacking them. The final theoretical
plate count for the regenerated column should be close to the
original one, and the surface properties and activity of the
final column should be similar to the original. A thermal
method ofregenerating column D was attempted (Section 2.7.5)
and the final column was checked for activity by repeating the
column loading studies. However, the retention parameters,
kappa (k), column efficiency (N^ ^), resolution (Rs) and the
symmetry factor, plotted against column loading of codeine and
norcodeine, before and àfter column regeneration (Figures 2.9
to 2.12) show that there was only a marginal improvement in
column performance using this method of regeneration. Subsequently,
Column D was repacked with fresh LiChroprep Si 60 silica, and
the column loading studies repeated once more (see Figures 2.9
to 2.12 for the column performance results). As a consequence
it was found that the column would separate 135 mg each of codeine
and norcodeine in a sample, with 100% purity, equivalent to a
-1loading capacity of 5.12 mg g These values were significantly 
greater than those obtained with the original and regenerated 
columns respectively with LiChroprgp Si 60. However, it was 
thought that the employment of a reversed phase material may
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improve the loading capacity further, with the advantage that
it might be used for longer periods of time without the need
for column regeneration. Hence, further attempts were
made to improve the loading capacity by utilising LiChroprep
RP18, 25 - 40 ym material with a .22% carbon loading, selected
for its high retention and loading characteristics. The loading
capacity obtained for the complete separation of codeine and
-1norcodeine (98% purity) was 9.48 mg g and equivalent to 
552mg codeine base and 450 mg norcodeine base in a 10 ml volume 
injection. The limiting factor was not the capacity of the column 
to separate the codeine from the norcodeine, but the solubility 
of thèse compounds in mobile phase. It was not considered 
feasible to employ a larger volume loop in this case because of 
the problems associated with injecting the sample with the column. 
For example, it may be necessary to use a second pump to do this.
A scheme was designed to demonstrate the efficiency of the 
combined extraction procedures developed to recover codeine 
and norcodeine from transformation media (Figure 2.15). A,
7 litre batch'.of fermentation liquor from a fermentation run 
was processed, and the % recovery after each stage of the 
extraction scheme determined by analytical HPLC(Table 2.21)
The complete beatch of liquor was initially passed through the 
100 g XAD-4 resin column to extract the drugs on a group basis. 
This was achieved by dividing the sample into three equal 
portions because the total quantity of drugs in the whole sample 
exceeded the extraction capacity of the resin. The recovered 
sample was then divided into two equal portions, and one sample
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was.Tpasséd through the straight phase preparative column (D) and 
the other portion through the reversed phase preparative column 
(F), to isolate pure codeine from norcodeine. An extra 
extraction step was required after the reversed phase separation 
to recover the drugs from the aqueous mobile phase. Consequently, 
the final recovery of the drugs from the fermented sample 
(Table 2.21) employing the reversed phase proecedure was slightly 
lower than the recovery employing the straight phase procedure 
(71.25% codeine and 80.69% norcodeine, compared to 79.20% 
codeine and 83.97% norcodeine respectively). However, the 
reversed phase system may be more economical in long term use 
compared to the straight phase system. The mobile phase employed 
for the reversed phase system was simpler (water combined with 
an organic modifier) and hence less expensive,as opposed to 
the tertiary component organic mobile phase employed for the 
straight phase system. In addition the reversed phase column 
was found in practice to provide longer service without the 
need for regeneration or repacking. Finally, the throughput 
and loading capacity that could be achieved with the reversed 
phase column for codeine and norcodeine was found to be far 
superior to the straight phase column material. This is most 
important in batch work to cope with the sample load, using the 
least solvent and analysis time.
CHAPTER THREE




Chapter 3. The N-déméthylation of codeine by submerged cultures of 
Cunninghamella sp.
3.1 Introduction
The growth and transformation ability of submerged cultures of
Cunninghamella species have been demonstrated in previous studies 
18by Sewell . A codeine substrate was N-demethylated with high
reproducibility when a two-stage growth and incubation protocol
was adopted. Employing glucose as the carbon source, codeine N-
demethylation was only observed after all the glucose was depleted
from the growth medium. This finding was attributed to glucose
inhibiting the synthesis of the N-demethylase enzyme in a form of
18catabolic repression . This phenomenon was not observed when 
succinate was employed as the carbon source.
Several workers have demonstrated the ability of Cunninghamella 
sp. to utilise n-alkanes for the construction of biomass^^ 100^ More 
recent studies have shown the possible involvement of monooxygenases 
in the metabolism of gaseous alkanes and hydrocarbons^^^. The 
metabolism of ethane, propane and butane by the fungus Acremonium 
required the presence of NADPH, and was inhibited by carbon monoxide, 
but not cyanide, characteristic of monooxygenase activity^^^.
More conclusive evidence for the association of n-alkanes with 
monooxygenase activity has been demonstrated in yeasts^^^. Lebeault 
et for example, reported the presence of a cytochrome P-450
type monooxygenase in Candida tropicalis utilising tetradecane as 
the sole carbon source. This system was capable of effecting the
\
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W  -hydroxylation of fatty acids and alkanes, showed a dependence
on molecular oxygen and NADPH, and was inhibited by carbon monoxide,
but not cyanide. The hydroxylase activity was induced by the
presence of tetradecane dispersed in the medium, but not by the
presence of glucose^^^. Similar studies have shown that other
suspected, monooxygenase enzymes can be induced by growing cultures
103-104on hydrocarbon sources and in particular, tetradecane
The aim of this study was to compare the growth and transform­
ation ability of submerged cultures of Cunninghamella in the presence 
of tetradecane; succinate and glucose carbon sources. Examination 
of the transformation profiles would show if tetradecane is cap^le 
of inducing the N-demethylase enzyme in Cunninghamella resulting 
in an increase in codeine N-demethylation.
3.2 Materials
3.2.1 Microorganisms
C. echinulata: IMI 199844; obtained from the Commonwealth
Mycological Institute, Kew, Surrey 
C. bainieriz C43; obtained from the American Cyanamid Company,
Lederle Laboratories, Pearl River, New York, U.S.A. 
Microorganisms stored under liquid nitrogen were transferred to 
Malt Extract Agar Slopes and incubated for 2 - 5  days at 27°C. The 
stock slopes were maintained at 4°c and subcultured at intervals 




Malt Extract Agar (Oxoid Ltd.) was prepared according to 
the manufacturer's directions. 10 ml.volumes were added to 20 ml. 
screw-capped glass universal containers, sterilised by autoclaving 
at 121°C for 15 minutes, and then inclined during cooling to produce 
a slope.
b) Chemically defined basal media:
These were prepared frcm Analar grade reagents (BDH Ltd.), 
and glass distilled water:
Stage-one basal medium. (mg £ ^); KH^^O^ (378.0), Na^HPO^.I2H2O
(989.0), (NH^)2S0^ (667.0), MgS0^.7H20 (28.0), CaCl2.2H20 (5.6), 
ZnS0^.7H20 (22.0), MnS0^.7H20 (2.20), CuS0^.5H20 (0.56),
FeS0^.7H20 (11.10), Na2S0  ̂ (56.0), NaMo0^.2H20 (5.60), disodium 
EDTA (66.70).
The above medium was prepared as a double strength solution, 
packed in 500 ml Schott bottles, and autoclaved at 121°C for 20 
minutes.
-1Stage-two basal medium. Salts (mg £ ); K2HP0  ̂ (3327.0), NaIÎ2P0^.2H20
(732.0), (NH^)2S0  ̂ (500.0), MgS0^.7H20 (290.0), disodium EDTA
(290.0).
-1Trace elements (mg £ ); CaCl2-2H20 (33.0), (NH^)^Moy02^.4H20
(93.0), FeS0^.7H20 (3.50), ZnS0^.7H20 (5.50), MnS0^.4H20 (0.75t,
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CuSO^.SH^O (0.20), Co(N02)2.6H20 (0.125), Na2B^0^.IOH2O (0.09).
The salts mixture was prepared as a double strength solution and 
was sterilized by autoclaving at 121°C for 20 minutes. The trace 
elements were dissolved in distilled water to produce a 50 X 
concentrate and the solution was sterilized by membrane filtration 
(0.2y pore size)
c) Amino acid mixture
A solution of 12 amino acids (Sigma London Chemical Co.)
-1(mg ml ) v/as prepared in 10 ml. distilled water; Arginine (1.87), 
aspartic acid (4.69), glutamic acid (1.40), glycine (0.94), histidine 
(1.40), isoleucine (3.75), lysine (4.68), methionine (0.94), 
phenylalanine (1.87), threonine (1.87), tyrosine (0.94), valine (3.75) 
The mixture was sterilized by membrane filtration and used within 
48 hours of preparation.
d) Carbon source solutions
Glucose and sodium succinate (Analar, BDH Ltd.) were 
dissolved in distilled water to produce 10% w/v solutions, and 
sterilized by membrane filtration. Tetradecane (Aldrich Chemical 
Co. Ltd.) was filter sterilized without dilution.
3.2.3 Chemicals and reagents
Tetradecane; Aldrich Chemical Co. Ltd.; n-hexane (HPLC grade); 
Fisons Ltd., Loughborough, U.K. Reagents used for the glucose 
determination were purchased from Sigma London Chemical Co. Ltd.:-
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PGO enzyme capsules, each containing peroxidase from horseradish 
(100 Purpurogallin units), glucose oxidase from Aspergillus niger 
(500 I.U.) and buffer salts. The contents of one PGO capsule 
were dissolved in distilled water (100 ml) contained in a foil 
covered glass bottle to produce reagent A.
dianisidine dihydrochloride, preweighed vial (50 mg) , the contents 
of which were reconstituted with distilled water (20 ml) to produce 
reagent B.
The combined enzyme-colour reagent (reagent C) was prepared by 
addition of reagent B (1.6 ml) to reagent A (100 ml) . Reagent C 
was stored at 4°C and used within 14 days of preparation,
-1Glucose standard solution, containing 3-D-glucose (1.0 mg ml ) 
in benzoic acid solution (0.1%), which was stored at 4°C.
3.2.4 Equipment and instrumentation
Automatic pipettes: Triple range (0.2, 0.5 and 1.0 ml) ,
Oxford Laboratories.
Variable range Gilson pipette; (Pipetman, 0.2 to 1.0 ml and 1 ml 
to 5.0 ml) Gilson Medical Electronics, France.
Pipette tips (polypropylene) were supplied by the respective pipette 
manufacturer. Tips were packed into DRG autoclave bags and steri­
lised by autoclaving at 121°C for 20 minutes.
Culture flasks; 250 ml., borosilicate glass, corner baffled, 
and Kipps burettes (5 and 10 ml volumes) ; Gallenkamp Co. Ltd.
Filtration units; Swinnex units, Millipore Corporation, Massachusetts, 
U.S.A.
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Rotary incubator; New Brunswick G25R, cooled, gyrotatory with 1" 
stroke. New Brunswick Scientific Co. Inc., New Jersey, U.S.A.
Gas Liquid Chromatograph; Packard Model 438, fitted with a flame- 
ionisation detector, Packard Instruments Ltd., Reading, England. 
GLC column; 1 m, glass, 4 mm. i.d. packed under nitrogen with 
3% SE-30 Ultraphase on Chromosorb W-HP, 100/120 mesh. Phase 
Separations, Queensferry, Clwyd.
GLC syringes; lixl volume. Scientific Glass Engineering UK Ltd., 
London.
3.3 Methods
3.3.1 Conditions for the growth and incubation of cultures
Microorganisms were grown and incubated in submerged liquid
18cultures according to the 2 stage protocol described by Sewell 
Sterile growth medium for stage-one cultures consisting of;- 
stage-one basal medium (25 ml.), amino acid mixture (5 ml.), carbon 
source solution (5 ml ) and distilled water (to 50 ml), was 
inoculated with mycelium from freshly prepared stock slopes of 
Cunninghamella, The stage-one cultures were incubated at 27°C 
with rotary agitation of 250 rpm for 3-4 days to produce a pelleted 
growth form. This was aseptically transferred to a sterile, 250 ml 
conical flask fitted with a sterile Kipps burette (10 ml). The 
flask was gently swirled to prevent settling of the mycelial 
pellets and 10 ml was dispensed into stage-two culture flasks 
containing sterile stage-two growth medium (stage-two basal medium
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25.5 ml., amino acid mixture (5 ml.), carbon source solution (5 ml.) 
and distilled water to 50 ml.). Stage-two cultures were incubated 
at 27°C with agitation of 250 rpm for 24 hours. The codeine phos­
phate substrate was then added as a filter sterilised solution 
to give a final codeine concentration of 1 mM in each stage-two 
culture (unless otherwise stated), and incubation was continued, 
for the required period (10 days, unless otherwise stated).
3.3.2 Estimation of biomass
Growth of cultures was estimated by determination of the 
dry cell weight of the biomass.
Whatman 542 hardened, ashless filter papers, 9.0 cm diameter,
were placed in petri dishes and dried in an oven at 70°C with the
lids removed. The petri dish, filter and lid units were then
allowed to cool to room temperature in a desiccator, and weighed
on an analytical balance. The entire contents of the culture vessel
were filtered through the filter paper in a Büchner apparatus under
negative pressure. Vessels were rinsed with distilled water (2 x
10 ml.) which was also filtered. The filter papers plus retained
material were transferred back to their respective petri dishes,
odried in the oven at 70 C to constant weight, and allowed to cool 
to room temperature in a desidcator. The petri dish units were 
re-weighed to determine the dry cell weight (DCW) of the bicmass.
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3.3.3 Determination of glucose in transformation media
Glucose was determined by the glucose oxidase procedure of 
Raabo and Terkildsen^^^. The assay is based on the oxidation 
of a colourless indicator 0-dianisidine by hydrogen peroxide 
formed from the oxidation of glucose. Oxidised dianisidine is 
coloured and is estimated spectrophotometrically.
a) Construction of the standard curve.
Standard solutions containing g-D-glucose over the concentration 
-1range 0.5 to 3.0 mg ml in stage-two growth medium were prepared.
Each standard solution was diluted 1 in 20 with distilled water
and an aliquot (0.5 ml) was pipetted into a stoppered test tube.
Reagent C (5.0 ml) was added to each tube and the contents
mixed thoroughly. A blank was also prepared containing distilled
water in plao.e of the standard solution. All tubes were incubated
in the dark at 37°C for 30 minutes. The tubes were then cooled 
oto 20 C in a water bath and the absorbance of each mixture was 
measured spectrophotometically against the blank at 450 nm. A 
plot of the absorbance obtained against the concentration of the 
standard solutions is shown in Figure 3.1 and gave the following 
linear regression analysis;
slope = 0.2 25
intercept = -0.0076
correlation coefficient = 0.998
The results show a direct correlation between the colour 
intensity produced in the assay and glucose concentration in the 
growth medium.
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(b) Determination of glucose in transformation media
Transformation samples (5.0 ml) were centrifuged (3000 rpm,
15 minutes) to remove cellular material. Clear supernatant 
was diluted 1 in 100 with distilled water to give glucose concen­
trations within the standard curve. Aliquots (0.5 ml) of these 
solutions and also of a distilled water blank were mixed with
reagent C (5.0 ml) and incubated at 37°C for 30 minutes. A 1 in
-120 dilution of the standard glucose solution (1.0 mg ml ) was 
similarly treated. The absorbance of each solution (at 20°C) 
was read against the blank at 450 nm, and the glucose concentration 
was calculated from equation 3.1
Glucose concentration _ Absorbance 450 nm of test x 5 
(mg ml"^) Absorbance 450 nm standard . 3.1
3.3.4 Determination of tetradecane in the transformation media 
Tetradecane in the transformation media was determined by 
the GLC procedure described below,
(a) Assay conditions; A glass column (1 m x 4 mm i.d.) packed
with SE-30 stationary phase and nitrogen carrier gas, at a flow
-1rate of 15 ml. min , were enployed. The flow rates of hydrogen
-1and air to the flame ionization detector were 25 and 250 ml.min 
respectively. With the oven temperature and injection temperature 
both at 190°C, and the detector temperature at 210°C, the retention 
time for tetradecane was 4 minutes.
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(b) Selection of internal standard; A known amount of an internal 
standard was added to the sample to compensate for minor fluctuations 
in the sample volume injected. The ratio of peak height of the 
analyte peak divided by peak height of the standard peak, is 
independent of the sample volume injected, provided that the
amount of each component injected is within the linear region of 
the assay. Tetradecanol was selected as the internal standard 
and had a retention time of 10.6 minutes for the assay conditions 
described in 3.3.4(a). A typical chromatogram is shown in Figure
3.2 with a summary of the assay conditions.
(c) Calibration procedure:
A series of calibration solutions was prepared by adding 4 ml
-1of a solution of tetradecanol in hexane (5 yg ml ) to the sample 
volumes of tetradecane shown in Table 3.1 contained in glass tubes 
and adding hexane to give a final volume of 5 ml in each case.
The tubes were capped and the samples mixed on a vortex mixer 
for 2 minutes. Each sample was assayed in duplicate by the GLC 
procedure injecting 1 yl volume each time. The continuous line 
in Figure 3.3 shows a plot of the peak height ratio of tetradecane/ 
tetradecanol against the concentration of tetradecane in hexane 




correlation coefficient = 0,9998
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Minutes
Analytical conditions
Column; 3% SE-30 on Chromosorb W-HP, 1 m x 4 mm i.d
-1Carrier gas; nitrogen, flow rate 15 ml min
oOven temperature ; 190 C 
Detection; F.I.D.
Injection volume ; 1 yl.
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The results indicated that the GLC assay was suitable for the 
estimation of tetradecane in hexane. It was therefore used to 
determine the extraction efficiency for the extraction of tetra­
decane from transformation media.
(d) Extraction of tetradecane from transformation media; Sample 
volumes ranging from 100 yl to 500 yl of tetradecane were transferred 
to test tubes (100 ml) each containing transformation medium (50 
ml.). The tubes were capped and each mixture was vortexed for 
2 minutes to disperse the tetradecane. A sample of the homogeneous 
mixture (2 ml.) was pipetted into a glass vial containing 0.5% 
tetradecanol in hexane (2 ml) and the mixture vortexed again for 
2 minutes. Samples (1 yl) of the hëxane upper layer were analysed 
by the GLC assay.
The broken line in Figure 3.3 shows a plot of the peak height
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Figure 3.3. Data for the extraction and GLC analysis of
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ratio of tetradecane to internal standard against the concentration 
of tetradecane in the growth medium samples. The regression 
analysis was as follows:
slope = 4.175
intercept = -0.007
correlation coefficient = 0.999 
and showed that the combined GLC and extraction procedure was 
suitable for the determination of tetradecane in transformation 
medium. The extraction efficiency was determined from equation 3.2
Extraction = slope of recovery plot from media , _. ■ V ------------~ z   ------  X 100% ... 3.2efficiency slope of recovery plot from hexane
and was 89.8% for the extraction of tetradecane from transformation 
medium into hexane.
3.4 Experimental
3.4.1 The effect of carbon source on codeine transformation
C. bainieri (C43) was cultured by the two-stage procedure 
described in Section 3.3.1 (page 133 ). The carbon sources in­
vestigated were glucose, succinate and tetradecane. These were 
added to both stage-one, and stage-two growth media, to provide 
an initial concentration of 1% w/v. The test substrate codeine 
phosphate (1 mM) was added to stage-two cultures after 24 hours 
incubation at 27°C, 250 rpm. Sufficient stage-two cultures were 
prepared to enable samples to be taken at 2 - 3 day intervals during
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the course of the transformation for the determination of growth, 
carbon source depletion and codeine N-demethylation.
On completion of the incubation period the growth was deter­
mined by the dry cell weight procedure described in Section 3.3.2. 
Samples of the filtrate retained from the dry cell weight deter­
minations were assayed for glucose by the procedure described in 
Section 3.3.3. In the case of cultures grown on a tetradecane 
carbon source, samples were assayed for tetradecane employing 
the procedure described in Section 3.3.4. Codeine transformation 
was determined in all cultures by assaying the filtrate for 
norcodeine by the Partisil 10 ODS-2 reversed phase procedure 
described in Section 2.4.4 and the external standard method des­
cribed in Section 2.3.3(b).
The total dry cell weight (mg) obtained for a transformation
culture was divided by the final volume to give the dry cell
-1weight in units of mg.ml . Codeine transformation was expressed 
from the norcodeine concentration in transformation mixtures and 
calculated from equation 3.3.
Norcodeine(VM) = cSaWinI^+^n!r%od^ine W )
In addition, the specific transformation was calculated for each
culture flask from equation 3.4;
Norcodeine concentration in the
Specific _ transformation mixture (yiM)  ... 3.4
transformation Total dry cell weight of culture(mg)
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to give a measure of the transformation of codeine obtained per unit DCW 
independent of the biomass at a given incubation time.
Progress curves for microbial growth (dry cell weight) and 
specific transformation obtained with the carbon sources glucose, 
succinate and tetradecane in the growth media, are shown in 
Figure 3.4. Progress curves for the depletion of glucose and 
tetradecane, and for the transformation of codeine are shown in 
Figure 3.5.
It can be seen from Figure 3.4 that C. bainieri did not grow 
as well in the presence of succinate or tetradecane carbon sources 
as it did in the presence of glucose. However, the specific trans­
formations obtained in the presence of succinate and tetradecane 
were both significantly higher than those obtained with glucose.
The profiles shown in Figures 3.5 show that the glucose and 
tetradecane carbon sources were utilised during the course of the 
incubation period. The transformation of codeine in the presence 
of glucose (Figure 3.5) demonstrated a definite lag phase, whereas 
this was not evident in the presence of tetradecane. The signifi­
cance of these findings are discussed on page 152.
3.4.2 The effect of substrate concentration on codeine transformation
In Section 3.4.1 the initial concentration of codeine phosphate
test substrate in the stage-two culture media was 1 mM. Previous 
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Fig. 3.4. Microbial growth and specific codeine
transformation by C. bainieri incubated at 
2?oc, 250 rpm with carbon sources, glucose 
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Figure 3.5. Tetradecane concentration ■ and glucose concentration 
o in the growth medium and codeine transformation • 
by C. bainieri incubated at 27°C, 250 rpm, in 
stage-two growth media.
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resulted in the maximum transformation of codeine by C. echinulata 
when grown and incubated under similar conditions with a glucose 
carbon source. Above 1 mM the codeine transformation fell drama­
tically, a phenomenon which was attributed to substrate inhibition
18by codeine phosphate . The results from Section 3.4.1 showed 
that cultures of C. bainieri grown on 1% tetradecane or succinate 
produced significantly higher specific codeine transformations 
than cultures grown on glucose. The aim of this study was to 
find out if cultures of Cunninghamella grown on succinate and 
tetradecane could tolerate higher codeine concentrations in the 
media and give higher codeine transformations than cultures grown 
on glucose.
Stage-two cultures of C. bainieri and C. echinulata were each 
prepared in stage-two growth medium (50 ml) containing one of each 
of the carbon sources (1%) glucose, succinate or tetradecane.
Each culture was inoculated with the respective stage-one growth 
(10 ml) cultured in the same media. All cultures were incubated 
at 27°C, 250 rpm, for 24 hours, and codeine phosphate was added 
to each culture as a filter sterilised solution. A range of 
codeine concentrations between 0.02 mM and 8.0 mM was examined.
The stage-two cultures were incubated for a further 10 days under 
the same conditions and samples of each were assayed for the 
determination of growth (dry cell weight) and codeine N-demethylation 
(norcodeine formed yM and specific transformation).
The microbial growth and codeine transformation obtained 
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Figure 3.6. Microbial growth, codeine transformation and specific 
transformation by C. bainieri incubated in the stage- 
two growth medium with glucose (1%) o , succinate 
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Figure 3.7 Microbial growth , codeine transformation and specific 
transformation by C. echinulata incubated in the 
stage-two growth medium with glucose (1%) o , 
succinate (1%) A and tetradecane (1%)« carbon 
sources at various substrate concentrations.
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echinulata grown in the presence of glucose, succinate and tetra­
decane are shown in Figures 3.6 and 3.7.
The maximum codeine transformations and specific codeine 
transformations by all the cultures studied, and with all carbon 
sources studied, occurred at a substrate concentration of approx­
imately 0.04 to 0.08 mM. Cultures grown on a tetradecane carbon 
source exhibited higher specific transformations than those grown 
on succinate or glucose, but the actual yield of norcodeine was 
similar for cultures grown on all the carbon sources investigated.
3.5 Discussion
The dry cell weight data in Figure 3.4 demonstrate the ability
of C. bainieri to grow satisfactorily in the chemically defined
growth media containing glucose, succinate or tetradecane carbon
sources. However, the maximal biomass production after 20 days
incubation was obtained with cultures grown on glucose. The
limited growth obtained with succinate may be attributed to an
unfavourable culture pH of 7.9 after two to three days incubation.
Further examination of Figure 3.4 shows that the initial rate of
growth on all carbon sources investigated was similar over the
first 6 - 8  days of incubation. After this period only cultures
on glucose continued to grow at the same initial rate. Studies by 
99Hoffmann and Rehm with C. echinulata grown on long-chained 
n-alkanes, including tetradecane , showed that these carbon sources 
were metabolised in a terminal degradation pathway to produce primary
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alcohols and aldehydes, which were in turn converted to fatty acids.
The resulting acids were then metabolised by 3-oxidation or
inserted directly, or after elongation with units, into the
99fungal lipids of the cell wall. Furthermore, they found that 
after 8 days incubation C. echinulata produced higher yields of 
biomass on n-alkanes compared to glucose, but after 30 days in­
cubation the reverse was true. The reasons for these observations 
were that in the exponential phase C . echinulata incorporated 
the degradation products of n-alkane metabolism directly into the 
lipids of the cell wall resulting in an increase in bicmass. However, 
in the stationary phase the lipids were used to a considerable
extent for cellular metabolism, as all the carbon source was
99depleted from the growth medium . This may explain the growth 
curve shown for C. bainieri in Figure 3.4 on tetradecane carbon 
source.
Despite their limited growth, the cultures grown in the presence 
of succinateand tetradecane demonstrated higher specific trans­
formation activities than cultures grown on glucose (Figure 3.4).
In addition, comparison of the transformation profiles obtained 
for cultures grown in glucose and tetradecane (Figure 3.5) shows 
different patterns. The glucose cultures were the most productive, 
in terms of norcodeine yield, when the carbon source in the culture 
medium was significantly depleted (after day 5 or 6). However, 
the tetradecane cultures demonstrated codeine transformation through­
out the microbial growth phase, despite the fact that the tetradecane
was not depleted until day 11 to 12 of incubation. This glucose
18effect was also observed by Sewell for the N-demethylation of
152
codeine by cultures of C. echinulata, and was thought to be 
caused by the catabolic repression of the N-demethylase enzyme 
by the readily utilised glucose carbon source. Once the glucose 
was depleted from the medium the enzyme was no longer inhibited, 
and transformation increased. As both succinate and tetradecane 
are relatively poorly utilised carbon sources this may explain 
why no apparent enzyme repression occurred in their presence.
Since the cultures grown on tetradecane demonstrated higher codeine 
transformations than those on glucose or succinate, it may be 
concluded that tetradecane was a good inducer of the N-demethylase 
in C. bainieri. Further experiments were performed in Section
3.4.2 to find if tetradecane cultures would produce higher codeine 
transformations if the substrate concentration was increased. The 
results with cultures of C. bainieri and C. echinulata are shown 
in Figures 3.6 and 3.7 respectively. As the codeine phosphate 
substrate concentration in the transformation mixture was increased, 
the biomass of all the cultures investigated, and for all carbon 
sources investigated, remained reasonably constant. This indicated 
that growth of the cultures was not affected by the presence of 
codeine in the concentration range investigated. The highest 
growth was obtained with carbon sources in the order glucose > 
tetradecane > succinate.
There was a significant decrease in transformation,and specific 
transformation, with all carbon sources when the substrate concen­
tration was increased from 0.08 mM to 0.2 mM probably due to 
substrate inhibition of the N-demethylase enzyme by codeine phosphate
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This occurred at a much lower concentration than the value of 
1 mM found by Sewell in previous studies^^, with C. echinulata. 
More important, although the specific codeine transformations ob­
tained with tetradecane cultures were higher than those obtained 
with glucose and succinate, the actual yield of norcodeine with 
tetradecane was similar to that obtained with the other carbon 
sources (see Figures 3.5 and 3.7). There was no advantage, 
therefore, in using a tetradecane culture with an increased 
codeine concentration to improve the transformation yield .
CHAPTER FOUR
THE N-DEMETHYLATION OF CODEINE BY
CELL-FREE EXTRACTS PREPARED FROM
Cunninghamella SPP>
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Chapter 4. THE N-DEMETHYIATION OF CODEINE BY CELL-FREE EXTRACTS 
PREPARED FROM C U N N I N G H A M E L L A  SPECIES
4.1 Introduction
In Chapter 3 various species of the fungus C u n n i n g h a m e l l a  
demonstrated the ability to N-demethylate the test substrate, 
codeine, added to the medium in which the cells were growing. In 
order to characterise the enzyme(s) responsible for N-demethylation, 
it would be required to extract the enzyme(s) from the fungal cells 
to produce a cell-free extract whidh retained its N-demethylase 
activity. Various methods which have proved effective in liber - 
ating enzymes from microbial cells have been reported by several 
workers^^^ . These methods generally involve mechanical rupture
of the cel1-wall and membrane by one or more of a combination of
108 . 109techniques, including hydraulic presses , sonication ,
mechanical shaking with abrasives^^^ and mechanical or manual
grinding^^^. The choice of procedure will depend on the ease
with which the cell is ruptured, and also the sensitivity and the
localisation of the enzyme within the cell. Mechanical rupture of
the rigid cell wall may liberate readily soluble enzymes, but not
enzymes which are membrane bound within the cell. Previous studies 
18by Sewell demonstrated that for the effective extraction of the 
N-demethylase enzyme from C. e c h i n u l a t a both a cell-wall disruption 
step, and also treatment with a detergent, Triton XlOO,was 
required in the extraction procedure. However, this method 
produced a crude cell-free extract, with a relatively low degree 
of N-demethylase activity.
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The aim of this study was to improve on Sewell's original ex­
traction procedure^^, and produce a cell-free extract from Cunning­
hamella species with a high degree of N-demethylase activity.
Some properties of the extract could then be investigated including 
preliminary characterisation of the N-demethylase enzyme, and 
optimisation of the reaction conditions for codeine N-demethylation.
4.2 Materials
4.2.1 Chemicals and Reagents
Triton XlOO, Coomassie G250 dye, semicarbazide HCl 
(Analar), sodium dithionite (Analar), carbon-monoxide gas,
1,1,1-trichloroacetic acid (Analar), formaldehyde solution 
(Analar), sodium chloride (Analar), ferrous sulphate (Analar), 
calcium chloride, potassium chloride (Analar), ethylene diamine 
tetraacetic acid, sodium salt (EDTA) and polyethylene glycol 
(P.E.G.) were all purchased from B.D.H. Ltd.
Bovine serum albumin, urea,xanthine oxidase, NADPH (tetra- 
sodium salt) and NADH (disodium salt) were purchased from Sigma 
London Chemical Co. Nitrogen gas (white spot); British Oxygen 
Ltd. Nash Reagent; this was prepared from ammonium acetate (112.5 g) 
acetylacetone (1.50 ml), acetic acid (2.25 ml) and distilled water
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to 250 ml. All these reagents were of Analar grade except 
acetylacetone (Puriss grade, Koch-Light Laboratories Ltd.) 
which was distilled immediately before use. The Nash reagent 
was stored at 4°C and discarded if not used within one week. 
Phosphate buffer was prepared freshly before use from Analar 
grade reagents, KH^PO^ and Na^HPO^, BDH Ltd. The pH of each 
solution was checked with a pH meter. Coomassie G250 dye was 
prepared as a 0.05% solution in 3% perchloric acid (Fisons, UK) 
and was filtered through Whatman No. 1 filter paper to remove any 
undissolved material. The stock solution was diluted with 3% 
perchloric acid solution to give an absorbance of 1.3 - 1.5 at 
465 nm, the absorbance maximum for the leuko form of the dye.
The stock solution was stored at room temperature.
4.2.2 Equipment and instrumentation
Incubation tubes; Glass, 15 ml capacity with screw caps, Fisons 
Scientific Apparatus Ltd.
Centrifuge tubes; Polypropylene, 15 ml capacity with closures,
MSE Scientific Instruments Ltd.
Water baths ; Recirculating, Grant Instruments Ltd., Cambridge
Centrifuge; MSE High Speed 18, with 16 x 15 ml rotor, MSE 
Scientific Instruments Ltd.
Homogeniser; 4 blade with baffled glass chamber, 100 ml capacity; 
MSE Scientific Instruments Ltd.
Ballmill; Braun cell homogeniser. Model MSK, operated at. a
radial frequency of 2000 rpm with capillary coolant (CÔ ) - 
Glasperlen.
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Shaking bottle; with ground stopper and retainer. Pyrex, 75 ml, 
Glasperlen.
Glass beads; 0.45 - 0.5 mm diameter, Glasperlen.
All glassware used for the cell-free extract experiments was 
washed and brushed in tap water until visibly clean, then rinsed in 
glass distilled water and treated with chromic acid solution for 
24 hours. The glassware was then rinsed five times with glass 
distilled water and finally soaked in fresh distilled water for 
12 hours before drying at 45°C.
Before use, centrifuge tubes were washed in RBS-25 solution 
(Chemical Concentrates Ltd., London),and thoroughly rinsed with 
tap water and then distilled water. The tubes and caps were dried 
at 45°C.
4.3 Methods
4.3.1 Enzyme extraction procedures
Culture flasks were prepared and inoculated with C. bainieri 
or with C. echinulata according to the procedures and incubation 
conditions described in section 3.3.1 (page 133 ). The freshly
harvested cells were washed with ice-cold 0.065 M phosphate buffer, 
pH 7.0, ^ d  then subjected to each of the enzyme extraction methods 
A - F described below. All extraction methods were conducted in a 
cold room at 3 - 4*̂ C unless otherwise stated.
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A. Homogenisation and agitation with Triton XlOO; Wet mycelia 
(20 g) was suspended in ice-cold 0.066 M phosphate buffer, pH 7.0 
(28.5 ml) contained in a glass homogenisation vessel. The exterior 
of the vessel was packed with ice and the suspension was sheared 
at maximum speed for 3 .minutes. An aqueous solution containing 
Triton XlOO (10% v/v) in phosphate buffer (0.066 M, pH 7.0) was 
prepared and cooled to 4°C. The homogenate was transferred to a 
pre-cooled 125 ml Erlenmeyer flask to which the Triton XlOO solution 
(1.5 ml) was added, giving a surfactant concentration of 0.5% w/v. 
The mixture was agitated on a radial shaker at 3 - 4°C for 30 
minutes.
B. Pestle and mortar and milling; Wet mycelium (lO g) was ground 
to a paste with ice-cold 0.066 M phosphate buffer, pH 7.0 j(10 ml) 
in a pestle and mortar. The paste was transferred to a pre-cooled 
pyrex shaking bottle (75 ml) containing 0.45 - 0.5mm diameter glass 
beads (50 g). The glass bottle was sealed, and shaken at 2000 rpm 
for two 30 second periods, inside a Braun Cell Homogeniser. The 
temperature of the glass bottle was maintained at 3 - 4°C by liquid 
carbon-dioxide cooling. Cell debris and the glass beads were 
removed by filtration through a stainless steel mesh (pore size 
0.4 mm) and this was washed with phosphate buffer (2 x 10 ml).
C. Pestle and mortar, milling, and agitation for 30 minutes; Wet 
mycelium (10 g) was ground to a paste with ice-cold 0.066 M phosphate 
buffer, pH 7.0 (10 ml) in a pestle and mortar, and milled in the
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Braun Cell Homogeniser as in (B) above. The cell debris and glass 
beads were removed by filtration (stainless steel mesh) and washed 
with phosphate buffer (2 x 10 ml). The combined filtrate and 
washings were transferred to a pre-cooled Erlenmeyer flask (125 ml) 
and agitated on a radial shaker at 3 - 4°C for 30 minutes.
D. Pestle and mortar, milling and agitation with Triton XlOO 
(0.5% v/v ) for 30 minutes; This method was as for method (C) above 
except for the addition of an aqueous solution containing Triton 
XlOO (10% v/v) to the filtrate and washings in the pre-cooled 
Erlenmeyer flask (125 ml), to give a final concentration of 0.5% v/v, 
which was then agitated on a radial shaker at 3 - 4°C for 30 minutes.
E. Pestle and mortar, and agitation with Triton XlOO (0.5% v/v) 
for 30 minutes ; Wet mycelium (10 g) was ground to a paste with 
ice-cold 0.065 M phosphate buffer, pH 7.0 (10 ml) in a pestle and 
mortar. The paste was washed into a pre-cooled Erlenmeyer flask 
(125 ml) with ice-cold phosphate buffer (20 ml) and Triton XlOO 
solution (10% v/v) was added to give a surfactant concentration of 
0.5% v/v. The mixture was agitated on a radial shaker at 3 - 4°C 
for 30 minutes.
At the end of the extraction methods (A - E) described above 
the resultant suspension in each case was immediately centrifuged 
in polypropylene tubes (15 ml) at 27,000 g, 4°C for 20 minutes 
to remove the cell debris. The supernatant was decanted to
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give a "cell-free extract".
F. Dialysis of the cell-free extract; A piece of Visking tubing 
(20 cm) was boiled in an aqueous solution of ethylene diamine 
tetraceti-c acid (EDTA) (1%) for two minutes to remove calcium ions 
(Ca^^). The tubing was tied at one end, cooled to 3 - 4°C, and 
cell-free extract was pipetted into it. This was then sealed with 
string, and immersed in a solution of ice-cold polyethylene glycol 
(P.E.G.), 10% w/v, in 0.066 M phosphate buffer, pH 7.0 contained in 
a conical flask (250 ml). The extract was left to dialyse in a 
cold room at 3 - 4°C for approximately 4 hours.
4.3.2 Determination of protein
112Protein was determined by the method of Sedmak and Grossberg
employing Coomassie Brilliant Blue G250 dye, and Bovine Serum
Albumin (B.S.A.) as the standard protein. This technique was
reputed to suffer no interference from free amino acids and chemicals,
113such as Triton XlOO, that interfere with the Lowry protein assay 
However, to confirm this, the calibration curve was conducted in 
the presence of possible sources of interference such as codeine 
phosphate and Triton XlOO.
A series of standard solutions containing B.S.A. over a
concentration range of 10 to 100 yg/ml in unbuffered saline
(sodium chloride solution, 0.14 M), containing codeine phosphate
(1 mM), Triton XlOO (0.5% v/v) and urea (3 M) were prepared.
The protein concentration was estimated by the method of Sedmak 
112and Grossberg in which an aliquot (0.5 ml) of each standard
16 1
Fig. 4.1. Calibration plot for protein in saline containing 
codeine phosphate (1 mM), Triton XlOO (0.5%) 








-1B.S.A. concentration (yg ml )
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solution was added to G250 solution (see page isg) in a stoppered 
tube and mixed immediately. Sodium chloride solution (0.5 ml) 
with B.S.A. omitted, mixed with G250 dye (0.5 ml) served as the 
control solution. The absorbance of each mixture was measured 
spectrophotometrically at 620 nm and 465 nm, against sodium chloride 
solution. Figure 4.1 shows the ratio of absorbance at 620/465 nm, 
as read against sodium chloride solution, plotted against the 
respective B.S.A. concentration, after the absorbance ratio of the 
1:1 dye-sodium chloride solution mixture (control) had been 






The protein concentration in cell-free extracts was calculated from 
equation 4.1:
620.
_ .  ̂ , -1, Absorbance ( 465) - control . ^protein concentration (^g ml ) =  ;--------------- ... 4.1
0.033
4.3.3 Estimation of N-demethylase activity
The oxidative N-demethylation of codeine produced an equimolar
quantity of formaldehyde and the secondary amine, norcodeine. The 
114method of Nash was used to determine the formaldehyde generated, 
since formaldehyde could arise from either the Q-demethylation or
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N-demethylation of codeine. A HPLC assay was employed to distinguish 
between O- and N- déméthylation, and measure the N-demethylated 
product, norcodeine, directly.
a) Determination of formaldehyde
One ml aliquots of the sample were pipetted into 15 ml poly­
propylene centrifuge tubes containing ice-cold 10% w/v 1,1,1-tri­
chloroacetic acid (1.5 ml). The samples were centrifuged at 27,000 g, 
4°C for 20 minutes, and volumes of the clear supernatant (2 ml) were 
transferred to glass screw cap tubes containing Nash reagent (1.0 ml). 
The samples were mixed and heated in a water bath at 60°C for 10 
minutes. After cooling to room temperature, the absorbance of 
both test and control (omitting enzyme) samples was determined spectro­
photometrically at 412 nm against a distilled water blank.
A standard curve was prepared for the assay of formaldehyde
standard solutions incorporating any reaction mixture components
which may interfere with the Nash reaction. A stock solution of
formaldehyde (approximately 40% w/v HCHO) was standardised by the
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method of the British Pharmacopoeia • This was used to prepare
standard solutions of formaldehyde with concentrations ranging
from 32.5 to 389.6 yM in 0.066 M phosphate buffer, pH 7.0, and
also containing codeine phosphate (1.5 mM), semicarbazide HCl
-1(3 mM), B.S.A. (1 mg ml ), Triton XlOO (0.5% v/v), tetradecane 
(1% v/v) and urea (3 M).
The standard plot obtained is shown in Figure 4.2, and gave the
Fig. 4.2. Standard plot for the determination of 












Formaldehyde concentration of standard solution (yM)
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following regression analysis results:
Slope = O.OOI6O
Intercept = -0.002
Correlation coefficient = 0.999
The molar extinction coefficient for the Nash reaction product,
-1 -13,5-diacetyl-l,4-dihydrolutidine was 8051 M cm , which was within
149the suggested limits of ± 2.0% for the calculated extinction
-1 -1coefficient of 8OOO M cm . This indicates that the incubation 
mixture components did not interfere significantly with the Nash 
assay.
The formaldehyde in the test samples is given by Equation 4.2:
(A - A )
Formaldehyde concentration (ym) = — 4.2
0.00160
where A = absorbance at 412 nm.
b) Determination of norcodeine
The transformation sample (1.5 ml) was heated in a water bath 
at 100°C for 10 minutes, and then the mixture was pipetted into 
polypropylene centrifuge tubes (2.0 ml) capped, and centrifuged at 
10,000 r.p.m. for 5 minutes. The supernatant was filtered through 
a 0.45 ym cellulose acetate membrane filter (Millipore), and 100 yl 
samples were assayed for norcodeine using the reversed phase HPLC 
method with ODS-Hypersil, 5 ym, described previously in Section 2.4.5
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and the external standard procedure described on page 57.
The linearity of the detector response and the precision of
response was reported in Section 2.4.5 for codeine and norcodeine
samples in both mobile phase and transformation media. These
values did not change significantly when the parameters above were
redetermined using standard solutions of codeine and norcodine in
transformation media, also containing Triton XlOO (0.5% v/v), BSA 
-1(1 mg ml ) urea (3 M) and semicarbazide HCl (3 mM) . This confirmed 
that the incubation mixture components do not interfere with the 
HPLC assay for norcodeine.
4.4 Experimental
4.4.1 Development and optimisation of a procedure for the extraction 
of the N-demethylase from C. echinulata and C. bainieri
a) Evaluation of the extraction methods A - E.
In order to assess the suitability of the various enzyme 
extraction methods described in section 4.3.2, (A - E),it was 
necessary to determine their efficiency under experimental conditions, 
The effectiveness of the extraction procedures was measured in terms 
of the protein concentration in the resulting cell-free extract, 
and also the N-demethylase activity of the extract on a codeine 
substrate.
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Ten day cultures of C. echinulata and C. bainieri were 
harvested and subjected to the extraction method (A-E) des­
cribed in Section 4.3.2. For each extraction method the 
following parameters were determined:- a) the weight of wet 
cells initially used for extraction, the protein concentration 
in the cell-free extract (by the procedure described in Section 
4.3.3) and the N-demethylase activity of the resulting extract. 
N-demethylase activity was determined using the following 
incubation mixture; cell-free extract (1.3 ml) , FeSO^.TH^O 
(0.1 mM) , NADPH (0.1 mM) , NADH (0.1 mM) , semicarbazide HCl 
(3 mM) , and 0.066 M phosphate buffer, pH 7.0, to 1.5 ml. The 
mixtures were incubated at 30°C and the reaction initiated 
by the addition of codeine phosphate (1.5 mM) as substrate.
Control mixtures in which codeine phosphate was omitted 
were also included. Samples of 1.0 ml were taken over the 
initial 30 minutes of incubation, and assayed for formaldehyde 
by the method described on page 163 • For the estimation 
of norcodeine the whole incubation mixture (1.5 ml) was 
subjected to the treatment described in Section 4.3.3 (b) ,
page 165. The N-demethylase activity of the cell-free extract 
was expressed by 1) the specific activity defined in equation 4.3:-
Specific activity _ Initial rate____________  ... 4.3
(yM min ^mg ) Protein in 1.3 ml extract
-1where the initial rate (y M min ) was obtained from the plot 
of formaldehyde produced in the incubation mixtures (y M) 
against time, and also by 2) the total activity defined in Equation 
4.4:-
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Total activity _ Max. norcodeine conc.(yM) x total volume 
(ymoles  of extract (ml)
1.3ml)
where the maximum norcodeine concentration (in the incubation mixture) 
was that determined by HPLC.
The results obtained for the extraction of C. echinulata and 
C. bainieri by methods A - E  are shown in Tables 4.1 and 4.2 
respectively.
The highest yield of protein, together with the highest N- 
demethylase activity of the extracts produced from both C. echinulata 
and C. bainieri was obtained by method D (Table 4.1 and 4.2).
This method consisted of grinding the cells in a pestle and mortar, 
milling the crude extract in a Braun Cell Homogeniser and then 
agitating the cell suspension with Triton XlOO (0.5% v/v)) for 
30 minutes.
b) The effect of Triton concentration, and agitation time, on 
the extraction of the N-demethylase from C. echinulata and 
C. bainieri
Further attempts were made to improve the enzyme extraction 
procedure by examining the effect of various surfactant concen­
trations and agitation times employed in Method D above. The 
effectiveness of each modification to the procedure was evaluated 
as in the previous section in terms of the protein yield in the 
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Ten day cultures of C. echinulata and C. bainieri were harvested 
and subjected to the pestle and mortar and milling procedures 
described for Method D above. The combined filtrate and washings 
obtained from separate extractions were combined with Triton XlOO 
solution (10%v/v) in pre-cooled Erlenmeyer flasks (125 ml) to 
give a range of surfactant concentrations in the final mixture 
from O to 3% v/v. A mixture containing no Triton XlOO was in­
cluded as a control. The mixtures were agitated on a radial shaker 
at 3 - 4°C for 30 minutes, and then centrifuged at 27000 g, 4°C 
for 20 minutes in polypropylene centrifuge tubes to remove the 
cell-debris. The protein yield in resulting cell-free extracts 
was estimated by the procedure described in Section 4.3.3, and 
the N-demethylase activity on a codeine substrate by the HPLC 
method described in Section 4.3.4(b). Plots of protein yield 
per wet cell weight, total activity per wet cell weight and specific 
activity all against Triton XlOO concentration (% v/v) were con­
structed, and are illustrated in Figure 4.3.
The results in Figure 4.3 showed that the amount of protein 
extracted increased with the Triton XlOO concentration used in 
the extraction procedure. However, the data in Figure 4.3 also 
showed that concentrations of Triton XlOO greater than about 0.5% 
caused a significant reduction in the N-demethylase activity of 
the cell-free extracts produced. The implications of these observations 
are discussed on page 195 . However, it was concluded from these 
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Figure 4.3. The protein yield, total activity and specific
activity of cell-free extracts from C . bainierioand 
C. echinulata ▲ with various concentrations of 
Triton XlOO used in the extraction procedure
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The extraction procedure was therefore repeated using a Triton 
XICK) concentration of 0.33% v/v and varying the agitation time 
from O minutes (no agitation) to 60 minutes. Since both micro­
organisms, C. echinulata and C. bainieri gave similar results 
the results for the extraction of C. bainieri only are shown in 
Table 4.3 below.
Table 4.3. The effect of agitation time with Triton XlOO (0.33%)
on the extraction of the N-demethylase from C. bainieri
Agitation time 
(minutes)









The amount of protein extracted, and also the N-demethylase 
activity of the extracts, reached an optimum at approximately 
30 minutes agitation with Triton XlOO (0.33% v/v). After this 
time there was no significant increase in the protein extracted, 
and the N-demethylase activity actually decreased. Therefore, 
agitation for 30 minutes with a Triton XlOO concentration of 
0.33% v/v was considered to be the optimum combination, and 
was incorporated into method D (page 159) and used in all subse­
quent enzyme extraction experiments. Furthermore, it was observed
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from the extraction studies that cell-free extracts prepared from 
C. bainieri generally exhibited higher N-demethylase activities 
than those prepared from C. echinulata. In view of this, C. bainieri 
only was used in all further studies.
c) The effect of urea on the extraction of the N-demethylase from
C. bainieri
The N-demethylase in Cunninghamella sp. could be membrane 
associated or membrane bound. Membrane associated proteins are not 
usually bound directly to the hydrocarbon portion of the lipid 
bilayer, and are readily dislodged from their membranes and 
solubilised by chelating agents or by lowering or increasing the 
ionic strength of the pH, without dissociating the lipid matrix 
of the membrane^^^. Alternatively, the enzyme could be more 
tightly bound to the membrane. If this was the case it may only 
be solubilized by disrupting the membrane with detergents eg.
Triton XIOO^^^. The nature of the N-demethylase in C. bainieri 
was investigated by extracting cultures with urea, and comparing 
the extraction results with those obtained with Triton XlOO.
Ten day cultures of C. bainieri were harvested and subjected 
to extraction method D. This procedure was repeated so that in 
the final stage of the method the crude extract was agitated with 
either (a) Triton XlOO at a concentration of 0.33% v/v, or with 
(b) urea at a concentration of 3 M. The procedure was also repeated 
with no additive to the crude extract, as a control. Protein in
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the cell-free extract was estimated as before (page 160) and the 
N-demethylase activity of the cell-free extract determined by the 
HPLC assay for norcodeine (page 79 ). The results obtained are 
shown in Table 4.4.
Table 4.4. The effect of urea (3 M) and Triton XlOO (0.33%)
on the extraction of N-demethylase from C. bainieri 
by extraction method D.




Agitation 30 mins 
(control) 0.35 15
Agitation 30 mins 
+ urea (3 M) 0.50 17
Agitation 30 mins 
+ Triton XlOO (0.33% v/v) 2.3 38
From the results in Table 4.4 the highest protein yield together 
with the highest N-demethylase activity was obtained using Triton 
XlOO in the extraction procedure. The results with urea were 
only slightly higher than the control results, indicating that 
urea was ineffective at solubilizing the enzyme which was probably 
membrane bound.
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4.4.2 Enrichment of the N-demethylase enzyme from cell-free extracts
of C.bainieri by dialysis
The cell-free extract produced by method D (page 159 ) consists 
of a mixture of the N-demethylase enzyme, plus other components 
extracted from the fungal cells, in phosphate buffer. The dialysis 
procedure (F) described in Section 4.3.1 (f) was performed in an 
attempt to remove aqueous medium from the extract to enrich the 
N-demethylase enzyme in the resulting extract.
Ten day cultures of C. bainieri were harvested and subjected 
to the modified extraction method D procedure described on page 172, 
using 0.33% v/v Triton XlOO and an agitation time of 30 minutes.
A known volume of the resulting cell-free extract was then sub­
jected to the dialysis procedure (F) (page 160) using dialyais 
tubing with an exclusion limit of 6000 molecular weight. The 
extract was allowed to dialyse at 3 - 4°C for about 4 hours.
After this time the extract was recovered and the final volume 
measured. The protein concentration, was determined in both 
the dialysed and undialysed extracts. In addition the N-demethylase 
activity of dialysed and undialysed extracts was estimated on a 
codeine substrate as in Section 4.4.1, and expressed as the 
specific transformation;
Norcodeine concentration (yM)
specific transformation = — -̂--------------------------  ... 4.5
Protein (mg) in 1.3 ml extract
The results obtained are shown in Table 4.5 .
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Table 4.5» The protein concentration and N-demethylase activity 









The results in Table 4.5 show that the protein concentration 
in the cell-free extract was increased by approximately a factor 
of 5 by dialysis, but the specific transformation decreased. This 
suggests that essential components necessary for the microbial N- 
demethylation process to occur may have been removed from the 
extract by dialysis. Therefore there was no advantage in employing 
this procedure in future extraction experiments.
4.4.3 Enrichment of the N-demethylase enzyme from cell-free extracts 
of C. bainieri by calcium chloride precipitation 
An attempt was made to isolate an active fraction from the 
cell-free extract of C. bainieri produced by method D (page 159.) 
by adapting the method of Kapelli et This involved the
precipitation of the microsomal fraction from C. bainieri cell-free 
extract by the addition of calcium chloride (CaClg). A diagram 
showing the stages of the procedure is shown in Figure 4.4.
177
Figure 4.4. Scheme for the enrichment of the N-demethylase enzyme 
from cell-free extracts of C. bainieri by calcium 
chloride precipitation
Cell-free extract 
obtained by method D 
(page 159 )
Centrifuge, 12,000 rpm, 15 mins
Sample 1
Supernatant
Centrifuge, 25,000 g, 15 mins
Sample 2
Supernatant 
+ solid CaClg (16 mM) 




Wash with 10 mM phosphate buffer, pH 7.0 








The cell-free extract obtained from C. bainieri by extraction 
method D, page 159 ,was immediately centrifuged in polypropylene 
tubes (15 ml) at 12000 g, 4°C for 15 minutes. The supernatant 
was then centrifuged at 25,000 g, 4°C for 15 minutes. Solid 
calcium chloride (CaClg) was added to the supernatant to a 
concentration of 16 mM, and the microsomal fraction collected by 
a further centrifugation at 15,000 g, 4°C for 15 minutes. The 
supernatant at this stage was discarded, and the sediment was 
washed once with KCl (150 mM) in 10 mM phosphate buffer, pH 7.0 
(a volume equal to the volume of supernatant discarded), and then 
the mixture centrifuged once more at 25,000 g, 4°c for 15 minutes.
The final pellet was resuspended in 0.066 M phosphate buffer, pH 7.0, 
to give the purified cell-free extract.
Samples (1 to 5) were taken from each stage of the purification 
procedure as shown in Figure 4.4 and analysed for the protein yield, 
and the N-demethylase activity against a codeine substrate.
The results obtained are shown in Table 4.6.
Table 4.6. Protein yield (mg) and specific transformation values
determined for samples 1 - 5  obtained from the enrichment 
of cell-free extracts of C. bainieri by calcium chloride 
precipitation (Figure 4.6).








The results in Table 4.6 show that there was a progressive 
decrease in protein yield in samples 1 to 5 taken at each stage 
of the calcium chloride enrichment procedure. However the specific 
transformation values in extracts 1 to 5 significantly increased 
indicating that the enrichment technique was successful. However, 
the overall procedure was considered to be too time consuming for 
the routine production of cell-free extracts for experiments 
described in this chapter.
4.4.4 Confirmation of N-demethylase activity from the incubation 
of cell-free extracts of C. bainieri and C. echinulata 
with codeine
114The method of Nash was used to estimate the formaldehyde 
generated from the incubation of codeine with cell-free extracts 
of Cunninghamella sp. It was assumed that the formaldehyde was 
generated from the microbial transformation of codeine. However, 
it could have arisen from the chemical degradation of codeine, 
or have been released from the cell-free extract (endogenous 
formaldehyde) under the test conditions.
The following control incubation mixtures were prepared 
to determine the origin of the formaldehyde generated in the 
test assay.
Mixture A) FeSO^.TH^O (0.1 mM),NADPH (0.1 mM), NADH (0.1 mM),
semicarbazide HCl (3 mM) and 0.066 M phosphate buffer, 
pH 7.0, to 1.5 ml.
Mixture B) FeS0^.7H20 (0.1 mM), NADPH (0.1 mM), NADH (0.1 mM),
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semicarbazide HCl (3 mM) and 0.056 M phosphate 
buffer, pH 7.0, to 0.2 ml.
To confirm whether or not the formaldehyde was generated from 
the chemical degradation of codeine, duplicate incubation mixtures 
(A) were incubated at 30°C, and codeine phosphate substrate was 
added to give a concentration of 1.5 mM in the mixture. Samples 
of 1 ml were taken immediately (O minutes) and after 30 minutes 
inclination, and assayed for formaldehyde by the Nash method (page 
163). There was no significant difference in the quantity of 
formaldehyde detected at zero and 30 minutes incubation indicating 
that formaldehyde was not produced fram the chemical breakdown 
of codeine in the test assay.
Cell-free extract (1.3 ml) was added to a series of incubation 
mixtures (B), and incubated at 30°C. Samples of 1.0 ml were taken 
over the initial 30 minutes of incubation, and assayed for form­
aldehyde as before. There was no significant increase in the 
quantity of formaldehyde found in the incubation mixtures over 
the 30 minute incubation period. This indicated that endogenous 
formaldehyde was not released from cell-free extracts during the 
course of the incubation procedure. The results of both sets of 
control experiments ensured that the formaldehyde was generated 
from the microbial transformation of codeine. However, this could 
have arisen from either the 0-demethylation of codeine to produce 
morphine or the N-demethylation of codeine to produce norcodeine. 
Therefore, incubation mixtures containing cell-free extract, test 
mixture components and codeine were incubated as before and samples
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taken for HPLC analysis, employing the ODS-Hypersil method 
(Section 2.4.5). The chromatograms obtained conclusively demon­
strated the presence of norcodeine, and the absence of morphine 
in the incubation mixture. This indicates that the formaldehyde 
generated by the cell-free extract arose only from the N-demethylation 
of codeine.
4.4.5 The effect of substrate concentration on the transformation 
of codeine by cell-free extracts from C. bainieri 
In all the cell-free extract experiments performed so far 
in this chapter the codeine concentration in the incubation mixtures 
was 1.5 mM. This codeine concentration was employed by Sewell^^ 
to study the transformation of codeine by cell-free extracts from 
C. echinulata, although no attempt was made to find if it was 
optimal. Therefore, the effect of codeine concentration on the 
transformation of codeine, by cell-free extracts from C. bainieri 
was investigated. The cell-free extract was prepared from ten day 
cultures of C. bainieri employing extraction method D described in 
Section 4.3.1. Incubation mixtures were prepared of the following 
composition : cell-free extract (1.3 ml) ; FeSO^.TH^O (0.1 mM) ,
NADPH (0.1 mM), NADH (0.1 mM), semicarbazide HCl (3 mM) in
0.065 M phosphate buffer, pH 7.0, (0.2 ml). The mixtures (1.5 ml) were
incubated at 30°C, and the reaction initiated by adding codeine
phosphate to provide a concentration range from O mM to 6.0 mM in
the final mixtures. After 30 minutes the reaction was terminated
by boiling the mixtures for 10 mimutes at 100°C. The protein
concentration of the incubation mixtures was determined, in
addition to the HPLC determination of norcodeine, and the transformation
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Figure 4.5. The effect of codeine concentration on codeine trans­














activity was expressed as the norcodeine produced (yM) per mg of 
total protein. These values were plotted against the codeine con­
centration in the incubation mixtures as shown in Figure 4.5.
The amount of codeine N-demethylated increased with codeine 
concentration up to a concentration of approximately 3 mM in 
the incubation mixture. At higher concentrations there was no 
significant increase in codeine N-demethylation, and so a codeine 
concentration of 3 mM was employed in all subsequent test assay 
incubation mixtures described in this thesis.
4.4.6 The effect of added co-factors on codeine transformation by 
cell-free extracts from C. bainieri
2+The co-factors NADPH and NADH and ferrous iron (Fe ) have
all been implicated as essential requirements for several microbial
22 23 25monooxygenase catalysed reactions ' ' . In each case the
25concentration reported to be optimal in previous studies was
0.1 mM. The effect on codeine transformation, by cell-free extracts
2+from C. bainieri of NADPH, NADH and Fe addition at concentrations 
-4of 1 X 10 M was initially investigated.
2+a) The effect of Fe
Incubation mixtures were prepared each containing the 
components.shown in Table 4.7.
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Table 4.7. Composition of incubation mixtures used to study the
effect of added Fê "*" on codeine transformation by




to phosphate buffer 
in each mixture
0.066 M phosphate 
buffer, pH 7.0 
(ml)
0.5 Codeine phosphate (3mM) 1.0
Semicarbazide HCl (3mlW) 10.75 FeSO^ THgO (O.lmM) 1 0.75
1.0 0.5
1.3 0.2
0.5 1.0Codeine phosphate (3mM) /
0.75 Semicarbazide HCl (3mM) 0.75
1.0 (controls) 0.5
1.3 ' 0.2
b) The effect of NADPH and NADH
Incubation mixtures were prepared each containing codeine 
phosphate (3 mM) and semicarbazide HCl (3 mM) and the components 
shown in Table 4.8. Each incubation mixture was allowed to 
equilibriate to 30°C, and the reaction was initiated by the 
addition of codeine phosphate. After 30 minutes the reaction was 
terminated by boiling each mixture for 10 minutes. Samples of each 
mixture were assayed for protein and norcodeine, and the trans­
formation activity expressed as the norcodeine produced (yM) per 
mg of total protein. The values obtained for both sets of incubation 
mixtures were plotted against the volume of cell-free extract used 
and are shown in Figures 4.6 and 4.7 respectively.
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Table 4.8. Composition of incubation mixtures used to study the
effect of added co-factors on codeine N-demethylation
by cell-free extracts from C. bainieri
Cell-free extract 
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2+Figure 4.6. The effect of added Fe on codeine transformation by
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Figure 4.7. The effect of added NADPH and NADH on codeine trans­
formation by cell-free extracts from C. bainieri at
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2+The addition of Fe , NADH and NADPH (each at a concentration 
of 0.1 mM) resulted in significant increases in the amount of codeine 
N-demethylated. The addition of NADH resulted in the highest 
N-demethylase activity, although there was a slight improvement 
found when both NADPH and NADH were added together. The above 
investigation was carried out using only one co-factor concen­
tration (0.1 mM). Further experiments were therefore carried out 
to observe the effect of various co-factor (NADH) concentrations 
on the N-demethylation of codeine.
Incubation mixtures were prepared each containing codeine 
phosphate (3 mM) and semicarbazide HCl (3 mM) and also the compon­
ents shown in Table 4.9.
Each incubation mixture was equilibriated at 30°C, and the 
reaction was initiated by the addition of codeine phosphate.
Samples of each mixture were taken after 30 minutes incubation and 
assayed for norcodeine and protein, and the transformation activity 
determined as described above. Plots of norcodeine produced (yM) 
per mg protein against volume of extract used for each co-factor 
concentration and the control mixtures (no co-factor added) 
are shown in Figure 4.8.
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Table 4.9. Composition of incubation mixtures used to study the
effect of co-factor concentration on codeine N-
demethylation by cell-free extracts from C. bainieri
Cell-free extract 
(ml)
Components added to 
phosphate buffer in 
each mixture
0.066 M phosphate 


























4.8. The effect of NADH concentration on codeine transformation










0.25 0.5 0.75 1.0 1.25
Volume of cell-free extract (ml)
The addition of increasing concentrations of NADH from 0.1 mM 
to 0.3 mM showed only a small increase in the amount of codeine 
N-demethylated, and so the NADH and NADPH concentrations used in 
all subsequent enzyme experiments remained at 0.1 mM.
4.4.7 Investigation of substrate and co-factor requirements on
codeine transformation by cell-free extracts of C. bainieri 
It was observed from previous experiments that the amount of 
codeine N-demethylation in incubation mixtures with cell-free extracts
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from C. bainieri was limited to about 4 - 5 %  maximum. The following 
experiment was designed to find out if this was due to a co-factor 
requirement, or due to an equilibrium imbalance between codeine 
and norcodeine in the incubation mixture.
Cell-free extract (1.0 ml) prepared from 10 day cultures of 
C. bainieri, employing extraction method D, was incorporated into 
5 similar incubation mixtures each containing the following;- 
codeine phosphate (3 mM), semicarbazide HCl (3 mM), FeSO^.TH^O 
(0.1 mM) , and 0.066 M phosphate buffer, pH 7.0 to 1.5 ml. A 
sixth tube was also included containing all the test mixture com­
ponents except codeine (control). The mixtures were allowed to 
equilibriate at 30°C, and the reaction was initiated by the addition 
of codeine phosphate. Samples (0.5 ml) were taken from each mix­
ture after 30 minutes incubation, and assayed for norcodeine by 
HPLC. Further additions were made to the remaining incubation 
mixtures as shown in Table 4.10.
These second incubation mixtures were incubated again for 
30 minutes at 30°C, after which samples were taken from each 
mixture and assayed for norcodeine. The concentration of 
norcodeine in each of the mixtures after the first and second 
incubation periods are shown in Table 4.10.
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Table 4.10. Components added to produce the second incubation 
mixtures, and the norcodeine concentration (yM) 
in the mixtures after the first and second incubations 
at 30°C for 30 minutes as described above.
Tube Components added to
produce the second 
incubation mixtures
Norcodeine in the incubation mixtures 
first (yM) second 
incubation incubation
1 Cell-free extract (1 ml) 25.4 51.9
2 Codeine phosphate (3 mM) 
in phosphate buffer (1 ml) 23.6 24.9
3 Phosphate buffer (1 ml) 22.6 22.3
4 Cell-free extract pre­
treated with xanthine 
oxidase (1 ml) 21.9 22.1
5 Cell-free extracted pre­
treated with boiled 
xanthine oxidase (1 ml) 22.6 45.1
6 Phosphate buffer (1 ml) None None
After the first 30 minute incubation period the results in Table 
4.10 show that codeine was N-demethylated to norcodeine to approx­
imately the same extent in tubes 1 to 5. Norcodeine was not 
detected in the control mixture (tube 6) containing no codeine. 
Incubation of a second portion of extract added to the original 
incubation mixture (tube 1) resulted in the doubling of the nor­
codeine concentrations. However, the addition of more codeine 
(tube 2), or more buffer, to dilute the original codeine present 
in the mixture (tube 3), both failed to increase the norcodeine
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concentration. These observations suggested that an equilibrium 
between codeine and norcodeine in the mixtures was not the reason 
for the limited transformation.
The concentration of norcodeine remained constant after the 
addition of a cell-free extract pretreated with xanthine oxidase 
(tube 4), an enzyme capable of deactivating co-factors such as 
NADPH and NADH. Whereas, the concentration of norcodeine was 
doubled when the xanthine oxidase was first boiled before adding 
it to the cell-free extract (tube 5). These results suggest that 
the N-demethylation reaction was limited by the availability of 
endogenous co-factors such as NADH or NADPH in the cell-free 
extract incubation mixture.
4.5 Discussion
A suitable procedure was required to extract the N-demethylase
from the fungal cells of Cunninghamella in order to characterise
the enzyme. The extraction methods investigated (A - E Section
4.3.1 ) were evaluated in terms of the protein concentration in
the resulting cell-free extract, and the N-demethylase activity
of the extract on a codeine substrate. Several of the extraction
procedures described incorporated the non-ionic surfactant,
Triton XlOO, a substance known to interfere with the Lowry 
113protein assay . It was possible to remove the Triton by
118adsorption onto Amberlite beads , but this was a time-consuming 
procedure. In practice, it was more convenient to use the Coomassie
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112Blue protein assay (Section 4.3.3) in which Triton XlOO did 
not interfere. The Coomassie Blue assay for proteins in 
solution depends on the conversion of Coomassie Brilliant Blue 
G250 dye in dilute acid from a brownish-orange (the leuko form) 
to an intense blue colour when the dye-anion interacts with the 
NH^ groups of proteins. Absorbance of the dye-protein mixture 
is measured spectrophotometrically. The assay is reputed to have
high reproducibility and to be more sensitive than the Lowry
 ̂ ■ 112 protein assay
The results obtained from extraction methods (A - E) performed
on harvested cells of C. echinulata and C. bainieri are shown in
Table 4.1 and 4.2 respectively. Extraction method A was that
18developed by Sewell to prepare crude cell-free extracts from C. 
echinulata. Homogenisation was found to effectively disrupt 
the fungal pellets, and the non-ionic surfactant, Triton XlOO, 
was included for the solubilisation of protein associated with the 
cellular membrane fragments^^. The additional methods B to E 
in Tables 4.1 and 4.2 were attempts to improve on Sewell's original 
extraction procedure,(Method A). Grinding the mycelium in a pestle 
and mortar, and milling the crude extract (method B), was found to 
effectively disrupt the fungal pellets but the protein yield and 
the N-demethylase activity of the final cell-free extract was 
relatively low. Agitation of the crude extract (produced by method 
B above) for 30 minutes in phosphate buffer, (method C), doubled 
the protein yield in the final extract, but there was no improvement 
in the N-demethylase activity over Sewell's original method (A).
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However, agitation of the crude extract (produced by method B) for 
30 minutes in the presence of Triton XlOO (method D) considerably 
enhanced both the protein yield, and N-demethylase activity of 
the resulting extract, confirming the importance of including Triton 
XlOO in the extraction procedure. Furthermore, the relatively 
low extraction results obtained with method E provided further 
evidence that initially an effective disruption process was required, 
prior to the Triton XlOO treatment, for the best results. Grinding 
with the pestle and mortar failed to efficiently disrupt the 
fungal cells, and hence produced low extraction results, even after 
the crude extract was agitated with Triton XlOO. Employing extraction 
method D, the protein yield and resulting N-demethylase activity 
were 8 - 1 0 ,  and 2 - 3  times greater than values obtained by 
Sewell's original extraction procedure (A) for the extraction 
of C. echinulata and C. bainieri
The effect of varying the surfactant (Triton XlOO) concentration 
and agitation time, on the extraction of C. bainieri and C. 
echinulata using extraction method D, produced the results shown in 
Figures 4.3, and Table 4.3 respectively. Increasing the Triton 
XlOO concentration from O to 3% produced a significant increase in 
protein yield in the final extract. However, the N-demethylase 
activity of the extract actually decreased with increasing Triton 
concentrations above 0.5% v/v, implicating that the Triton XlOO 
may be exerting a deleterious effect on the N-demethylase enzyme.
A Triton XlOO concentration of 0.33% v/v was found to be optimal, 
and employing this concentration, the optimum extraction results
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were obtained by agitating the mixture for at least 30 minutes, 
after which time there was no further effect. Furthermore, 
the protein yield and N-demethylase activity of extracts prepared 
by method D incorporating Triton XlOO (0.33%), were considerably 
higher than those obtained with urea (3 M) . This suggested that 
the N-demethylase enzyme was tightly bound to the membrane 
(membrane bound) as opposed to being simply membrane associated.
Triton XlOO has been used previously to solubilize a number of
membrane bound proteins, including membrane enzymes^^^'^^^, without
121 122 loss of their biological activities . It has been proposed
that Triton XlOO functions by solubilization of enzymes with an
amphiphilic structure consisting of a water-soluble enzymic moiety
and a hydrophobic moeity which is bound to the cell membrane. Triton
XlOO is capable of solubilizing the hydrophobic part of the enzyme
122preventing its adsorption to hydrophobic surfaces. . The
effect of increasing detergent concentration on the solubilization
of membrane bound proteins has been studied by Tanford and Reynolds^^^.
They found that at low detergent to membrane ratios, the single
chain amphiphile will partition between the aqueous solution and
the lipid-protein bilayer. As the detergent to membrane ratio is
increased, some protein-lipid complexes may be released from the
membrane with bound detergent, and at very high detergent to membrane
ratios lipid detergent mixed micelles and protein detergent complexes
115are formed, resulting in separation of the lipid from the protein 
Many membrane bound enzymes have been found to depend on specific 
lipids for activity^^^'^^^, and this may be one of the reasons why 
Triton XlOO concentrations above 0.5% used in the extraction process
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profoundly affected the activity of the N-demethylase enzyme. Loss
of N-demethylase activity may also have resulted from the dénaturation
of the N-demethylase enzyme at higher Triton XlOO concentrations.
125Yoshida and Kumaoka found, for example, that a monooxygenase
isolated from Candida tropicalis showed a significant loss of
biological activity at surfactant concentrations above 1% v/v.
Dénaturation was thought to be caused by a complex formed between
125the non-ionic surfactant and the monooxygenase enzyme
An attempt to enrich the N-demethylase enzyme in cell-free extracts
prepared by extraction method D by dialysis (Section 4.4.2) resulted
in an increase in the protein yield, but with a significant reduction
in N-demethylase activity. The activity could not be recovered by 
2+the addition of Fe , NADPH and NADH to the dialysed extract indi­
cating that other essential components for N-demethylation must have 
been dialysed out of the original extract.
Kapella et demonstrated a procedure for the isolation
of an enriched hydroxylase enzyme from the yeast Candida tropicalis 
by precipitation of the microsomal fraction with calcium chloride. 
Employing this procedure with cell-free extracts from C. bainieri 
(Section 4.4.3) successfully provided an enriched final extract, 
with a high degree of N-demethylase activity. However, the 
procedure was considered impracticable for routine experimental use 
because it was time-consuming and produced only small quantities 
of purified cell-free extract.
The use of control incubation mixtures in which codeine, and/or 
the cell-free extract were omitted (Section 4.4.4) provided evidence
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that formaldehyde was generated from the microbial transformation 
of codeine. Furthermore, HPLC analysis revealed that only nor­
codeine was present in the reaction mixtures, implicating that 
the formaldehyde generated by the cell-free extracts resulted from 
the N-demethylation of codeine, as opposed to 0 -déméthylation. 
Preliminary characterization of the cell-free extract prepared from 
C. bainieri by extraction method D was carried out from incubation 
experiments, with a codeine substrate. Incubation temperatures of 
30°C, and a pH of 7.0, were used, as previous studies by Sewell^^ 
showed these to be optimal for the N-demethylation of codeine using 
cell-free extracts from C. echinulata. The transformation of 
codeine by C. bainieri was found to increase up to a concentration 
of 3 mM codeine in the incubation mixtures with 1.3 ml of cell-free
extract; and this codeine concentration was used in all subsequent
2+extract experiments. The addition of Fe (see Figure 4.6),
NADH and NADPH (see Figure 4.7) to the incubation mixture were all
found to be necessary for significant codeine N-demethylation by C.
bainieri. The inclusion of NADH resulted in a higher codeine
N-demethylation than NADPH, but the highest codeine transformation
was obtained by adding both NADH and NADPH together, implicating
that a synergistic effect may be occurring. Increasing the NADH
concentration in the incubation mixture from 0.1 mM to 0.3 mM
resulted in corresponding increases in the amounts of codeine N-
demethylated. However, these increases were not significant
enough to warrant using higher concentrations in subsequent incubation
experiments. The co-factors NADH and NADPH have been reported
22 23as essential requirements for both mammalian * and microbial
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24 25monooxygenase ' catalysed reactions, serving as active electron
donors. Ferrous iron has also been reported^^ to play an important
role in the function of cytochrome P-450 linked monooxygenases and
2+is believed to involve the Fe mediated reduction of molecular 
oxygen in the cytochrome-substrate complex, thus permitting the 
incorporation of an oxygen atom into the substrate. The co­
factor requirements described above for codeine N-demethylation by 
C. bainieri, suggest that the reaction is probably mediated by a 
type of monooxygenase enzyme. Control experiments performed in 
Section 4.4.7 showed that the limiting factor for codeine transfor­
mation in incubation mixtures with C. bainieri was not an unfav­
ourable equilibrium between codeine and norcodeine, as increasing 
and decreasing the codeine concentrations in the mixture failed 
to improve transformation. The probable reason for low transform­
ations was because endogenous co-factors present in the cell-free 
extract were utilised in the reaction and were not replenished.
Since the identity of the endogenous co-factor was not known, it 
was not possible to add them to the incubation mixture to further 
improve the transformation yield.
CHAPTER FIVE
INVESTIGATION OF THE MECHANISM OF 
MICROBIAL N-DEMETHYLATION OF CODEINE 
BY CELL-FREE EXTRACTS OF 
C. bainieri.
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CHAPTER 5. INVESTIGATION OF THE MECHANISM OF MICROBIAL N-DEMETHYLATION 
OF CODEINE BY CELL-FREE EXTRACTS OF C. BAINIERI
5.1 Introduction
Over the past 30 years or so the in vivo N-, O- and S- dealkyl-
ation of a wide variety of drugs and foreign compounds has been
22demonstrated in a variety of mammalian species . In many cases
dealkylations of this type have been attributed to cytochrome P-450
23linked monooxygenases . These enzyme systems exhibited a wide 
substrate specificity and required the presence of molecular oxygen 
and the reduced cofactor NADPH (reduced nictoninamide adenine di­
nucleotide phosphate). The feature of cytochrome P-450, which 
by definition was diagnostic for the presence, and presumed 
activity of this enzyme, was a characteristic absorption peak at 
450 nm, observed as a U.V. difference spectrum in the presence of 
carbon monoxide in the test cuvette only. Sodium dithionite 
was added to both cuvettes of the recording spectrophotometer so 
that the haem iron present in the enzyme was fully in its 
reduced form (ferrous)
The presence of monooxygenases of the P-450 type have also
been reported in several micro-organisms which Effect the oxidative
127metabolism of a variety of organic compounds . A bacterial
128monooxygenase, for example, was described in Pseudomonas
putida which effected the oxidation of camphor, and contained an
enzyme (P-450 ) which was similar in many respects to the cyto-cam
chrome P-450 present in mammalian systems. The structure of this
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129cytochrome P-450 was reported to resemble a cytochrome P-450
isolated from rabbit liver microsoraes with a similar subunit
molecular weight and amino acid composition, but very different
substrate specificity and solubility. In general, the substrate
specificity of bacterial monooxygenases appears to be more limited
25than mammalian monooxygenases . However, fungi and yeasts have 
demonstrated oxidative capabilities comparable to those effected 
by mammalian systems. Smith and Rosazza^^^ having studied the 
comparative metabolism of xenobiotics by mammalian and microbial 
systems, first coined the term, "microbial models of mammalian 
metabolism" to describe the close parallel between the two sytems^^^. 
Several examples in which complex organic substrates have been
transformed by fungi and yeasts have been reviewed by the same
131 25 132authors . Ferris et al. ' have demonstrated a fungal mono­
oxygenase system in Cunninghamella bainieri (ATCC 9244) capable 
of carrying out reactions similar to those of mammalian liver 
systems. When used as a ce11-suspension, supplemented with NADPH, 
this culture was shown to carry out the N-demethylation of amino- 
pyrene, the 0-demethylation of p-nitroanisole and anisole, the aryl 
hydroxylation of anisole, aniline and naphthalene and the reduction
of both 1,2-dimethyl- S' - (p-carboxyphenylazo)-5-hydroxy-benzene
132and p-nitrobenzoic acid . These reactions were inhibited by
carbon monoxide, SKE-525A and metapyrone, but not cyanide, and
the requirement of molecular oxygen was proved by incorporation
experiments. Furthermore, Ferris et al. later provided evidence
25for the presence of cytochrome P-450 . The fungal enzyme extract
from C. bainieri (ATCC 9244) was solubilized in aqueous digitonin
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followed by dithionite reduction and the addition of CO to give a 
maximum U.V. absorbance at 450 nm, characteristic of cytochrome 
P-450.
The possible mechanism(s) for the oxidative N-dealkylation
of substrates containing tertiary amine functions, by both
mammalian and microbial enzyme systems, has been a subject of debate
over recent years, largely because the reaction intermediates
have been transient and have not been observed. Essentially two
routes of tertiary amine oxidation have been proposed for this 
133process . These are illustrated in Figure 5.1. In the first, 
primary oxidative attack is thought to occur upon the carbon a to 
the nitrogen (a-C oxidation) to give a carbinolamine, N-dealkyl­
ation may proceed directly via carbinolamine formation by an 
oxene insertion reaction, or alternatively, the substrate may 
undergo dehydrogenation to an iminium ion which then adds the 
equivalent of hydroxide to form the carbinolamine. The carbinol­
amine then cleaves due to its instability, and forms the secondary 
amine and the corresponding carbonyl product (Figure 5.1). The 
second mechanism proposes metabolic attack on the nitrogen (N- 
oxidation) to produce an N-oxide which yields the corresponding 
secondary amine and carbonyl products. Additionally, tertiary 
amine N-oxides are readily reduced to the parent drug^^^'^^^ 
and some may undergo a rearrangement to the corresponding a- 
carbinolamine^^
The ability of various species of the fungus Cunninghamella
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129cytochrome P-450 was reported to resemble a cytochrome P-450
isolated from rabbit liver microsomes with a similar subunit
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pyrene, the 0-demethylation of p-nitroanisole and anisole, the aryl 
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132and p-nitrobenzoic acid . These reactions were inhibited by
carbon monoxide, SKB-525A and metapyrone, but not cyanide, and
18the requirement of molecular oxygen was proved by incorporation
experiments. Furthermore, Ferris et al. later provided evidence
25for the presence of cytochrome P-450 . The fungal enzyme extract
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primary oxidative attack is thought to occur upon the carbon a to 
the nitrogen (a-C oxidation) to give a carbinolamine, N-dealkyl­
ation may proceed directly via carbinolamine formation by an 
oxene insertion reaction, or alternatively, the substrate may 
undergo dehydrogenation to an iminium ion which then adds the 
equivalent of hydroxide to form the carbinolamine. The carbinol­
amine then cleaves due to its instability, and forms the secondary 
amine and the corresponding carbonyl product (Figure 5.1). The 
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to N-demethylate the tertiary amine, codeine, was demonstrated 
18by Sewell , and also previously in Chapter 3 of this thesis.
It was demonstrated in Chapter 4 of this thesis that for
codeine N-demethylation to occur by cell-free extracts of C.
2+
bainierif the co-factors NADPH, NADH and iron (Fe ) were required 
to be present in the reaction mixture. The aim of this study, 
therefore, was to prepare cell-free extracts of C. bainieri to 
N-demethylate codeine and codeine N-oxide substrates, and estimate 
the N-demethylase activity in each case using the quantitative 
HPLC assay (developed in Chapter 2) to determine the transformation 
product, norcodeine. The technique would be used to determine 
kinetic data for the N-demethylation of codeine and codeine N-oxide 
substrates, and to investigate the affect of selected inducers and 
specific enzyme inhibitors for the same transformations. The 
evidence gained from these experiments could then be used to 
propose a reaction mechanism for the N-demethylation of codeine by 
cell-free extracts of C. bainieri.
5.2 Materials
5.2.1 Chemicals and Reagents
Hydrogen peroxide (100 volumes) - Fisons Ltd.
Palladium (Pd) on carbon (10% w/w) - Aldrich Chemical Co.
SKF 525A (proadifen hydrochloride); Smith Kline and French Ltd 
Potassium cyanide, sodium sulphite (AnalaR), 2-mereaptoethanol 
and L-CyStine- BDH Ltd.
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5.2.2 Test compounds
Codeine N-oxide; was prepared from codeine base by the method 
137of Groutas et ai. 3o% Aqueous hydrogen peroxide (10 ml) was
added to codeine base (4.8 g; 15 mmol.) in methanol (20 ml) 
contained in a lOO ml round bottomed flask. The solution was stirred 
for 48 hours at room temperature, and then heated on a steam 
bath for 2 h. Excess peroxide was destroyed by adding 10% Pd on 
carbon (0.1 g) and stirring the cooled reaction mixture for 1 hour. 
The reaction mixture was filtered (Whatman No. 1 filter paper) and 
the solvent removed by evaporation under reduced pressure to 
leave a white solid (3.6 g). This was dissolved in the minimum 
of hot ethanol, filtered and allowed to cool to room temperature 
to yield white crystals of codeine N-oxide (1.8 g).
Analytical; melting point 213°C (lit.^^ 214°C).
NMR (DgO, codeine N-oxide); 1.21 (2H, t, C^^-H); 1.85 
(IH, d, C^^-H); 3.09 (2H, d, C^^-H); 3.39 (3h , m. C^^-H, C^-H)
Cg-H); 3.76 (IH, s, O-II, exchanges with D^O); 3.ü4 (3H,
s, 0-Me); 4.34 (IH, m, C^-H); 4.74 (3H, s, N-Me); 5.07
(IH, d, Cg-H), 5.35 (IH, m, C^-H); 5.72 (IH, d, Cg-H); 6.79
(d.d, C^-H, Cg-H).
Diazepam: Roche Products Ltd.
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5.2.3 Equipment and Instrumentation
Neutral glass ampoules; 2 ml capacity, Epsom Glass Industries 
Ltd., England. All glassware used for the cell-free extract experi­
ments was prepared according to the procedures described in Section
4.2.2 (page 156 ) .
5.3 Methods
5.3.1 General methods
Culture flasks were prepared and inoculated with C. bainieri
according to the procedures and incubation conditions described in
Section 3.3.1. Cell-free extracts were prepared from 10 day
cultures of C. bainieri employing extraction method D described in
Section 4.3.2. Extracts were stored at 4°C in an atmosphere of
nitrogen until required for use. Protein in the cell-free extract
112was determined by the method of Sedmak and Grossberg described 
in Section 4.3.2. N-demethylase activity of the cell-free extract 
was determined by assaying the norcodeine produced in incubation 
mixtures described in Section 4.4.1, page igg by the HPLC 
procedure described in Section 4.3.3(b).
5.3.2 Estimation of cytochrome P-450
Each cell-free extract was subjected to the standard method 
of Omura and Sato^^^ to detect the presence of cytochrome P-450.
Two matched quartz cuvettes were filled with cell-free extract, 
and nitrogen gas was bubbled through the extract in each cuvette
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for 2 minutes. Solid sodium dithionite, Na^SgO^, (10 mg) was added 
to each cuvette, and a linear baseline spectrum was measured from 
380 nm to 520 nm on the UV/visible spectrophotometer with a full 
scale deflection of 0.1 absorbance units. Carbon monoxide was then 
bubbled through the sample cuvette for 30 seconds, and the spectrum 
retraced from 380 nm to 520 nm. An absorption maximum in the 450 nm 
region suggested the presence of cytochrome P-450, and the cyto­
chrome P-450 concentration was calculated from the absorbance 
difference A^^^ - A^^^ on the assumption that the Cunninghamella 
cytrochrome P-450 has the same absorption coefficient as reported
by Omura and Sato^^^ for liver microsomal cytochrome P-450 of
“1 "”1 91 cm mM
5.4 Experimental
5.4.1 Determination of the stability of the N-demethylase enzyme in 
the cell-free extract of C. bainieri
It was required to determine the stability of the cell-free 
extract to ensure that there was no appreciable loss of N-demethylase 
activity during the time required to conduct kinetic experiments.
Cell-free extract, prepared from codeine induced cultures of 
C. bainieri was divided into 1.5 ml aliquots and sealed in 2 ml 
glass ampoules. Prior to sealing, half of the ampoules were purged 
with a stream of nitrogen gas for 2 minutes to displace the air, 
and the remainder were sealed in air. The ampoules sealed under
air and nitrogen were divided once more, and some of each type
o ostored in a fridge at 4 C and the others in a freezer at -20 C.
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At intervals during a 10 day period, ampoules were taken from 
storage, opened and the N-demethylase activity of the cell-free 
extract determined by the procedure described in Section 4.4.1 
page using codeine phosphate as the test substrate. The
N-demethylase activity of unstored cell-free extract was assumed 
to be 100%, and the activities of stored extracts were determined 
with respect to this value. From these results plots of the 
N-demethylase activity of extracts stored in various conditions 
with storage time were constructed and shown in Figure 5.2.
From these results it was observed that the activity of all the 
extracts decreased to approximately 70% of the original activity 
after 60 - 70 hours' storage. However, the overall trend was 
that extracts stored in atmospheres of nitrogen, maintained a 
higher % activity over the period of storage than extracts stored
in air, but there was no significant difference between storage
o oat 4 C and storage at -20 C.
5.4.2 The effect of reducing agents on the stability of cell-free
extracts from C. bainieri
An attempt was made to improve the stability of the cell-free 
extract of C.bainieri during storage by the addition of selected 
reducing agents. Extracts were sealed in 2 ml glass ampoules as 
described above in the presence of one of the following reducing 
agents: sodium sulphite (1 mM), L-cystine (5 mM) or 2-mercapto-
ethanol (5 mM). The extracts were stored at 4°C in a nitrogen 
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a 10 day period and the N-demethylase activity after storage 
compared with an unstored control extract containing no reducing 
agent.
The % N-demethylase activity with time plotted for the various 
storage conditions is shown in Figure 5.3. The results showed 
that there was no improvement in the stability of the cell-free extract 
by the inclusion of any of the reducing agents investigated. As a 
result of these stability studies it was decided to store the cell- 
free extract at 4°C, in an atmosphere of nitrogen, as 95 - 100% 
activity would be maintained over the period of time required to 
conduct any of the experiments described in the following chapters.
5.4.3 Evidence for the presence of cytochrome P-450 in cell-free 
extracts from C. bainieri
Each cell-free extract prepared was subjected to the standard 
method of Omura and Sato^^^ described in Section 5.3.2 to detect 
the presence of cytochrome P-450. If present, the quantity of cyto­
chrome P-450 was estimated from the UV carbon monoxide difference 
spectrum assuming that the Cunninghamella cytochrome P-450 has
the same absorption coefficient as reported by Omura and Sato^^^
-1 -1for liver microsomal cytochrome P-450 (91 cm mM ) .
A typical UV spectrum of absorbance against wavelength plotted 
from 380 nm to 520 nm of a cell-free extract from C. bainieri in­
















































was produced from 380 to 520 nm when the cell-free extract, reduced 
with dithionite, was placed in both sample and reference cuvettes. 
This is shown by the broken line in Figure 5.4. When carbon monoxide 
was bubbled fpr 30 seconds into the extract contained in the sample 
cuvette only, a maximum absorbance was observed in the 450 nm 
region of the UV CO reduced difference spectrum, shown by the 
continuous line in Figure 5.4. This provides strong evidence that 
the N-demethylase present in C. bainieri is a cytochrome P-450 
type monooxygenase.
5.4.4 Determination of apparent and V values for the N-demethyl: 
ation of codeine and codeine N-oxide substrates by cell-free 
extracts from C. bainieri
It has been suggested that the N-oxide could be a possible
intermediate in the N-demethylation of tertiary amines by cyto-
133chrome P-450 linked monooxygenases (Figure 5.1). The following 
kinetic experiments were therefore performed to determine the 
apparent Michaelis constant (1̂ ) and maximum velocity (V̂  for 
the N-demethylation of both codeine and codeine-N-oxide substrates, 
bj cell-free extracts of C. bainieri. These results would 
provide evidence to suggest whether or not the N-oxide is an inter­
mediate in the N-demethylation of codeine by C. bainieri.
Incubation mixtures were prepared containing the following 
cell-free extract (1.3 ml), FeSO^.TH^O (0.1 mM), NADPH (0.1 mM),
NADH (0.1 mM), semicarbazide HCl (3 mM) and 0.066 M phosphate 
buffer, pH 7.0, to 1.5 mis. Each mixture was incubated at 30°C,
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and the reaction initiated by the addition of either codeine, or 
codeine N-oxide substrates. The experiments were constructed with 
different substrate concentrations in the range 0.512 to 2.56 mM. 
The reaction was terminated after O, 0.5, 1.0, 2.0, 4.0, 6.0,
8.0 and 10.0 minutes of incubation at 30°C by boiling each mixture 
for 10 minutes in a water bath. Each mixture was then assayed for 
norcodeine by the procedure described in Section 4.3.3(b). Plots 
of the norcodeine concentration (yM) in the incubation mixture 
against time were constructed, and the initial reaction rates were 
calculated for each substrate concentration.
These data were used to construct standard Lineweaver-Burke 
(1/v against 1/ [ s ])/ and Woolf plots ( [&]/ v against [S ]) shown 
in Figures 5.5, and 5.6, respectively, where v is the initial 
reaction rate and [s] is the substrate concentration. From these 
plots the apparent Michaelis constant (k̂ M) and V values for 
the N-demethylation of codeine and codeine N-oxide substrates by 
C. bainieri (C^^) were determined. The results obtained were:-
Table 5.1. Kinetic data for the N-demethylation of codeine and 
codeine N-oxide substrates by cell-free extracts of 
C. bainieri.
Su hstrate Lineweaver-Burke Woolf
App.
mM Y. . -1nm min
App. kivt 
f*M -  . -1nm min
Codeine 3.45 0.62 3.97 0.67
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The significance of these results in relation to the mechanism 
of codeine N-demethylation is discussed on page 223
5.4.5 The effect of enzyme inducers on codeine N-demethylation by 
cell-free extracts from C. bainieri
Organisms can increase monooxygenase activity to more 
effectively metabolise certain foreign substances. This response 
may result in a quantitative enhanced capacity to utilize a given
138substrate or substrates, and is generally referred to as induction 
If codeine N-oxide was an intermediate in the N-demethylation of 
codeine, it would be expected to be a good inducer of the enzyme .
Enzyme induction experiments were performed by adding 
various substrates as possible inducers to the medium in which the 
microorganism, C,bainieri, was growing. The effectiveness of each 
substrate as an inducer was assessed by measuring the specific 
transformations of cell-free extracts produded from the induced 
cells. The specific transformation was defined, in this case, 
as the transformation of codeine to norcodeine per mg of protein 
in the cell-free extract.
The enzyme inducers listed in Table 5.2 were added to the 
stage-2 cultures 24 hours after inoculation with the first stage 
cultures to give a concentration of 1 mM in the medium. Codeine 
N-oxide, codeine base and codeine phosphate were dissolved in 
phosphate buffer, pH 7.0, before addition, diazepam was dissolved 
in 95% alcohol and tetradecane was added directly to the medium 
to give a final concentration of 1% w/v. Using codeine phosphate
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as a test substrate, the N-demethylase activities of the cell-free 
extracts prepared from induced cultures, were compared to those 
from cultures containing no inducer . The specific transformations 
for the conversion of codeine to norcodeine by cell-free extracts 
prepared from cultures induced with various substrates are given 
below:
Table 5.2. Effect of inducers on the N-demethylation of codeine by 
cell-free extracts from C. bainieri.








-1 -1* specific transformation = yM norcodeine, mM codeine , mg protein.
The data in Table 5.2 show that codeine N-oxide was found to be a 
less effective inducer than codeine itself. The significance of 
these findings are discussed on page 224.
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5.4.6 The effect of inhibitors on codeine N-demethylation by
cell-free extracts from C. bainieri
139-140Cytochrome P-450 monooxygenases from both mammalian 
25and microbial systems are known to be inhibited by a variety of
138substances, including SKF-525A and carbon monoxide , whereas
141potassium cyanide is known to be an N-oxide demethylase inhibitor 
In an attempt to characterise the codeine N-demethylase in C. 
bainieri, the effect of these typical inhibitors was investigated. 
The results of these experiments may then enable a prediction to 
be made concerning the mechanistic route of codeine N-demethylation 
by C. bainieri.
Incubation mixtures were prepared in glass screw-cap tubes 
(15 ml), containing the components described in Section 5.4.3, 
page 210. Duplicate pairs of test and control incubation mixtures 
(containing no inhibitor), maintained at 4°C, were then subject 
to one of the following treatments:-
a) untreated - No inhibitor added - control.
b) Potassium cyanide: - Added as a solution in 0.066 M phosphate
buffer to provide a concentration of 5 yM.
c) SKF-525A:- - Added as a solution in 0.066 M phosphate
buffer to provide a concentration of 1 mM.
d) Carbon monoxide: - Bubbled into the surface of the incubation
mixture through a glass pipette for 30 
seconds and the tube then closed.
In addition, an incubation mixture was prepared containing cell- 
free extract which had been boiled at 100°C for 10 minutes.
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The incubation mixtures were then equilibriated at 30°C, and the
reaction initiated by the addition of codeine or codeine N-oxide
substrates respectively in 0.056 M phosphate buffer, pH 7.0, to
-3give a final concentration in each case of 1.5 x 10 M, in each 
test mixture. The tubes were closed, gently shaken and incubated 
at 30°C for 30 minutes. Samples of each mixture were taken (1 ml), 
filtered through a 0.45 ym cellulose acetate membrane filter 
(Millipore), and then assayed for norcodeine by HPLC (see Section 
5.3.1). To ensure that the presence of inhibitors would not affect 
the HPLC assay for norcodeine, the calibration procedure described 
in Section 2.4.5 was repeated,using standard norcodeine solutions 
with the addition of inhibitors at the concentrations stated above. 
In each case it was found that there was no change in the detector 
response to norcodeine with excellent precision maintained. Data 
for transformation of codeine to norcodeine by cell-free extracts 
of C. bainieri in the presence of these inhibitors are presented 
in Table 5.3. A 100% transformation was assumed if no inhibitor 
was present. The transformations in mixtures containing an inhibitor 
have been calculated relative to this.
It can be seen from Table 5.3 that the N-demethylation of both 
codeine and codeine N-oxide by the cell-free extract was inhibited 
by SKF-525A and carbon monoxide but there was no significant 
inhibition by potassium cyanide. The significance of these findings 
is discussed on page 225.
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Table 5.3. Effect of enzyme inhibitors on N-demethylation of codeine 






No inhibitor 100 100
Potassium cyanide (5 yM) 96 85
SKF-525A (10 M) 12 23
Carbon monoxide 9 29
Boiled enzyme 3 4
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5.5 Discussion
A cell-free extract which retained its N-demethylase activity
over the time required to conduct kinetic experiments was required
to facilitate these studies. The % of the initial N-demethylase
activity of cell-free extracts from C. bainieri remaining with
o ostorage time, for extracts stored at 4 C, - 20 C, in atmospheres
of air, and nitrogen, are illustrated in Figure 5.2. After an
initial period of stability over the first 20 hours of storage, the
N-demethylase activity of all the extracts decreased between 20
and 70 hours of storage to approximately 60 to 80% of its original
activity. The extracts then retained this level of activity over
the remaining storage time (about 1 week). The inclusion of reducing
agents such as sodium sulphite, L-cystine and 2-mercaptoethanol,
on storage at 4°C in a nitrogen atmosphere failed to enhance the
stability of the cell-free extract (Figure 5.3). However, since
the extracts stored at 4°C, in a nitrogen atmosphere, maintained
95 - 100% of their original activity for approximately 20 hours,
this was considered acceptable for subsequent studies. The reason
25for the loss in activity was uncertain. Ferris et al. found that
the activity of an aryl hydrocarbon hydrolyase enzyme present in
cell-free extracts from C. bainieri (ATCC 9244) decreased appreciably
on standing at 5°C, and lost up to 90% of the original activity
after 24 hours. Furthermore, they too were unable to stabilise the
enzyme by the inclusion of reducing agents, but tests for the
25presence of protease enzymes in the extract were negative, 
revealing that the loss of activity was unlikely to be due to 
endogenous proteolytic enzymes.
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In the previous chapter it was established that the N-demethylase
enzyme present in the cell-free extracts from C. bainieri
was capable of N-demethylating codeine, providing the co-factors
2+NADPH, NADH and iron (Fe ) were present in the incubation mixture.
In this chapter further characterisation of the cell-free extract
was carried out by determining the carbon monoxide UV difference
spectrum shown in Figure 5.4. A maximum absorbance in the 450 nm
region provides strong evidence for the presence of a cytochrome
P-450 linked enzyme in the cell-free extract of C. bainieri induced
with codeine. This is consistent with the findings of Ferris et 
25al. , who also demonstrated that the hydroxylase enzyme found
in cell-free extracts of C. bainieri (ATCC 9244) was of a cyto­
chrome P-450 type.
The concentration of cytochrome P-450 found in cell-free 
extracts of C. bainieri prepared by extraction method D was approx­
imately 20 nmol per mg protein, calculated using the absorption
-1 -1 126 coefficients of 91 cm mM reported by Omura and Sato for
liver microsomal cytochrome P-450.
The two proposed mechanisms for the N-demethylation of tertiary
133amines is illustrated in Figure 5.1. It has been suggested that 
the N-oxide could be a possible intermediate in the N-demethylation 
of tertiary amines by cytochrome P-450 linked monooxygenases.
If the N-demethylation of codeine was proceeding through an N-oxide 
the Michaelis constant (l̂/v\) for the transformation of codeine 
N-oxide would be expected to be smaller than that for the trans­
formation of codeine, because the N-demethylase enzyme would be
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expected to have a greater affinity for codeine N-oxide. In 
addition, the maximum velocity, V for codeine N-oxide transformation 
should be greater than for codeine transformation, since the codeine 
to norcodeine reaction would involve two steps if the N-oxide was 
an intermediate, and would not be expected to proceed as fast as 
the N-oxide to norcodeine reaction which only involves one step.
Standard Lineweaver-Burke and Woolf plots constructed from 
the results of kinetic experiments carried out with codeine and 
codeine N-oxide substrates are shown in Figures 5.5 and 5.6 
respectively. Apparent values and V values derived for codeine 
and codeine N-oxide from these plots are listed in Table 5.1.
The krw values for codeine (3.45 mM; 3.97 mM) and codeine N-oxide 
(2.56 mM; 3.11 mM) were similar, and the V values observed for 
codeine were greater than for codeine N-oxide (Table 5.1) suggesting 
that codeine N-oxide was not an intermediate in the N-demethylation 
of codeine by C. bainieri.
The highly polar character of N-oxides have made difficult a
full appreciation of the extent to which N-oxidation of tertiary
133
amines occurs in mammalian systems . In kinetic studies con­
cerned with the oxidation of aniline derivatives by liver micro­
somes, Kiese^^^ found that the value for oxygen utilisation in 
the N-oxide reaction was 40 times greater than that for the N- 
demethylation reaction. This seems to rule out N-oxidation as an 
intermediate step in N-dealkylation, and is consistent with the 
results described above.
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Microbial monooxygenases of the cytochrome P-450 type are
known to be inducible for substrates which are added to the medium
in which the microorganism is growing^^^. If codeine N-oxide was
an intermediate in the N-demethylation of codeine it would be
expected to be a good inducer of the enzyme reaction. The results
of enzyme induction experiments carried out with C.bainieri in
Section 5.4.4 are shown in Table 5.1. These results showed that
very little transformation occurred if no inducer was used. More
important, codeine N-oxide was found to be a less effective inducer
than codeine phosphate or codeine base and gave lower specific
transformations values for the codeine to norcodeine reaction (Table
5.2). It was even less effective than compounds not chemically
related to codeine, such as diazepam and tetradecane. These
substances were included in the enzyme induction experiments because
it has been demonstrated that C.bainieri can N-demethylate diazepam
18from previous studies . Also, the presence of a cytochrome P-450 
containing enzyme system has been demonstrated in yeasts, (e.g.
143Candida tropicalis) grown on tetradecane as the sole carbon source , 
and the results of experiments conducted in chapter 3 of this thesis 
suggested that tetradecane may be a good inducer of the N-demethylation 
in C. bainieri.
In fact the high specific transformation shown in Table 5.2 
suggests tetradecane is a good inducer of the N-demethylase in 
C. bainieri. However, further attempts to characterise the cell- 
free extracts prepared from tetradecane induced cells from C. 
bainieri was prevented by the turbidity of the resulting extract 
and interference to the assay procedures.
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Further information on the mechanism of microbial N-demethylation 
was obtained by the use of specific inhibitors. Carbon monoxide 
and SKF 525A are known as classical inhibitors of cytochrome P-450 mono­
oxygenases in both mammalian^^^'and microbial systems^^. Potassium
cyanide has been found not to inhibit hepatic cytochrome P-450 or
25fungal cytochrome P-450 , but is known to be an N-oxide demethylase
141inhibitor . Therefore, if the N-demethylation of codeine by C. 
bainieri proceeded via the N-oxide intermediate it would be expected 
that the reaction would be inhibited by potassium cyanide, but not 
SKF 525a or carbon monoxide. However, if the transformation was 
occurring via an alternative intermediate it would be inhibited by 
SKF 525A and carbon monoxide,only, and would be unaffected by 
potassium cyanide. The effect of these inhibitors on the transformation 
of codeine and codeine N-oxide substrates is shown in Table 5.3. When 
no inhibitor was included in the incubation mixture the transformation, 
codeine to norcodeine, was assumed to be lOO%. The boiled enzyme 
control showed that norcodeine was produced by enzyme activity and 
not by chemical breakdown in the test assay. SKF 525A and carbon 
monoxide were found to inhibit the N-demethylation of both codeine 
and codeine N-oxide, and provides further evidence that the fungal 
monooxygenase found in C. bainieri was a cytochrome P-450 type.
However, potassium cyanide produced no significant inhibition of 
codeine or codeine N-oxide N-demethylation. In addition, with 
codeine N-oxide substrate, codeine was found as well as norcodeine 
in the reaction mixture. These findings suggest that norcodeine 
was not produced from codeine N-oxide directly, but from the 
reduction of codeine N-oxide back to codeine, and through a second 
chemical pathway. The microbial reduction of tertiary amine N-oxides
has been reported for other compounds including pyridine N-oxide
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145 146and trimethylamine N-oxide . Sindelar et al. have investigated
the possibility that nicotine-1'-N-oxide was formed as an intermediate
in the N-demethylation of nicotine by M. gypseum and unexpectedly
found the N-oxide was efficiently reduced back to nicotine in cell- 
146free systems . Although the enzyme system involved in N-oxide
reduction is not known, an inducible tertiary amine N-oxide reductase
147has been isolated from E. coli . This was found capable of reducing
tiaramide N-oxide to tiaramide under anaerobic conditions in the
presence of NADPH^^^, and strong evidence suggests that this reaction
was induced by phénobarbital and 3-methylcholantWrene, while
148carbon monoxide inhibited the reaction . Similar results were
149obtained with studies on N,N-dimethylaniline N-oxide reduction
126Consequently, it has been proposed that tertiary amine 
N-oxide reduction and a-carbon oxidation of the resulting 
teriary amine may be catalysed by the same enzyme. Such a reaction 
sequence could explain the presence of codeine, as well as nor­
codeine, in the reaction mixture resulting from the transformation 
of codeine N-oxide by cell-free extracts of C. bainieri. In con­
clusion, the evidence presented seems to discount the N-oxide as 
an intermediate in the N-demethylation of codeine by C. bainieri, 
and suggests that N-demethylation proceeds via a different inter­
mediate. This, could arise by the attack of molecular oxygen, in 
the presence of the en zyme, on the carbon alpha to the nitrogen 
(a-C oxidation) to produce a carbinolamine, N-hydroxymethylcodeine 
(Figure 5.7). However, the N-hydroxymethylcpdeine intermediate 
was unstable, and hence transient ,breaking down to norcodeine 
and formaldehyde. It has also been proposed^^^ that a hydroxy- 




































amine N-oxide intermediate. For example, in the N-demethylation
24of trimethylamine by Ps. aminovorans, Large proposed an N-oxide
intermediate which was non-oxidatively demethylated to formaldehyde
23and dimethylamine. However, there is considerable doubt as to
whether this mechanism is generally applicable, since other
mechanisms must be invoked to explain the dealkylation of compounds
22other than tertiary amines . Therefore, it seems likely that 
the rearrangement of codeine N-oxide to N-hydroxymethylcodeine 
by C. bainieri if it occurred, was a minor pathway, since the evi­
dence supports the following two-step reaction pathway leading 
to the N-dealkylation of codeine N-oxide; (1) reduction of the 
N-oxide and (2) the cytochrome P-450 mediated N-dealkylation of 
the resulting tertiary amine, codeine, to norcodeine (Figure 5.7).
The mechanism(s) by which cytochrome P-450 catalysed oxidations 
proceed is not fully understood. However, the overall stoichiometry 
of the reaction is believed to involve a two electron oxidation 
of the substrate by oxygen (Ô ) which is coupled to a two electron 
oxidation of NADPH and the formation of one mole of water. The 
process is given below with the oxidation of a tertiary amine to 
the corresponding carbinolamine, and its subsequent decomposition 
to the secondary amine and formaldehyde^^^.
monooxygenase
OH+ I +RgNCHg + NADPH + + H R^N-C% + NADP + H^O
R^NH + HCHO
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The role of cytochrome P-450 in oxidative transformations is 
illustrated in Figure 5.9. The process is thought to be initiated 
by the activation of dioxygen (Ô ) to an oxenoid species such as
oxene (Î0 ). This electron deficient oxygen atom, is capable of 
establishing a bond to the tertiary amine substrate at the methyl 
carbon alpha to the nitrogen atom in the presence of the mono­
oxygenase. Present evidence^^^ suggests that the substrate (R^N-CH^) 
binds to a hydrophobic region of cytochrome P-450 which is situated 
in close proximity to the oxidized (Fê "*") iron containing haem
2tgroup. Once the substrate is bound, the iron is reduced to Fe
in a reaction catalysed by the NADPH requiring enzyme cytochrome
P-450 reductase. This reduced form of cytochrome P-450 accepts
dioxygen (Og) as an axial ligand on the surface to which the
sutstrate is bound (Figure 5.8). This system is reduced by a
second electron to form a species which may cleave the oxygen-oxygen
bond and yield with the addition of two protons one mole of water
3+ •*and "active oxygen" - namely a ferric-oxene complex (Fe :O ).
3+ **However, the details concerning the pathway by which Fe 10
converts a tertiary amine to the corresponding a-carbinolamine are
not clear. Direct oxygen insertion between the C-H bond has been
proposed^^^, as well as an alternative pathway which involves
an initial electron transfer from nitrogen to oxygen to form bound
3+ "superoxide radical anion (Fe îO*) and the radical cationic nitrogen
species (R^N'-CH^). Hydrogen radical abstraction from R^N'-CH^
3+ *• +leads to Fe î O Î H and the imminium ion R_N=CH., and final transfer • •  ̂ Z
of the hydroxide group to the imminium ion would yield the carbino­
lamine product. Although there is some evidence for the involvement
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of imminium ion intermediates in the microsomal oC-C oxidation
of tertiary amines, an alternative pathway involving direct oxene 
insertion to generate a carbinolamine which might be in equilibrium 
with the corresponding imminium ion, could also explain these data.
CHAPTER SIX
13APPLICATION OF C NMR SPECTROSCOPY
TO STUDY THE MECHANISM OF CODEINE 
N-DEMETHYLATION BY CELL-FREE EXTRACTS OF 
C. bainieri.
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Chapter 6. Application of ^^C NMR spectroscopy to study the
mechanism of codeine N-demethylation by cell-free
extracts of C. bainieri.
6.1 Introduction
In Chapter 5 evidence was presented from kinetic, enzyme 
induction and eqzyme inhibitor studies which seemed to discount 
the N-oxide as an intermediate in the N-demethylation of codeine 
by C. bainieri. It has been suggested that N-demethylation pro­
ceeded via an alternative route involving a carbinolamine inter­
mediate. Unfortunately, this could not be confirmed during those 
studies since N-hydroxymethylcodeine was unstable, and decomposed 
to the secondary amine, norcodeine, and formaldehyde.
Some applications of ^^C NMR to metabolic and biosynthetic 
problems were reported in Section 1.8 of this thesis. In this 
chapter a ^^C NMR spectroscopic technique was employed to detect 
.the possible intermediates in the N-demethylation of codeine. 
Codeine was synthesised with 90% enrichment of the N-methyl group 
with carbon-13, and this was N-demethylated in the NMR tube by 
cell-free extracts of C. bainieri, so that the intermediates, and
subsequently, the formaldehyde liberated, were also enriched.
13The C spectra constructed at progressive times during the enzyme 
reaction will show signals for the carbon enriched species only, 
and these could be identified by their chemical shift values and 
off-resonance splitting patterns, providing further evidence for 




6.2.1 Chemicals and reagents
Formaldehyde solution (19% w/v) with 90 atom% ^^c was pur­
chased from Prochem B.O.C. Ltd., England.
Formic acid (90% w/v), Hydrazine hydrate, phenylhydrazine HCl 
and sodium metabisulphite were all Analar grade and purchased from 
B.D.H. Ltd. Poole, England.
Alcohol dehydrogenase, and tetramethylsilane (T.M.S.). - internal 
standard for NMR, were purchased from Aldrich Chemical Company, 
Gillingham, Dorset.
6.2.2 Test compounds
Codeine ^N-Me- Ĉ  ; This was prepared in two stages. In 
stage-one norcodeine was prepared from codeine base (see page 48) 
In stage-two codeine ^N-Me-^^cJ was prepared from norcodeine by 
the method of Anderson and Woods^^^, employing ^^C formaldehyde 
with 90% atom enrichment.
Norcodeine (1.027 g; 3.6 mmoles), absolute alcohol (42.5ml),
^^C formaldehyde (0.67 ml; 4.25 mmoles) and formic acid 90% w/v 
(4.25 ml; 80 mmoles) were heated under gentle reflux for 90 
minutes in a 50 ml. round bottomed flask. The alcohol and excess 
formic acid were removed by rota évaporation under reduced pressure 
leaving an oily residue. This was dissolved in HCl (0.25 N, 17.5 ml.), 
and the crude product precipitated by addition of N. NaOH to 
pH 9. Chloroform (3 x 20 ml.) was used to extract the product.
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The chloroform layer was washed with water (25 ml.), dried (anhydrous 
MgSO^) and evaporated to yield a white powder (1.028 g). This was 
dissolved in the minimum of hot ethanol, and ethanolic HCl added 
dropwise until the solution was acidic. Cooling to room temperature 
yielded white crystals (1.07 g) of codeine ^ N-Me-^^Cj HCl.
Analytical;
melting point, 279°C (lit.^^ 280°C).
^H NMR, H*̂ (CDClg codeine ^N-Me-^^c) base); 1.86 (2H, m, C^^-H) ;
2.44 (5H, m, C^^-H, C^^-H, C^^-H); 2.32 (3H, s, N-^) ; 3.29
(IH, m, Cg-H); 3.73 (3H, s, 0-Me); 3.90 (IH, s, 0-H, exchanges
with DgO); 4.21 (IH, m, C^-H); 4.84 (IH, d, C^-H); 5.29
(IH, m, C^-H); 5.72 (IH, d, C^-H); 6.6 (2H, d.d, C^-H, Cg-H)
^^C NMR (DgO; codeine j^N-Me-^^cj HCl; 21.54(OFR, t, C-IO);
36.3 (OFR t; C-15); 38.7 (OFR d; C-9); 41.5 (OFR q; C-17 N-
Methyl); 42.2 (OFR s; C-13); 4/.4 (OFR t; C-16); 56.7 (OFR q,
C-18); 60.8 (OFR d, C-14); 66.4 (OFR d; C-6); 91.4 (OFR d, C-5);
114.6 (OFR d, C-1); 120.8 (OFR d, C-2); 124.65 (OFR s, C-11);
126.2 (OFR d, C-W); 129.6 (OFR s, C-12); 133.96 (OFR d, C-7);
142.46 (OFR s, C-3); 147.0 (OFR s, C-4).
Codeine N-oxide was prepared from codeine base by the method 
described in Section 5.2.2 (see page 204).
^^C NMR ^C (DgO; codeine N-oxide); 26.0 (OFR t, C-10);
30.9 (OFR t; C-15); 34.0 (OFR d, C-9); 41.9 (OFR s, C-13)
57.0 (OFR t, C-16); 58.0 (OFR q; C-17 N-methyl); 58.3(OFR q,
C-18 0-Methyl);
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59.6 (OFR d; C-14); 66.7 (OFR d; C-6); 74.7 (OFR d; C- 5);
114.95 (OFR d; C-1) ; 120.85 (OFR d; C-2); 124.5 (OFR s; C-U);
127.5 (OFR d; C-8 ) ; 130.1 (OFR s; C-12); 133.1 (OFR d; C-7);
142.6 (OFR s; C- 3); 147.0 (OFR s; C- 4).
6.2.3 Equipment and instrumentation
NMR spectrometer: A Jeol FX 90Q high resolution Fourier
Transform NMR spectrometer operating at 22.5 MHz. was used to 
observe ^^C resonances. This was interfaced to a FA-100 NMR 
data system based on the 980 B computer with 8 K data points.
For an average spectral width of 5000 Hz, a 4 ysecond pulse, 
corresponding to a tilt angle of 30° was employed, with a 1.8192 
second interval (acquisition time + 1 second pulse delay) between 
pulses. Probe temperature control; The NMR spectrometer was 
installed in an air conditioned room maintained at a temperature 
of 21'± 0.5°C. A Jeol JES-VT temperature controller was employed 
to vary the p robe temperature from 5 - 40°C (± 0.5°C). For 
low temperature control (below 21°C) nitrogen gas evaporated 
from liquid nitrogen in a 10 litre metal Dewar flask was employed, 
the evaporation rate was controlled automatically. For high temp­
erature control (above 21°C) air from an air compressor passed 
through the heat blasting pipe was employed, the temperature of 
the air was automatically controlled.
NMR sample tubes ; glass, 10 mm internal diameter. Tubes were 
prepared as described in Chapter 4, page 157 . A sealed d ^O




Shake flasks were prepared and inoculated with C. bainieri 
according to the procedures and incubation conditions described in 
Section 3.3.1. Codeine phosphate was added after 24 hours incu­
bation of the stage-two cultures to give a codeine concentration 
of 1 mM. After 10 days the microbial cells were harvested by 
filtration, washed with ice-cold 0.066 M phosphate buffer, pH 7.0 
and extracted according to Method D, Section 4.3.2 to produce the 
cell-free extract used in thse studies. Protein in the cell-free 
extract was determined by the method reported in Section 4.3.2.
6.3.2 NMR procedure
The probe temperature was adjusted to the required value
using the Jeol JES-VT temperature controller, and the instrument
was allowed to stabilise at this temperature. The sample in
the NMR tube was lowered into the NMR probe and spun by compressed
air at an average rate of 30 r.p.m. The instrument was then locked 
2onto the H signal of the deuterated solvent. Spectra were 
initially constructed in the NMR mode of operation (complete de­
coupled spectra), and then the operation repeated in the OFR mode 
(off-frequency) to observe ^H-^^C coupling.
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6.4 Experimental
6.4.1 NMR of standard solutions
NMR spectroscopy was performed on concentrated solutions 
of codeine hydrochloride and codeine N-oxide (lOO mg in 0.5 ml) 
prepared in DgO. The complete decoupled spectra (C.O.M.) and off- 
resonance spectra (OFR) constructed for each solution are illustrated 
in Figures 6.1 to 6.4. The chemical shifts were calculated with 
reference to methanol (MeOH 49.5 ppm). .
NMR spectra were interpreted with the aid of reference compounds 
and chemical shift values assigned to the N-methyl carbons of codeine 
HCl and codeine N-oxide. These were 41.5 ppm and 58.3 ppm 
respectively, with TMS as a reference (O ppm).
6.4.2 NMR of formaldehyde and various 'trapping agents'
Microbial N-demethylation of codeine produces norcodeine and
an equimolar quantity of formaldehyde. Free formaldehyde is
capable of combining with other components in the transformation
mixture to produce various labelled artefacts. For example,it
could under certain conditions react with norcodeine to form a 
18geminal diamine . To prevent this occurring, formaldehyde may 
be 'trapped' by the addition of a reagent to the reaction mixture 
with which it will react to give a single product. The trapping 
agents most commonly used are carbonyl scavenger compounds which 























































































































such as formaldehyde, to form non-volatile addudts.^^^
NMR spectroscopy was performed on solutions in D^O (3 mM) 
of each of the trapping agents listed in Table 6.1 in the presence 
of labelled formaldehyde solution (50 yl). The sodium bi­
sulphite solution was prepared freshly from sodium metabisulphite 
solution (5% w/v) to give a final concentration with formaldehyde
and D^O of 1% w/v sodium bisulphite. Alcohol dehydrogenase (2 I.U.) 
-4and NADH (10 M) were added to the formaldehyde solution (50 yl) 
in 0.5 ml. DgO.
13 13Chemical shift values for C NMR spectra determined for C
labelled formaldehyde with various trapping agents are shown in
Table 6.1. The chemical shift values for the N-methyl carbons
of codeine HCl and codeine N-oxide have also been included in Table
6.1 for comparison.
Ideally, the trapping agent employed in NMR enzyme trans­
formation studies was required to possess one signal in the complete
decoupled ^^C NMR spectrum (COM) and be well displaced from codeine
^N-Me- ĉj HCl and possible intermediates, in the N-demethylation
reaction. This was in order to simplify interpretation of the 
resulting spectra. A1 1 the trapping agents investigated possessed 
one signal only, except for semicarbazide and hydrazine (Table 6.1).
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Table 6.1 Chemical shifts of various trapping agents with formaldehyde
Substance Chemical nature Chemical shift from











Hydrazine hydrate + **HCHO NHg-N^CHg 137.8,75.9,70.8
Phenylhydrazine HCl **+ HCHO PhNH-N=CH2 82.4
1% sodium bisulphite *
*+ HCHO
74.7
Sodium sulphite *+ HCHO ^ S O ^  Na
79.4
Alcohol dehydrogenase * CHg-OH 49.5NADH + HCHO
Notes: 1) The enriched carbon is shown by an asterisk (*)
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6.4.3 N-demethylase activity of cell-free extract in the presence 
of trapping agents
At the concentrations used the trapping agents were required
not to interfere with the N-demethylation process. This was
investigated by determining the transformation activity of the cell-
free extract in the presence of each trapping agent in the following
incubation mixtures:- cell-free extract (1.3 ml), FeS0^,7H20 (0.1 mM),
NADH (0.1 mM) , NADPH (0.1 mM) and one of each of the trapping agents:-
semicarbazide HCl (3 mM), phenylhydrazine HCl (3 mM), sodium
bisulphite (1% w/V), sodium sulphite (3 mM) or alcohol dehydrogenase
(2 I.U.)/NADH (0.1 mM) in 0,066 M phosphate buffer (0.2 ml.) pH
o
7.0. The mixtures were incubated at 30 C, and the reaction was 
initiated by the addition of codeine phosphate (3.0 mM) as 
substrate.. After 30 minutes the reaction was terminated by boiling 
the mixtures for 10 minutes at 100°C. Each of the mixtures was 
centrifuged at 10,000 r.p.m. for 5 minutes, and the supernatant 
filtered through a 0.45 ym Millipore type HA filter, prior to the 
determination of norcodeine by the HPLC method described in Section 
2.4.5. The results obtained are shown in Table 6.2.
18It was shown in previous studies that̂  semicarbazide HCl 
does not impair the N-demethylation process, and so the activity 
of the cell-free extract in the presence of semicarbazide HCl. was 
assumed to be 100%(Table 6.2). The activity of the cell-free 
extract in the presence of the other trapping agents is shown 
in Table 6.2, in relation to the semicarbazide system, and showed 
that only phenylhydrazine substantially interfered with the N- 
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(page 256 ) sodium sulphite was preferred as the formaldehyde trapping 
agent, and was employed in subsequent NMR enzyme transformation studies 
described in this chapter.
6.4.4 NMR chemical shifts of N-methyIcarbons in the presence 
of the test mixture components
It was possible that the test mixture components may affect 
the NMR chemical shift values of the N-methyl carbons of codeine
HCl and the sulphite-formaldehyde adduct. Therefore these 
values were determined, at the operating temperature of the instrument 
(23°C), employing the following test mixture:- boiled cell-free 
extract (1.3 ml), FeSO^.TH^O (0.1 mM), NADH (0.1 mM), NADPH (0.1 mM), 
sodium sulphite (3 mM), ^^C labelled formaldehyde solution (50 yl) 
and codeine ^N-Me-^^C^ HCl (10 mg in 0.066 M phosphate buffer, pH
7.0, 0.2 ml). TMS was added as a reference standard.
The chemical shift value for the N-methyl carbon of codeine 
^N-Me-^^C^ HCl was observed to be 41.6 ppm with reference to TMS 
(O ppm), and was not significantly different to the value of
41.5 ppm obtained in the absence of test mixture components (page 
237 ). In the enzyme transformation mixtures no internal
reference was used, so the chemical shift of the formaldehyde- 
sulphite adduct was determined relative to codeine ^N-Me-^^C^ HCl. 
This was observed to be +37.2 ppm with reference to codeine or, 
78.8 ppm with reference to TMS, in the test mixture investigated 
at 23°C.
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6.4.5 NMR spectroscopy of enzyme transformation mixture at 23°C
The NMR enzyme transformation experiment was initially performed 
at the normal operating temperatures of the instrument (23°C). The 
enzyme reaction was initiated by adding codeine ^N-Me-^^cJnCl.
(10 mg) in a solution (0.2 ml) of FeSO^.TH^O (0.1 mM). NADH 
(0.1 mM) , NADPH (0.1 mM) and sodium sulphite (3 mM) in phosphate 
buffer (0.066 M, pH7.0), to cell-free extract (1. 8 ml) contained 
in a 10 mm. i.d. NMR saipple tube. The NMR instrument was locked 
onto the D^O capillary placed coaxially inside the NMR tube , 
and accumulation of spectra commenced in the COM mode. ^^C NMR 
spectra were constructed at frequent intervals to observe the 
progression of the enzyme transformation. The operation was re­
peated in the OFR mode with a fresh enzyme transformation mixture, 
as described above. A typiCcxl series of COM NMR spectra produced 
at progressive time intervals is shown in Figure 6.5. A signal 
corresponding to the N-methyl group of codeine ^N-Me-^^C^ HCl
(A) was seen above the noise level after only 6 pulses. A signal
(B) at + 37 ppm, relative to codeine, was observed after 250 pulses. 
This corresponded to the formaidehyde-sulphite adduct, and showed 
that the N-methyl group had been completely cleaved. Resonances
due to intermediates in the N-demethylation reaction would occur 
downfield from codeine if the N-methyl group was oxidised by the 
N-demethylase enzyme in the cell-free extract. The signal (C) in 
Figure 6.5 at + 26 ppm, relative to codeine, was clearly seen 
at 500 pulses corresponding, to a possible intermediate.,
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Figure 6.5. Time-dependent COM NMR spectra for the N-demethylation
of ( N-Me-13c) codeine by cell-free extract of Cunninghamella 
bainieri. (Temp. 23°c, pH 7.0)
a) 5 pulses; (b) 250 pulses; (c) 500 pulses; (d) 1000 pulses, 
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6 ppm from Codeine [N-Me-^^C ] HCl
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Figure 6.6. C NMR OFR spectrum for the N-demethylation
of (N-Me-l^c) codeine by cell-free extract of
Cunninghamella hainieri ( T e m p . ^23 c, pH 7.0,
28,000 pulses). A. Codeine N-CH^, quartet; B.
Intermediate, triplet; C. Sulphite-adduct 
*
HO-CH^-SO^Na, triplet.
10 2010 3060 50 30 20 040 4-
5 ppm from codeine [N-Me-̂ Ĉ ] HC1
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Figure 6.5 shows the OFR spectrum of the same transformation 
mixture at 23°c, accumulated over alonger period of time (28,200 
pulses). The codeine ^N-Me-^^cJHCl signal (A) was observed to be 
a quartet, typical of the splitting pattern of an N-methyl group. 
The sulphite adduct (B) was a triplet due to the methylene group 
present, and the signal at + 26 ppm (C) was also a triplet impli­
cating that it also was a methylene group (CHg).
6.4.6 NMR spectroscopy of enzyme transformation mixtures at 
various temperatures
Chemical shifts of the N-methyl carbons of codeine ^N-Me-^^cJ HCl 
and the formaldehyde-sulphite adduct were determined, in the presence 
of the test mixture components, at temperatures between 5°C and 
40°C., employing similar test-mixtures to those described in 
Section 6.4.5.
The results at the extremes of the temperature range (5°c and 
40°C), and the values obtained previously at 23°C (page 247) . 
are shown in Table 6.3. These results demonstrated that the chemical 
shift values did not vary significantly over the temperature range 
used.
^̂ C NMR transformation experiments with active cell-free 
extracts and the test mixture described in Section 6.4.5 were 
therefore performed., in both the COM and OFR mode of operation, 
at different temperatures in the range 5 - 40°C. NMR


























MUZ  -pw  us  0W  T3Cl4 '0W  (d« 00 (M OqW  b vD r- r-ro m  mH  n + + +W  QhQ  rH
o  bu  w
-PU0DT3(de ro 00 roA  Q)Oj -p 00 00 00•H r- r- r~W  Æ
Eh Ak  rHH  0
tu WW
H




a  uEh nrH1 un ro1 iH rH rH





Q)P0 0) U  U+j n u  0 0fd 0 u 0 ro op p 0 irt (N Tf0) AA6 B0) aEh g
252
Table 6.4. Chemical shifts of signals relative to codeine (O ppm) 
produced in enzyme transformation mixtures at various 
temperatures for the transformation of codeine by 
C. bainieri at pH 7.0
Temp, of NMR 
probe
(°c)
Chemical shift of species 






















Codeine N-oxide + 16.7 ppm relative to codeine (quartet)
The protein concentration determined fjr each cell-free 
extract varied from O.75 to o.1 mg ml
? indicates that the splitting pattern could not be 
interpreted
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Data from these spectra are shown in Table 6.4, and discussed later 
on page 258.
6.4.7 NMR spectroscopy of control enzyme transformation mixtures
at various temperatures
The NMR experiments were repeated at each of the temperatures
in the range 5°C to 40°C, using codeine ^N-Me-^^cJHCl and the
test mixture component described in Section 6.4.5, with cell-free
13extract which was boiled for 10 minutes prior to its use. C NMR
spectra of control transformation mixtures containing boiled enzyme 
showed no product or intermediate peaks at any of the temperatures 
used.
6.5 Discussion
It was necessary to determine the chemical shifts for carbon 
atoms of the N-methyl group of codeine, and subsequent intermediate 
N-substituent groups, which may arise during code.tne N-demethylation 
by C. bainieri. The assignments were required for identification 
purposes in subsequent enzyme transfornmtion experiments. Chemical 
shift values of 41.5 ppm and 58.3 ppm were obtained for the N-methyl 
groups of codeine HCl, and codeine N-oxide respectively, with TMS 
as reference (O ppm).
For the enzyme-transformation studies it was desirable that 
the free formaldehyde, produced by the microbial N-demethylation of
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codeine, was 'trapped' by a suitable reagent included in the 
reaction mixtures. The trapping agent - formaldehyde product 
was required to possess one signal in the COM NMR spectra, well 
displaced from the codeine ^N-Me-^^C^HCl and possible inter­
mediates in the N-demethylation reaction. Signals from ^^C NMR 
spectra determined for ^^C labelled formaldehyde with various 
trapping agents, selected for their ability to react rapidly with 
aldehydes^^^ were shown in Table 6.1 . The chemical shifts of the 
N-^^CHg of codeine HCl and codeine-N-oxide were included for 
comparison.
All the trapping agents investigated, except semicarbazide 
and hydrazine, produced a single resonance, in the COM NMR spectra. 
Semicarbazide and formaldehyde reacted to form a semicarbazone 
and produced a doublet at 56.9 ppm and 59.9 ppm. Both signals 
were triplets in the OFR spectra implicating methylene groups (CH^). 
The duplicity of signals was believed to occur because the 
semicarbazone can form two different cyclic structures which may 
be stabilised by hydrogen bonds (see Figure 6.7). The magnetic 
environment of the methylene group in each ring is different thus 
affording different chemical shifts. In a similar manner the reaction 
of formaldehyde with hydrazine affords three signals (Table 6.1) 
arising from the hydrazine, and possibly a further reaction with
154a second molecule of formaldehyde, or of hydrazine to give an azine 
illustrated in Figure 6.7.
Alcohol dehydrogenase (A.D.H.) in the presence of the co­











































* + ADH * +ECHO + NADH + H ------->  CH^OH + NAD
The enriched methanol produced a singlet at 49.5 ppm in the
NMR spectra (Table 6.1)
A furthere requirement was that the trapping agent should 
not interfere with the N-demethylation process at the concen­
tration used. Determination of the transformation activity of the 
cell-free extract, in the presence of each trapping agent, pro­
duced the results shown in Table 6.2. The transformation 
activity in the mixture incorporating semicarbazide was assumed
to be 100%, since no evidence of enzyme impairment by this
18compound was found in previous studies . Comparison of the
activities of the mixtures containing the other trapping agents
revealed that only phenylhydrazine significantly impaired the
N-demethylation of codeine. The alcohol dehydrogenase system
was undesirable as the methanol signal at 49.5 ppm might conceal
intermediates in this region of the NMR spectrum. Since both
semicarbazide and hydrazine produced multiplet peaks in the
COM NMR spectra, the most suitable trapping agents were
sodium sulphite or sodium bisulphite. The sulphite was preferred,
since kinetic studies have shown that it reacts with formaldehyde
155much more rapidly than bisulphite , and its signal in the 
COM NMR spectrum was further downfield from codeine ^N-Me-^^C^HCl, 
so it was less likely to obscure intermediate signals in the 
N-demethylation process.
Determination of the chemical shifts for codeine ^N-Me-^^cJHCl
257
and the formaldehyde-sulphite adduct in the presence of all the 
test mixture components, at the operating temperature of 
the instrument (23°C) revealed that these values were not 
significantly affected by the presence of the other components 
in the test mixture.
The NMR transformation experiment was therefore per­
formed initially at the operating temperature of the instrument 
(23°C). Single resonances in the COM NMR spectra of 41.5 ppm
and 78.8 ppm (with reference to TMS) were attributed to 
13codeine^N-Me-^ C^HCl and the formaldehyde-sulphite adduct res­
pectively. In the OFR NMR spectra the codeine ̂ N-Me-^^C^HCl 
signal ((A) in Figure 6.6) produced a quartet typical of the 
splitting pattern of an N-methyl group, and the formaldehyde 
sulphite adduct signal ((B) in Figure 6.6) produced a triplet 
characteristic of the methylene group present.
The rate of an enzyme catalysed reaction can be markedly 
influenced by temperature. At sub-optimum temperatures the 
reduced rate of the reaction may enable transient inter­
mediates to appear for longer periods of time. Sewell^^ 
demonstrated that codeine N-demethylation by cell-free extracts 
from C u n n i n g h a m e l l a  species exhibited a broad optimum between 
30 and 32°C. Enzyme dénaturation occurred at temperatures
above 40°C, and the optimum temperature for the growth of the 
o 13organism was 27 C. Further C NMR transformation experiments
were therefore performed over a temperature range of 5°c to
40°C. Determination of the chemical shifts for codeine^N-Me-^^cJ HCl
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and the formaldehyde-sulphite adduct, in the presence of all 
the test mixture components, revealed that these values did 
not vary significantly over the temperature range used (Table 
6.3). The results of subsequent enzyme transformation experi­
ments (Table 6.4) demonstrated that codeine was N-demethylated 
at all the temperatures studied. The signals which were 
triplets at about+37 ppm (relative to codeine), confirmed 
the presence of the formaldehyde-sulphite adduct. Various 
possible intermediate signals were also observed, but only 
one occurred in all the spectra at each temperature (Table 6.4) 
This was a triplet in the OFR spectra, in each case centred 
at +26 ppm relative to codeine.
NMR spectra of control transformation mixtures 
containing boiled cell-free extract, showed a resonance at 
about 41.5 ppm corresponding to codeine ^N-Me-^^C^HCl, but 
no product or intermediate peaks at any of the temperatures 
used. This confirmed that the signals observed in the active 
transformation mixtures were caused by N-demethylase activity 
and not by chemical breakdown of codeine in the NMR tube.
The two proposed mechanisms for the N-dealkylation of tertiary 
amines were described in Chapter 5 of this thesis, and illu­
strated in Figure 5.1. In addition, it was concluded in 
Chapter 5 that the tertiary amine, codeine, was N-demethylated 
probably by a cytochrome P450 type mixed function oxidase 
extracted from Cunninghamella bainieri, in the presence of 
molecular oxygen, to yield the secondary amine, norcodeine 
and formaldehyde.
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If N-demethylation of codeine was occurring by N-oxidation 
an N-methyl signal in the OFR spectra would be seen as a quartet 
centred at 58.3 ppm (or +15.7 ppm relative to codeine) and no 
such signal was observed (Table 6.4). Alternatively, the
133
mechanistic route might involve a carbinolamine intermediate 
generated by direct a-carbon oxidation, with an N-hydroxymethyl 
function giving a triplet in the OFR spectrum. The triplet 
at +26 ppm (relative to codeine) in Table 6.4 may well corres­
pond to this. However, confirmation of this cannot be obtained 
by chemical synthesis since N-(hydroxymethyl)-codeine is 
unstable.
Comparison of the data with those for other compounds con­
taining the carbinolamine moeity (N-CH^-OH) was nbt possible 
since stable carbinolamines are rare, and for those that are 
known there is no ^^C NMR data available. Gorrod and Temple^^^ 
have reported a series of carbinolamines found as stable 
metabolites in various mammalian metabolic studies. A 
prerequisite for their stability appears to be the presence of 
an electron withdrawing group (such as carbonyl) adjacent to 
the nitrogen (Figure 6.&). The stability is afforded by the 
formation of hydrogen bonds between the electron withdrawing 
group X, and the hydroxyl group to form a ring structure^^^.
157In the search for possible anti-tumour agents, Stevens , 
has synthesised a series of stable N-(hydroxymethyl) compounds 
related to formamide. Values for the N-(hydroxymethyl) carbon 
for two of these compounds are listed in Figure 6.8.
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X CHz
^ Y - N ^IR
Basic structure of a stable carbinolamine 
V — X  = electron with-drawing group
p h ^  i
N-(hydroxymethyl)-benzamide 
^^^2^ 63.Gppm TMS ref.,+21.5ppm Codeine ref.
^-Bu —  Ph PI
4-(t-butyl)-N-(hydroxymethyl)benzamide
*
Ô (CH2) 69.66ppm TMS ref.,+28.16ppm Codeine ref
Figure 6.8. Chemical shifts of stable N-(hydroxymethyl) 
compounds.
(* denotes ^^C enriched carbon)
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The nitrogen of the codeine carbinolamine intermediate 
is tertiary and part of the phenanthrene ring, with no electron 
withdrawing group adjacent to the nitrogen to stabilise it, so 
the chemical shift of the carbon is likely to be slightly diff­
erent to the values shown in Figure 6.8. However, all these 
values are similar and suggest, but cannot confirm, that the 
intermediate at +26 ppm relative to codeine (67 ppm ref. to 
TMS) observed during the microbial N-dealkylation of codeine, 
could be the carbinolamine proposed. This is consistent with 
the results of enzyme kinetic, induction and inhibitor experi­
ments performed in the previous chapter (5).
CHAPTER SEVEN
A STUDY OF THE N-DEALKYLATION OF A
SERIES OF 1.4-BENZODIAZEPINE COMPOUNDS
BY C. bainieri AND SOME OF THEIR




Studies with both mainmalian^^' and microbial preparations^^,25,28
have shown that a large variety of compounds of very different
chemical structure can be N-dealkylated by monooxygenases. However,
although substrate structure transformation activity studies have
159-153been extensively reported for hepatic systems , very few
have been reported for microbial systems. It is generally accepted
that the relative rate of oxidative metabolism of a substrate by
liver microscomal monooxygenases is related to the substrate lipid
solubility^^^'^^^. This is because the enzyme system is thought to
be surrounded by a lipoidal barrier which is penetrable only by
compounds with high oil-water partition coefficients. This concept
has resulted in several studies relating partition coefficients to
rates of metabolism with varying degrees of success^^^ 162^ por 
159example, McMahon found a rough correlation between the partition
coefficients of 6 N-methylamines and their rate of N-dealkylation
164by rat liver microsomes. Further studies by Hansch et al. 
showed that the relative rates of N-demethylation of these tertiary 
amines was indeed related to the partition coefficient, and the 
data could be expressed by equation 7.1;
log BR = 0.470 log P - 0.268 (pKa - 9.5) - 1.305 7.1
n = 18, r = 0.89 s = 0.222 
where n is the number of points used in the regression analysis, r 
is the correlation coefficient, s is the standard deviation, BR is
263
the biological response (i.e. the relative rate of i n  v i t r o  N-
demethylation by rat liver microsomes), P is the octanol-water
partition coefficient, and Ka is the ionization constant. It
154was concluded by Hansch et a l . that both the partition coeff- 
icent and the pKa were statistically significant predictors of 
the relative rate of N-demethylation. The strength of the base 
is thought to regulate the amount of substrate available distri­
bution between the buffered aqueous phase and the lipid phase.
Its partition is a function of its state of ionization, so the 
neutral form of the base would be expected to have a substantially 
higher partition coefficient than the ionized form. In support 
of this view, McMahon and Easton^^^ showed that the rate of N- 
demethylation of a series of aliphatic amines increased with 
decreasing base strength, and concluded that these results were 
influenced by the effect of base strength on lipid solubility^^^.
Another variable which may affect the rate of N-dealkylation 
of a substrate is the steric hindrance caused by an increase in 
branching on the carbon atoms attached to the nitrogen. For 
example. La Du,et observed a decrease in the rate of
N-dealkylation of a group of aminopyrine homologues when the 
alkyl chain length was increased from methyl to n-butyl, despite 
the increases in the lipophilicity of the substrate. Contrary to 
this, Zeigler et demonstrated that tertiary amines containing
N ,N-dimethylalkylamine moieties with 8-12 carbons in the side chain 
were oxidised faster than compounds with shorter alkyl chains.
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The ability of a compound to partition between a relatively 
non-polar solvent and water is normally used as a measure of its 
hydrophobic-hydrophilic character, and expressed as the partition 
coefficient (P). This parameter is commonly determined by means 
of an octanol and water partition system. However, the work of 
Martine and Synge^^^, and Consden et in establishing relation­
ships between the Rf values obtained from partition chromatography
and the partition coefficient, has provided an alternative to
169octanol-water partition. Martin deduced on theoretical grounds 
that for partition chromatography on paper or lipid impregnated 
plates ;-
log P = aRm + b(log C) 7.2
where P is the partition coefficient, C is a constant for the 
system, and Rm is the log of (1/Rf) - 1, where Rf is the retention 
of the system. The use of this linear relationship to predict 
partition coefficients from chromatographic data has been ex­
tensively reviewed by Tomlinson^^^. Furtheremore, as the column 
capacity ratio (k) used to describe solute retention in HPLC 
(see Equation 1.2) is analogous to the Rm value, the partition 
of a compound between a HPLC stationary phase and mobile phase 
can be given by:
log p = a log K + b 7.3
McCall^^^ chromatographed a wide variety of chemical compounds 
with known log P values(determined from octanol-water studies) 
on a Corasil C-18 reversed phase HPLC column. He confirmed the 
relationship between P and k in Equation 7.3, providing the 
process was predominantly one of partition. A vigorously silylated
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column generally gave better correlations than an untreated
column except in the case of the more bulky compounds examined.
These were probably sterically hindered from reaching the available
silanol sites. Some of the potential advantages of using
chromatography to replace the often tedious octanol-water partition
coefficient measurements have been described^^^. These include
the speed and reproducibility of the HPLC technique, and because
solvent lipophilicity can be rapidly adjusted, compounds whose
partition coefficients vary substantially can be quickly measured.
Samples need not be pure since contaminants do not interfere
with K determinations and most compounds can be determined as
171long as they can be chromatographed and detected
Diazepam, a member of the 1,4-benzodiazepine group of minor
172tranquiliser drugs, is only very slightly soluble in water 
However, several species of Cunninghamella were reported by Sewell 
to N-deraethylate this compound with comparatively high transformation 
yields. Therefore, it was envisaged that other 1,4-benzodiazepine 
compounds structurally related to diazepam may also be N-dealkylated 
by Cunninghajnella sp. It was envisaged that the extent of 
transformation could be related to the relative lipid solubility 
and base strength of the substrate.
In the present study, a selection of 1,4-benzodiazepine 
compounds, structurally related to diazepam, were examined for 
their transformation yield when incubated with growing cell cultures 
of Cunninghamella bainieri over a given time period. Reversed phase 
HPLC was employed to determine the column capacity ratios (k ) for
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Table 7.1. Structural variations of 1,4-benzodiazepines selected
for microbial transformation studies; chlordiazepoxide 
























* Chlordiazepoxide (1) contains an N-oxide group (N— ^o) 
at position 4,
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each compound. Since the k value has been shown to be directly
171related to the partition coefficient (P) (Equation 7.3) it 
should be possible to observe whether the amount of substrate 
transformed is related to the k value, and hence the lipid 
solubility.
The benzodiazepine compounds selected for this study 
(shown in Table 7.1) are members of an important group pf psycho­
therapeutic drugs which possess sedative-hypnotic and tranquillizing 
173properties . They all possess a characteristic seven membered 
diazepine ring with nitrogens in position 1 and 4. Chlordiazepoxide 
(1 in Table 7.1) contains an N-oxide group at position 4, and a 
methylamino group at position 2. Unlike the other compounds 
studied the N-methyl group of chlordiaxepoxide is presented as 
a secondary amine. The N-methyl functions of temazepam (2) and 
diazepam (3) are presented as cyclic amides, but temazepam differs 
from diazepam in the presence of a hydroxyl group at position 3. 
Flurazepan (4) was included in the series to investigate the capacity 
of C. bainieri to remove more conplex N-alkyl functions, and 
medazepam (5) contains a tertiary amine group (position 1) with 
no additional functional groups on the diazepine ring.
7.2 Materials
7.2.1 Transformation substrates
Chlordiazepoxide hydrochloride. Diazepam, Flurazepam, 
dihydrochloride and medazepam; were gifts from Roche Products Ltd.,
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Welwyn Garden City.
Temazepam; Extracted from Normison capsules (Wyeth Laboratories, 
Maidenhead, Berks), The contents of 20 capsules (20 mg) were added 
to 2 N HCl (5.0 ml), neutralised to pH 7.0 with 2 N NaOH, and 
extracted into diethylether (4 x 10 ml). The organic phase 
was separated, dried (anhydrous MgSO^) and evaporated to dryness 
to yield temazepam free base (360 mg).
7.2.2 Reference standards
Nor- methylchlordiazepoxide, normethyldiazepam and desalkyl 
flurazepam; Roche Products Ltd.
Normethy1-temazepam (Oxazepam); Extracted from serenid tablets 
(Wyeth Laboratories). 30 tablets (15 mg) were crushed and dissolved 
in 2 N HCl (25 ml). The solution was filtered, basified (2 N NaOH) 
to pH 8.0, and extracted into chloroform (4 x 25 ml). The organic 
phase was separated, dried (anhydrous MgSO^) and evaporated to 
dryness.to yield the nor-temazepam free base (410 mg). 
Nor-methylmedazepam; This was prepared by adapting the method used 
by Montzka et A solution of 2,2,2-trichloroethylchloroformate
(0.4 ml) in dry toluene (2 ml) was added dropwise to a mixture 
of medazepam (0.5 g), very dry Na^CO^ (0.5 g) and dry toluene 
(6 ml) contained in a 50 ml round bottomed flask. The mixture 
was stirred vigorously at room temperature for 24 hours. Diethyl­
ether (10 ml) was added, and the whole was washed with 2 N.HCl (2 x 
10 ml) and water (10 ml). The organic layer was separated, dried 
(anhydrous MgSO^) and evaporated to leave an oil, which was dissolved
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in glacial acetic acid (20 ml) and refluxed with zinc dust (2 g)
for 1 hour. The mixture was then stirred at room temperature
for a further 4 hours, poured onto ice, basified (5 N NaOH),
and extracted into chloroform. The organic layer was dried
(anhydrous MgSO^) and evaporated to give pale yellow solid (220 mg).
Analytical; NMR (CDCl^; normedazepam); 50.65 (OFR t; C^);
63.85 (OFR t; C^); 118.10 (OFR d; Cg); 125.8 (OFR s; C^); 128.4 
(OFR m; ,, C^, ), 128.9 (OFR m; ,/ C^,); 129.33 (OFR s; C^^); 
129.60 (OFR d; C^); l3o.06 (OFR d; Cg); 130.75 (OFR d; C^,); 139.73 
(OFR s; C^,); 148.85 (OFR s; Cg^); 171.78 (OFR s ; C^). These 
data are consistent with the structure of nor-medazepam.
7.2.3 HPLC stationary phase and internal standards ; LiChrosorb- 
RP-2, 5 ym particle size, was purchased from Jones Chromatography 
G lamorgan.
Nitrazepam; British Pharmacopoeia Commission, London,
Phenacetin ( Analar) - bdh Ltd.
7.3 Methods
7.3.1 HPLC assay methods..
Quantitative HPLC assay procedures were required for each 
transformation product and its corresponding nor-metabolite. Some 
of the benzodiazepine compounds were so strongly retained on existing 
HPLC columns (Partisil-10 ODS-2 in Section 2.4.4, ODS-Hypersil 5 ym
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in Section 2.4.5) resulting in poor chromatography. To reduce 
the retention times a smaller column was employed (5 cm x 4.6 mm 
i.d.), packed with LiChrosorb RP-2 reversed phase material, a 
stationary phase of silica bonded with a hydrocarbon chain 2 carbons 
long, 9s opposed to 18 in the ODS materials listed above.
(a) Column packing and testing; A stainless steel column
(5 cm X  4.6 mm i.d. ) was packed with LiChrosorb RP-2, 5 ym particle 
size, by the method described in Section 2.3.2 (page ). The
packed column was subjected to the column tests described in Section 
2.3.2, page 54 to evaluate the quality of the packing and the 
column efficiency, as described by h. (Equation 1.5), was found 
to be 5.5.
(b) HPLC conditions ; 10 yl volumes of samples were injected 
Onto the LiChrosorb RP-2 HPLC column. Each assay was performed
at 40°C, maintained by immersing the mobile phase reservoir, column
and injector into a thermostatically controlled water bath. The
”1mobile phase flow rate through the column was 2 ml min , and the 
remaining operating conditions for each assay are shown in Table 7.2
Typical HPLC chromatograms demonstraing the resolution of 
substrate, internal standard and transformation product in each 
assay are shown in Figures 7.1 and 7.2.
(c) Construction of calibration plots; Stock solutions of 


































I\  0 
S'?, gN X f3 fd H  a  p fd eu p en N • r4 eu fd Q  fx4 Q  P
. §pq E4
1  S's N
S'gN eufd -P





















































































































































































































in the appropriate mobile phase (Table 7.2) . Stock solutions containing 
the respective internal standard in mobile phase were also prepared 
for each assay. Stock solutions were then serially diluted with 
the same mobile phases to produce a series of calibration solutions 
for each assay in the concentration ranges shown in Table 7.3, each
incorporating the internal standard at the particular concentration 
shown in Table 7.3. Samples of each calibration solution (10 yl) 
were assayed in triplicate by the HPLC procedure described above 
(see Table 7.2).
Calibration plots for each system (A to E) were constructed 
from the ratio of the peak heights of the analyte to the internal 
standard obtained at each analyte concentration. Each plot was 
subjected to regression analysis to provide the data shown in 
Table 7.3. These data were used to calculate the transformation 
and specific transformation from HPLC peak ratios obtained in the 
analysis of transformation mixture extracts.
(d) Precision of the detector response; This was determined 
for each HPLC assay system by chromatographing a calibration 
solution of test substrate and transformation product( from the 
middle of the calibration range) ten times under the conditions 
described in Table 7.2. The results obtained for the peak heights 
of the analytes from 10 injections are shown in Table 7.4, and 
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7.3.2 Extraction of substrate and transformation products from
transformation mixtures
The aqueous transformation mixtures usually contained a concen­
tration of benzodiazepine test substrate (and its transformation 
product) of 1 mM in a volume of 50 or 60 ml. These systems were 
basified and extracted into organic solvent (3 x 50 ml). The organic 
solvent was separated, dried (anhydrous MgSO^) and evaporated to 
dryness. The residue was dissolved in the appropriate mobile 
phase incorporating the internal standard and serially diluted with 
mobile phase to provide a sample concentration within the HPLC assay 
calibration range (see Table 7.3). The conditions for the extraction 
of each substrate and corresponding transformation product and 
the respective extraction efficiencies, determined by the procedure 
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7.4.1 Microbial transformation of 1,4-benzodiazepine oompounds
in submerged cultures of C. bainieri
C. bainieri was cultured by the two-stage transformation protocol
described in Section 3.3.1 (page 133 ). The stage-two culture flasks 
containing stage-two growth medium (50 ml) with glucose carbon 
source (1% w/v), were inoculated with stage-one growth (10 ml) and 
incubated at 27^C, 250 rpm, for 24 hours. Each benzodiazepine 
test substrate was then added to stage-two cultures as a filter 
sterilised solution, to produce a concentration of 1 mM in the 
transformation mixture. Cultures were incubated under the same 
conditions for a further 14 days. Control flasks were also prepared 
containing each test substrate in stage-two growth medium with 
glucose (1% w/v) and incubated as described above. Sufficient 
stage-two cultures (including controls) were prepared to enable 
samples to be taken at 2-3 day intervals during the course of 
the incubation for the determination of growth (dry cell weight, 
page 134 ) and substrate transformation (HPLC). Substrate trans­
formation was expressed as the concentration of transformation product 
(yM), and specific transformation as the transformation (y M) per mg 
dry cell weight of the biomass.
Progress curves constructed from the transformation results 
for the transformation obtained with temazepam, diazepam and meda- 
zepam are shown in Figure 7.3, and for chlordiazepoxide and fluraze- 
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Figure 7.4. Progress curves for chlordiazepoxide transformation 
(a) and flurazepam transformation (b) by C. bainieri 
incubated at 27°C, 250 rpm in stage-two growth 
medium with glucose (1% w/v); Chlordiazepoxide 
transformation product (A) (A)/ desalkyl flurazepam
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weight of the biomass, substrate transformation and specific tran­
sformation for each test substrate are shown in Table 7.5.
The results in Table 7.6 show that the test substrates 
temazepam, diazepam and medazepam each formed their respective 
normethyl transformation products only. Chlordiazepoxide sub­
strate also formed a single transformation product in high yield. 
However, this product (A) was found to possess a HPLC retention 
near to, but not identical with, the retention of normethylchlor- 
diazepoxide standard. For the purposes of this study the concen­
tration of product A in the samples was still estimated from 
the normethylchlordiaaepoxide standard to give an approximation 
of the transformation yield. The significance of the chlordiaze­
poxide transformation results are discussed on page 289 
Finally, flurazepam, with its long N-alkyl group, produced three 
transformation products. Unfortunately, standards for all the 
potential transformation products of flurazepam were not available, 
but suggestions as to their possible identity are discussed on 
page 295.
7.4.2 Determination of the column capacity ratio (k) of the 1,4-
benzodiazepine compounds by reversed phase HPLC
Each of the test substrates was dissolved in propan-2- cL to
-1give sample concentrations of 0.01 mg ml . Sample volumes (10 yl) 
of each benzodiazepine solution were injected onto the LiChrosorb 
RP-2 HPLC column. Retention times of the benzodiazepines and of 
the unretained propan-2-ol were obtained from the resulting
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chromatograms, and these used to calculate the respective column
capacity ratios (k ). (see Equation 1.2, page 26 )• In the
first series of experiments the mobile phase employed consisted
of propan-2-ol; 0.066 M phosphate buffer, pH 7.0 (25; 75) and
-1the mobile phase flow rate was 2 ml. min . The temperature of 
the HPLC system was varied from 35°C to 60°C, by means of a 
thermostatically controlled heated water bath. Retention data 
obtained were used to construct plots of log column capacity ratio 
(log k) against reciprocal absolute temperature (1/T) for each 
benzodiazepine in the series, shown in Figure 7.5.
In the second series of experiments the temperature was 
maintained at 40°C. Mobile phases were prepared containing in­
creasing proportions of propan-2-ol (from 20% to 35% v/v) in 
0.066 M phosphate buffer,pH 7.0. The retention data obtained 
for each benzodiazepine sample injected onto the column, with 
each mobile phase, were used to construct plots of log column 
capacity ratio (log k) against the percentage of propan-2-ol in 
the mobile phase, shown in Figure 7.6. Each plot shown in both 
Figures 7.5 and 7.6 was subjected to regression analysis to give 
the constants listed in Table 7.7.
The data in Table 7.7 shows that the 1,4-benzodiazepines are 
retained on the reversed phase column in the same order each time, 
for all the experimental conditions investigated. Therefore the 
plots in Figures 7.5 and 7.6 were extrapolated to predict the k 
values of each benzodiazepine at 27°C (the transformation temperature)
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Figure 7.5. Plots of log column capacity ratio (log k ) against
reciprocal temperature (1/T) for a series of 1,4-benzo­
diazepines obtained using a mobile phase of propan-2-ol
(25); 0.055 M phosphate buffer, pH 7.0, at a flow 
-1.rate of 2 ml. min through a LiChrosorb RP-2 HPLC 
column. (Chlordiazepoxide (A ); Temazepam ( f ); 







-lo T K "4X 10
286
Figure 7.6. Plot of log column capacity ratio (log k ) against
the percentage propan-2-ol in the mobile phase for
a series of 1,4-benzodiazepines obtained using a
LiChrosorb RP-2 HPLC column at 40°C, pH 7.0 and
-1mobile phase flow rate 2 ml. min . (chlordiazepoxide 
(A); temazepam (•); diazepam (o); flurazepam (4) 
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Table 7.7. Data for the regression analysis of the plots shown 
in Figures 7.5 and 7.6.
Log K against 1/T
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Benzodiazepine Slope Intercept Correlationcoefficient
Chlordiazepoxide 1223.6 -2.98 0.9999
Temazepam 1306.5 -3.38 0.9956
Diazepam 1431.0 -3.51 0.9899
Flurazepam 1038.0 -2.05 0.9859
Medazepam 1694.0 -3.68 0.9928
Log K against % propan—2—ol
Benzodiazepine Slope Intercept Correlationcoefficient
Chlordiazepoxide -0.062 2.42 0.977
Temazepam -0.055 2.12 0.999
Diazepam -0.064 2.68 0.998
Flurazepam -0.065 2.92 0.999,
Medazepam -0.085 3.88 0.999
and at 0% organic modifier (i.e. as would be found in transformation 
media). The derived k values are shown in Table 7.8.
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Table 7.8. Column capacity ratios (k) predicted for the 1,4- 
benzodiazepines on the LiChrosorb RP-2 HPLC column 
at 27°C, and with 0% organic modifier in the mobile phase.







The implication, of these results is discussed on page 301.
7.5 Discussion
The data in Table 7.6 show that all the 1,4-benzodiazepines 
studied were transformed by C. bainieri to give products which 
were not detected in the control flasks. The growth of the 
cultures was not significantly affected by the presence of the 
test substrates, with the chlordiazepoxide cultures attaining 
the greatest final biomass. Temazepam (2), diazepam (3) and 
medazepam (5) each gave single transformation products, and HPLC 
analysis showed that these products corresponded to the respective 
normethyl-derivatives. The yields of nortemazepam, nordiazepam 
and normedazepam were 31.4 yM, 130.1 yM and 261.5 yM respectively.
289
Chlordiazepoxide (1) also gave a single transformation product
(A) in an exceptionally high yield (772.9 yM; Table 7.5). However, 
HPLC analysis revealed that product A was not normethylchlordiaze- 
poxide. When pure standards of normethylchlordiazepoxide and 
nordiazepam (also a possible transformation product of 1) were 
added to a 14-day sample of the chlordiazepoxide transformation 
mixture, and analysed by HPLC, the chromatogram obtained (see 
Figure 7.7) clearly shows the retentions of product A and the 
standards are not the same.
The metabolism of chlordiazepoxide has been reported in man
and dog^^^ 177^ but not by micro-organisms. The chlordiazepoxide
biotransformation products identified in the plasma of man and 
178dog include, normethylchlordiazepoxide, demoxepam, normethyl-
diazepam and oxazepam. Structures of these metabolites, and a
178postulated biotransformation pathway for the metabolism of 
chlordiazepoxide to oxazepam, in man and dog, are shown in Figure 
7.8. Since the HPLC analysis showed that product A did not corre­
spond to the normethylchlorodiazepoxide or nordiazepam standards, 
the other metabolites in Figure 7.6 were examined. Oxazepam 
was chromatographed by the chlordiazepoxide HPLC assay procedure 
but it was found to elute immediately after the solvent front, 
therefore discounting it as being product A. Unfortunately, 
demoxepam could not be analysed because there was no standard 
available.
Further attempts were made to identify product A by isolating
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Figure 7.7. HPLC chromatogram of a sample taken from chlordiaze­
poxide transformation mixture, after 14 days incubation 
with C. bainieri at 27°C,250 rpm with the addition of 









( HPLC conditions as described in Section 7.3.1 )
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Figure 7.8. Metabolic pathway for chlordiazepoxide to oxazepam in
















it from 14-day chlordiazepoxide transformation mixtures. The 
culture flasks were basified and extracted with chloroform,and. 
an orange solid was recovered from the extracts which HPLC analysis 
showed to be a mixture of product A (70%) and chlordiazepoxide 
(30%).This was dissolved in the minimum of ethylacetate, and applied 
to preparative TLC plates (Silica gel GF) as narrow bands. The 
plates were developed with ethylacetate mobile phase, and visualised 
by UV at 254 nm to show that chlordiazepoxide (Rf = 0.13) and 
product A (Rf = 0.35) were well separated. Product A was scraped 
off the plates with the silica, and taken up in chloroform. 
Undissolved silica was removed by filtration (Whatman No. 1) and 
the solvent evaporated to yield an orange coloured solid. However, 
HPLC analysis revealed the presence of several peaks as well as 
product A, suggesting that product A had degraded during the recovery 
process.
As the chlordiazepoxide-product A mixture obtained from the
chloroform extracts showed no signs of degradation, samples were
subjected to TLC, NMR and mass spectral analysis. The TLC system
177developed by Dixon et al. to separate chlordiazepoxide from
its metabolites was employed. This consisted of silica gel GF plates,
chloroform (80); acetone (5); ethanol (5) mobile phase and visualis-
177ation by UV at 254 nm. Comparison of Dixon's results with those 
obtained for the chlordiazepoxide-product A mixture is shown below.
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Compound 177Dixon’s results 
Rf




Demoxepam 0.3 No standard
Nordiazepam 0.4 0.38
Chlordiazepoxide- 
product A mixture - 0.19, 0.24
An Rf value of 0.24 for product A compared to a theoretical
177value of 0.3 for demoxepam suggests they were not the same,
but this could not be confirmed without using an authentic demoxepam
standard.
NMR spectra constructed for the chlordiazepoxide standard 
were compared with spectra constructed for the product A-chlordiaze- 
poxide mixture. Only one additional peak was observed in the 
spectrum for the mixture, and this occurred at 67.96 ppm relative 
to TMS (O ppm), which was a triplet in the off-resonance spectrum. 
Carbon-13 NMR signal assignments have been made for several benzo­
diazepines compounds including chlordiazepoxide and its metabolites 
The carbonyl group of demoxepam would be expected to produce a signal 
at approximately 169 - 170 ppm downfield from TMS, but no such 
peak was observed in the spectrum of the product A mixture. This 
was further evidence to suggest that Product A was not demoxepam.
The chromatographic data (HPLC and TLC) for chlordiazepoxide trans­
formation showed product A, but no additional product peaks, so it
179
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may be inferred that product A was produced directly from chlor­
diazepoxide. Furthermore, the triplet at 67.96 ppm in the NMR 
spectrum of the product A mixture implicates the presence of an 
additional methylene group in product A. This value is similar 
to those obtained for the carbons of typical N-(hydroxymethyl) 
groups reported in the previous chapter (page 260), and so product 
A may be in fact the semi-stable carbinolamine of chlordiazepoxide. 
Unlike the carbinolamine intermediate of codeine, some stability 
may be rendered, to the chloridazepoxide carbinolamine by the 
formation of hydrogen bonds as illustrated in Figure 7.9.
P  CH, 
H NH
Figure 7.9. The carbinolamine of chlordiazepoxide stabilised by 
hydrogen bonds
If this was the case, mass spectral data would be expected to show 
molecular ion fragments of mass 316 corresponding to the carbino- 
lamines, and mass 299 corresponding to chlordiazepoxide also present 
in the mixture. However, a m/e signal of 316 was not observed, 
and the fragmentation pattern of the product A-chlordiazepoxide
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mixture was almost identical to that of the chlordiazepoxide standard. 
Although these results proved negative for the carbinolamine, this 
could be due to its rapid decomposition during the mass spectral 
process. Overall, no positive confirmatory evidence could be obtained 
for the identification of product A. Interpretation of these
results was made difficult by the instability of product A and 
also of chlordiazepoxide. The low stability of chlordiazepoxide 
is well documented^^^'^^^, and it has been reported to hydrolyse 
to demoxepam in aqueous media under certain conditions. However, 
there was no evidence of significant chlordiazepoxide degradation 
in the control flasks in the present study, except after prolonged 
periods of incubation (12 days or more). It could be possible that 
chlordiazepoxide hydrolysis was accelerated in the presence of the 
microorganism, and product A was demoxepam, but this could only be 
confirmed by acquiring the demoxepam standard and conducting further 
control experiments.
Flurazepam (4) was transformed by C. bainieri to give three 
products which were not present in the control flasks (see Table 
7.6). One of the products corresponded to the desalkylflurazepam 
standard, but products B and C were not positively identified 
because of a lack of authentic standards. The incubation was 
allowed to continue up to 25 days because there was a significant 
increase in transformation activity from 12 days onwards. A typical 
HPLC chromatogram of the flurazepam transformation mixture after 
20 days incubation is shown in Figure 7.10. Providing the mechanism 
of HPLC retention was the same for flurazepam and its products these 
results indicate that products B and C are. of..intermediate molecular
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Figure 7.10. HPLC chromatogram of flurazepam transformation
mixture after 20 days incubation with C. bainieri 








(For details of HPLC see Section 7.3,1)
297
size to flurazepam and desalkylflurazepam, and suggest that they 
have arisen from the loss of part of the alkylamino side chain.
The most likely route of flurazepam biotransformation by C. bainieri 
is shown in Figure 7.11
The flurazepam HPLC assay incorporated a pairing ion, pentane
sulphonic acid, which reacts with basic nitrogens to form ion pairs
depending on the pKa of the solute, and the pH of the mobile phase.
At pH 6.4, the nitrogen in the side chain of flurazepam (pKa 7.9)^^^,
and the nitrogen at position 1 of the diazepine ring of desalkyl-
flurazepam (pKa 11.76)^^^ would be expected to form ion pairs with
pentane sulphonic acid. Similarly, the metabolites of flurazepam,
monodesethyl and didesethyl flurazepam, (Figure 7.11) would also
form ion pairs at the nitrogens in their respective alkyl amino
side chains. The nitrogen at position 4 in these compounds would be
insufficiently protonated at pH 6.4 for ion pairing to occur
182(pKa flurazepam 1.42, desalkylflurazepam 2.57) . Therefore, it
can be assumed that the compounds in Figure 7.11 are retained on 
the HPLC column in order of molecular weight, and the unaccounted 
products B and C could be tentatively identified as monodesethyl 
and didesethylflurazepam respectively. Furthermore the removal 
of all or part of the alkylamino chain from flurazepam leaves the 
UV absorbing part of the molecule intact. Since a UV detector 
was employed, the response factor of the compounds studied (de­
fined as the peak height or area per weight of solute) will be 
similar, and directly proportional to the retention time of the 
solutes on the HPLC column. Response factors for flurazepam 










Figure 7.11. Possible route of flurazepam biotransformation 
by C. bainieri.
299
heights obtained by chromatographing authentic standards of known 
weight per ml. These response factors were plotted against their 
respective retention times, and using the known retention times 
of products B and C response factor values were also obtained 
from the plot. Equation 7.4 below was then employed to estimate 
the concentrations of the unknown products B and C in the transform­
ation mixture :-
Unknown Product . , . ^ , ̂ , peak height (U) response factor(U) known _ .concentration (y) = -— ;  ̂ x----^----- -—  -- —  x __  7.4(weight/ml) peak height(S) response factor(S) cone.
The results obtained were used to construct the progress curves for
flurazepam transformation by C. bainieri, illustrated in Figure
7.4(b). Product B was detected in the transformation mixture after,
only three days of incubation, providing further evidence that it
could be the monodesethyl metabolite of flurazepam. Product C and
desalkyl flurazepam were not detected until much later (day 10-15),
This would also be expected if product C was the didesethyl-
metabolite, and the flurazepam was metabolised by C. bainieri
according to the pathway described in Figure 7.11. Although these
results were not conclusive because of a lack of authentic standards,
the fact that desalkylflurazepam was identified as a transformation
product implies that C. bainieri was capable of cleaving the whole
alkylamino chain of flurazepam. This is an interesting observation
18considering Sewell's earlier findings that no function greater 
than methyl was cleaved from a series of 6,7-benzomorphans by C. 
echinulata.. However, further analysis of the transformation 
products of flurazepam (e.g. Mass spec. NMR etc.) are required to 
confirm these observations.
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Previous experiments conducted by Sewell^^ demonstrated that
codeine transformation by C. echinulata occurred predominantly
within the fungal cells when a codeine substrate was added to the
stage-two medium filtrate which had been removed from the mycelium
after various stages of incubation, the codeine transformation ob-
18tained was found to be insignificant. In Chapter 4 of this
thesis it was concluded that the N-demethylase enzyme in C. bainieri
was membrane-bound. Certainly it is clear that the substrate must
penetrate at least one membrane before it is in contact with the
enzyme. Because of the lipoid nature of cell membranes in general,
it is believed^^^ that the greater the lipophilicity of the drug
(a high lipid partition coefficient), the faster will be its rate
of penetration into the membranes, for subsequent transformation
by the enzyme. For a weak electrolyte the partition will be a
function of the 'state' of ionization of the substrate^^^; generally
cell membranes are more permeable to the unionized form than the
ionized form of the drug, mainly because of the greater lipid
185solubility of theiunionized form. Fujita and coworkers have 
taken into account the ionization of the drug in partition by 
multiplying the partition coefficient by a factor (1-a), where 
a is the degree of ionization in the aqueous phase. The benzo­
diazepines studied are weakly basic compounds with the following
183-184reported pKa values ; chlordiazepoxide 4.5, temazepam
1.31, diazepam 3.3, flurazepam 1.42 and 7.9 and medazepam 4.4. 
Substituting these pKa values and the pH of the transformation (7.0) 
into Equation 2.7 (page 59 ) showed that all the benzodiazepines
will be at least 99.9% unionized in the transformation media.
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Therefore, a in the factor (1-a) will be insignificant for these 
benzodiazepines, and their partition coefficients alone can be 
regarded as a measure of lipid solubility.
The data in Figures 7.5 and 7.6 demonstrate that the column 
capacity ratios (k ) of the benzodiazepines studied were directly 
related to the temperature and the % of organic modifier in the mobile 
phase respectively. Also, the order of retention was constant in 
each case. Therefore, from the plots it was possible to predict 
theoretical  ̂values for a transformation temperature of 27°C, and 
for a purely aqueous system (Table 7.7). The k value has been 
shown to be directly related to the partition coefficient P by 
Equation 7.3, and so the k values in Table 7.7 represent the relative 
lipid solubility of the benzodiazepine compounds. For the substrates 
temazepam, diazepam and medazepam a direct correlation was found 
between the k values (and hence the partition and lipid solubility) 
and the extent of their N-demethylation by C. bainieri (Figure 7.12).
It would have been desirable to have more data in support of this 
evidence, but unfortunately there were no other compounds available 
for study. As expected, chlordiazepoxide, a secondary amine, and 
flurazepam, with its long N-alkyl substituent, did not fit the 
correlation.
The relationship in Figure 7.12 provides evidence that N-dem- 
ethylation by C. bainieri was related to the partition coefficient, 
a property of the drug molecule as a whole. Temazepam, diazepam an 
medazepam differ only in the functional groups attached to diazepine 

















Column capacity ratio (k)
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Figure 7.12. Relationship between N-demethylation yield of 
temazepam A , diazepam #  and medazepam H  
by C. bainieri at pH 7,0, and.column capacity ratio 
(k) obtained at 27 c (A) and 0% organic modifier
(B) .
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or substituents to the overall P value from the chromatographic
data^^^. Functional group contributions towards retention was
defined earlier in Equation 1.12 as t = log ) where
K. is column capacity ratio of the unsubstituted or parent solute
and K . is the column capacity ratio for the substituted solute.
Substituting the retention data for temazepam, diazepam and
medazepam into Equation 1.12 gave t values of -0.69 for the
carbonyl group (diazepam compared to medazepam) and -0.99 for the
further addition of the hydroxyl group (temazepam compared to
medazepam).'The difference in these values represents the
contribution of the hydroxyl group (-0.30) which is similar to
the values of -0.3 and -0.45 for 3-hydroxy and 4-hydroxy substituted
193benzoic acids respectively . The ranges of published x values 
depends upon the chromatographic conditions used, especially the 
percentage carbon loading of the column packing material, so that 
values are most useful for a given solute series under identical 
chromatographic conditions. However, even with such a small series 
of solutes the principle of this approach is clearly demonstrated, 
and the compilation of further values would be of benefit as indices 
of hydrophobicity for relating the physico-chemical properties of 








18Previous workers at Bath have demonstrated that several 
species of the fungus Cunninghamella are capable of N-demethylating 
codeine and other drug molecules containing N-methyl functions.
This reaction, which may be difficult to achieve by chemical methods, 
is often used in the synthesis of drug intermediates. The aim of 
this project was to make further developments in this field, and in 
particular, to apply analytical techniques such as HPLC, UV and NMR 
to overcome some of the problems encountered in transformation 
studies.
Initial investigations were concerned with the development of 
HPLC methods for the routine analysis of transformation mixtures.
This was to replace the time consuming GLC procedures employed by 
Sewell^^, which required extraction and derivatisation of the samples 
Both straight phase and reversed phase HPLC procedures were 
developed for the separation and quantitative determination of a 
model compound, codeine, and its N-demethylated transformation 
product, norcodeine. The straight phase HPLC separation on a 
Partisil 5 ym silica, column (A) was initially achieved by TLC to 
reduce time and solvent usage. This procedure was justified 
by demonstrating that there was a direct correlation between the 
TLC retention of codeine and its congeners, and their HPLC 
retention (Figure 2.16, page 114 ). The straight phase Partisil 
5 ym HPLC assay of codeine and norcodeine produced excellent
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linear regression results (Table 2.6), but suffered from the dis­
advantage that the drugs still had to be extracted from the trans­
formation media prior to analysis. This problem was partially over­
come by employing a Partisil-lO-ODS reversed phase HPLC column 
(B) to analyse codeine and norcodeine in the transformation media 
directly. It was not possible to use an internal standard procedure 
because the large solvent front of the transformation samples 
tended to obliterate the standard peak. Instead an external standard 
procedure was employed. A more sensitive HPLC assay employing an 
ODS-Hypersil 5 ym column (C) was developed for enzyme kinetic 
studies. An important modification to this assay was the inclusion 
of a pairing ion, pentane sulphonic acid, to enhance the retentions 
of the solutes, avoiding any interferences from the solvent front.
The recovery and isolation of codeine and norcodeine from 7 
litre batch cultures of transformation media was achieved by a two- 
stage procedure. In the first stage, various non-ionic resins 
and reversed phase materials were investigated to determine the 
optimum conditions for the adsorption and desorption of the drugs 
from fermentation media prior to their separation, by preparative 
HPLC. Amberlite XAD-4 resin was found to be the most suitable, and 
a column containing 100 g of resin was capable of extracting up 
to 100 mg of combined codeine and norcodeine in 250 ml of trans­
formation media with extraction efficiencies of 85.8% and 98.5% 
respectively. In the second state of the extraction procedure, 
straight phase and reversed phase modes of preparative HPLC were 
compared for their loading and separation capabilities. The reversed 
phase method provided a superior throughput and loading capacity
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which was only limited by the solubility of the drugs in the mobile 
phase. However, a disadvantage of this procedure was the necessity 
for a further extraction step to recover the drugs from the aqueous 
mobile phase. Overall it would probably be more economical in 
long term use compared to the straight phase system, as it employs 
a relatively simple and cheap mobile phase, and was found in practice 
to provide longer service without the need for regeneration or 
repacking.
In growth media development studies Cunninghmaella bainieri 
(043) demonstrated the ability to grow satisfactorily in chemically 
defined media containing glucose, succinate or tetradecane carbon 
sources. Over the initial 6-7 days of incubation the rate of
growth similar on all carbon sources, but after this period
the glucose cultures easily attained the highest biomass. The 
reduction in growth rate of tetradecane cultures after 8-10 days 
incubation was attributed to cellular metabolism of lipids as 
the carbon source was depleted from the medium. Furthermore, 
cultures grown on glucose exhibited significant codeine N-demethyl­
ation only after the carbon source in the medium was depleted.
This was thought to be due to cataboliterepression, and was not 
evident with cultures grown on tetradecane. A possible explanation 
for this was the rate limiting mass transfer of alkane in to the 
aqueous media. High specific transformations obtained with 
tetradecane cultures compared to glucose cultures suggested that 
tetradecane was a good inducer of the N-demethylase in C. bainieri, 
Increasing the codeine concentrations in the transformation mixture 
above 0*2 mM significantly reduced the level of codeine N-demethylation
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for cultures grown on all the carbon sources. However, the microbial 
growth appeared to be unaffected by codeine phosphate concentrations 
up to 8 mM, therefore this observation was attributed to substrate 
inhibition of the N-demethylase by codeine.
A satisfactory procedure was developed to facilitate the
preparation of a cell-free extract from Cunninghamella with a
degree of N-demethylase activity far superior to that obtained
18by Sewell's original method . The requirement of a surfactant,
Triton XlOO, in the extraction procedure, suggested that the N- 
demethylase was membrane bound. However, the N-demethylase activity 
of extracts decreased with Triton XlOO concentrations above 0.5% 
v/v, and a concentration of 0.33% v/v was found to be optimal.
Futther attempts to enhance the N-demethylase activity of the cell- 
free extract by dialysis, or by a calcium chloride precipitation 
technique, proved unsuccessful or impracticable. It was demonstrated 
that formaldehyde generated from the incubation of codeine with 
cell-free extracts arose from N-demethylation of the codeine sub­
strate. The amount of codeine N-demethylated by cell-free extracts 
of C. bainieri increased with codeine concentration up to a con­
centration of 3 mM in the incubation mixture. The activity of cell- 
free extracts was also increased independently by the addition of 
the co-factors Fê "*", NADH and NADPH. However, there was no pref­
erence of the system for NADPH rather than NADH, but there was a 
perceptible synergistic effect observed by adding NADPH and NADH 
together. It was demonstrated that codeine N-demethylation was 
limited by the availability of endogenous cofactors utilised in 
the reaction by C. bainieri and not replenished.
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Cell-free extracts stored at 4°C, in a nitrogen atmosphere, 
retained a satisfactory degree of N-demethylase activity over the 
period of time required for subsequent studies. The presence of 
a maximum absorbance in the 450 nm region of the UV carbon-monoxide 
reduced difference spectrum provided strong evidence that the N- 
demethylase from C. bainieri was a Cytochrome type P-450 mono­
oxygenase. Enzyme activity of cell-free extracts from C. bainieri 
was estimated in terms of codeine N-demethylation using the ODS- 
Hypersil HPLC assay to determine the transformation product, 
norcodeine. This technique was used to determine apparent Michaelis 
constants and maximum velocity (V) values for the N-demethyl­
ation of codeine and codeine N-oxide substrates. Data from the 
kinetic studies implied that codeine N-oxide was not an intermediate 
in the N-demethylation of codeine by C. bainieri. Further evidence 
to substantiate this view was obtained from investigations on the 
effect of selected enzyme inducers and enzyme inhibitors on the 
same transformations. Codeine N-oxide was found to be a less 
effective inducer than codeine phosphate or codeine base. Codeine 
N-demethylation was inhibited by carbon monoxide and SKF 525A 
typical of cytochrome P-450. However, potassium cyanide produced 
no significant inhibition of codeine or codeine N-oxide N-demeth­
ylation, and codeine, as well as norcodeine, was detected in 
the codeine N-oxide reaction mixture. On the basis of these data 
it was proposed that codeine N-demethylation by C. bainieri occurred 
via a-C oxidation rather than N-oxidation, to produce a carbino- 
1amine intermediate. However, this would be difficult to confirm 
as the carbinolamine is unstable, and hence transient, decomposing 
to norcodeine and formaldehyde.
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An elaborate spectroscopic technique was developed to
detect the possible intermediates in the N-demethylation of codeine. 
Codeine ^N-Me-^^cJ HCl was N-demethylated in the NMR tube by 
cell-free extracts of C. bainieri to give norcodeine and ^^C 
labelled formaldehyde. The labelled formaldehyde liberated was 
trapped with sodium sulphite and the sulphite adduct, as well as 
intermediates were located in the NMR spectrum. Codeine N-demethyl- 
ation was observed at a variety of selected temperatures from 5 to 
40°C. Intermediate resonances assignable to codeine N-oxide were 
not detected in any of these enzyme transformation studies, and a 
methine signal was not observed in the OFR spectrum. However, a 
resonance signal was observed, occurring at all the temperatures 
studied, which corresponded to a possible intermediate. This 
signal was a triplet in the OFR spectrum implicating a methylene 
group (CHg) and was tentatively identified as the N-(hydroxymethyl) 
group of a possible codeine carbinolamine intermediate. These 
results were consistent with the previous kinetic data, and provided 
further evidence regarding the mechanism of codeine N-demethylation 
by C. bainieri.
The dependence of microbial N-dealkylation o n substrate 
lipophilicity was examined by determining the column capacity 
ratios (k ) of a selected group of 1,4-benzodiazepines, and 
plotting these values against the microbial transformation yields 
obtained over a fixed incubation period with growing cells of C. 
bainieri. However, chlordiazepoxide was not N-demethylated, but 
a transformation product was observed in high yield which was
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tentatively identified as a carbinolamine, possibly stabilised by 
intra-molecular hydrogen bonding. Flurazepam was transformed 
to various products, including one which corresponded to the 
desalkylflurazepam reference standard, indicating cleavage of the 
N-(diethylamino)ethyl function. Of the benzodiazepines with N- 
methyl functions, temazepam, diazepam and medazepam, N-demethylation 
was effected in yields of 3%, 12% and 26% respectively . These 
transformation yields were directly proportional to the predicted 
K values (see Figure 7. 12, page 302 ), and suggested that microbial 
N-dealkylation was affected more readily as the lipophilic character 
of the substrate was increased.
8.2 Suggestions for future work
The present studies have been mainly concerned with the develop­
ment of analytical techniques which were applied to study the micro­
bial transformation of a model compound codeine. These techniques 
should be utilised in future studies to examine alternative trans­
formation systems. For example, to scale up the transformation 
of a selected benzodiazepine compound, and to employ the Amberlite 
resin/preparative HPLC extraction procedure with slight modifications 
to isolate the products. This would be of value in the preparation 
of reference metabolites, and the laboratory scale preparation 
of nor-intermediates of drug compounds which may be difficult to 
obtain by chemical procedures. The NMR spectroscopic technique, 
described in Chapter 6 of this thesis, should also be employed 
to detect possible intermediates in the N-dealkylation of alternative
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13drag molecules. The substrate would have to be C enriched, and 
if not available commercially, would have to be synthesised from 
its nor-intermediate compound. Again, preparative HPLC could be 
utilized to isolate enough nor-intermediate from a microbial trans­
formation mixture to do this. Data from these NMR studies may 
provide a more complete picture concerning the mechanism of microbial 
N-dealkylation of drugs.
The induction of Cunninghamella sp. was shown to be severely 
catabolite repressed by the presence of carbohydrates, such as 
glucose, in the medium. Repression was not apparent when a 
tetradecane carbon source was employed, and the results demon­
strated that tetradecane was in fact a good inducer of the 
N-demethylase enzyme. Therefore, in future experiments, catabolite 
repression may be avoided by growing the cultures initially on 
glucose to achieve a high cell-mass quickly and when this has been 
achieved, the glucose should be made limiting and a tetradecane 
inducer added. In this way, maintenance energy for the duration 
of the transformation period will be provided in the form of the 
alkane.
Codeine N-demethylation by C. bainieri was demonstrated to
be limited by the availability of endogenous co-factors (NADH,
NADPH) in the incubation mixture (Chapter 4, page 183). Although
this may be overcome by incorporating a co-factor regeneration 
189system to enhance the transformation it is doubtful if this 
would be viable on a larger scale of study. For example, it may be
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possible to use the formaldehyde liberated from N-demethylation as 
a potential source of reducing equivalents for co-factor regener­
ation. A possible alternative solution to this, and to the problems 
previously discussed, may be to immobilise the microbial cells
on an inert support. - Whole cell; immobilization may overcome
188the problem of co-factor provision ; and offers further advantages
which include the regeneration and reuse of cells; a greatly
increased catalyst density, increased cell stability and lower
188risks of contamination from other microorganisms . It would 
avoid the requirements of an enzyme extraction procedure, and cata­
bolite repression and substrate inhibition could be avoided.
194Preliminary studies by Hubble showed that the cells of C.
echinulata could easily be immobilised onto calcium alginate gel.
However, the N-demethylation of codeine phosphate was unsuccessful
because the phosphate caused dissolution of the gel entrapment
matrix. Other workers with immobilised systems have had more success.
190For example, Schubert et al. managed to entrap an active micro­
somal P-450 system in calcium alginate which was capable of N-
191demethylating aminopyrene and ethylmorphine. Also Yamamoto et al. 
immobilised the cells of Pseudomonas putida ATCC 4359 on a poly­
acrylamide gel lattice to provide the continuous production of 
oL-citrulline at 37 C for 1 month. Future studies should investigate 
the possibility of using alternative support materials for the 
immobilization of whole cells of Cunninghamella. Inert materials 
such as polyacrylamide gels, collagen dispersions or polymeric 
metal hydroxide gels could be investigated. A system may be 
developed for the transformation of the model compound codeine 
and also for selected benzodiazepines.
313
It has already been suggested that the NMR studies should
be continued with other drug molecules containing enriched
N-methyl groups. These data could be supported by transformation
14studies with substrates labelled with C, both in the N-methyl 
group, and also in the nucleus of the molecule. In this way the 
fate of the formaldehyde liberated during microbial N-demethylation 
could be investigated. For example, subsequent analysis of the 
various cell fractions may reveal the ability of the cell to 
assimilate formaldehyde from N-dealkylation in a possible detoxi­
fication mechanism. It may also be possible to determine the 
actual site of N-demethylation in the microbial cell with the 
aid of the radiolabelled precursors.
The results of the benzodiazepine structure-activity study 
suggested there was a direct relationship between substrate 
lipophilicity and N-demethylation by C. bainieri. Further studies 
should be performed with other substituted benzodiazepines to 
confirm this correlation. The structures of compounds suggested 
for further study are illustrated in Figure 8.1
Figure 8.1 Structures of 1,4-benzodiazepines for further study 
(For table see page 314)
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Figure 8.1 Structures of 1,4-benzodiazepines for further study 
(cent.)
«2 *3
MethyIbromaz epam Br CH3 Pyridyl H
Methyl nitrazepam NOg CH3 «2 H




Prazepam Cl «2 H
Further studies should be performed to confirm the identity of 
the chlordiazepoxide transformation product (A) described in 
Chapter 7. Preparative HPLC could be employed to isolate Product 
A for further analysis and identification. If product A is the 
carbinolamine suggested, it should be further investigated for 
possible cytotoxic properties.
An alternative approach to improve the microbial transformation
of polar substrates with ionizable groups might be to react the
drug with an ion pair of opposite charge. Since upon ion pairing
the ionized substrate tends towards electrical neutrality it
will have greater lipoidal solubility. The use of ion pairs to
improve the biological absorption of ionized molecules has been
192proposed by other workers. For example, Tomlinson has shown 
that the penetration of anhydrocarbonaceous polyamide 5 membrane 
by sodium cromoglyate was enhanced substantially by the presence of
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an organic ion of opposite electrical charge. This idea should 
t>e pursued in an attempt to improve the transformation yield of 
compounds such as codeine phosphate or chlordiazepoxide. HCl. 
Initial experiments should be concerned with employing a relatively 
small ion-pair reagent e.g. C^or C^, and the effect of the size of 
the carbon chain of the pairing ion on microbial transformation 
might then be investigated.
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